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ABSTRACT

MECHANISMS OF SORTING AND TRAFFICKING FOR MELANOSOME
BIOGENESIS AS REVEALED BY STUDIES OF THE HUMAN PIGMENT CELL
PROTEIN OCA2

Anand Sitaram
Advisor: Michael S. Marks, Ph.D.

Certain cell types harbor specialized lysosome-related organelles (LROs) that derive from
the endocytic system like conventional lysosomes but have unique functions. The
coexistence of LROs and lysosomes in some cell types implies the existence of sorting
mechanisms that divert resident cargo proteins to LROs. Based on the pigmentsynthesizing melanosome in melanocytes as a model LRO and two melanosomal resident
proteins as model cargoes, current models suggest that cargoes are sorted from early
endosomes to melanosomes via one of two independent pathways mediated by the
multisubunit complexes AP-3 or BLOC-1, each of which is defective in subtypes of the
LRO biogenesis disease Hermansky-Pudlak Syndrome (HPS). An AP-3-related protein
complex, AP-1, is thought to function in concert with BLOC-1. In this thesis, I assess the
pigment-cell-specific putative transporter protein OCA2, as a third potential cargo protein
with which to further dissect the relationships between AP-3, AP-1 and BLOC-1 in
melanosomal transport. I first investigate the localization and site of action of OCA2. I
iv

use biochemical approaches in combination with site-directed mutagenesis and indirect
immunofluorescence microscopic analysis of exogenously-expressed OCA2 in
melanocytes to show that OCA2 is indeed a melanosome resident protein and does not
function within the endoplasmic reticulum as has been suggested by other models. I show
that melanosome localization is essential for OCA2 function and requires an acidic
dileucine motif in the N-terminal cytoplasmic domain that can bind to both AP-3 and AP1. Using site-directed mutagenesis in combination with yeast three hybrid assays and
immunofluorescence microscopy analyses in melanocytes derived from mouse models of
HPS and controls, I define the features of the OCA2 sorting signal that direct binding to
AP-1 or AP-3 and show that OCA2 requires both AP-3 interaction and BLOC-1 for
melanosomal localization. My results resolve a controversy regarding OCA2 localization,
shed light on the interplay between AP-1 and AP-3 in melanosomal trafficking, and
provide the first direct evidence for cooperation between BLOC-1 and AP-3 in trafficking
to a LRO.
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CHAPTER 1. INTRODUCTION
1.1 Context of the presented work
The human body is composed of many different systems of organs, each specialized to
perform particular functions for the benefit of the whole organism. The individual cells of
the body too harbor several different types of internal organelles, each specialized for
particular functions within the cell. Some of these organelles perform essential cellular
functions and are common to the vast majority of the hundreds of different cell types,
while other organelles are found only in restricted cell types and allow these cells to carry
out their novel activities. The function of an organelle is directly dependent on the cohort
of proteins that are localized to it, and thus it is essential for cells to have mechanisms in
place to ensure delivery of these resident proteins to the appropriate organelles.

Integral membrane proteins, for example, are synthesized from ribosomes that are docked
at the endoplasmic reticulum. Following their synthesis in the endoplasmic reticulum,
most proteins must be trafficked either to the cell surface for plasma membrane
expression or secretion, or to other intracellular organelles. The existence of several
different cellular organelles underscores the need for a sorting system that identifies the
correct destination for an integral membrane protein and engages cellular machinery to
deliver it there. Numerous studies have identified cis-acting signals encoded within cargo
proteins as well as trans-acting proteins that recognize these determinants and can
segregate cargo proteins into directed trafficking routes towards their destinations.
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Failure of these processes can lead to organellar, cellular, and ultimately organic
dysfunction, and thus ultimately to disease.

In order to better understand how cells direct protein sorting, we have chosen to focus on
the sorting of cell type-specific integral membrane proteins to a group of organelles
called lysosome-related organelles (LROs), and more specifically to the pigmentproducing melanosome – a LRO within pigmented cells such as the melanocytes of the
skin, hair bulb, and choroid, and the pigmented epithelial tissues of the eye. Lack of
melanosome function causes the hypopigmentation disorder known as albinism, and
albinism-associated mutations are found in several genes that encode proteins that direct
cargo protein trafficking to the melanosome. Studies of the localization of melanosomal
cargo proteins in melanocytic cells that are deficient in some of these trafficking genes
have helped us assemble a model of pathways by which cargoes are delivered to
melanosomes. However, gaps in our understanding of the relationship between these
trafficking proteins and how they function within their respective pathways still remain.

In this thesis I focus on the melanocytic protein OCA2, whose trafficking has not been
previously characterized. I first resolve a debate in the literature regarding the steadystate localization and site of function of this protein by showing that it localizes to the
melanosome and that mutant forms that remain in the endoplasmic reticulum or
mislocalize to the cell surface are non-functional, reaffirming the important link between
proper protein localization and function. I also identify critical cis and trans determinants
of the melanosomal sorting of OCA2. I then proceed to use OCA2 as a model
2

melanosomal cargo to probe current models of melanosomal trafficking. I provide new
evidence for a previously undescribed pathway that is dependent on two trans-acting
protein complexes which had been previously thought to act independently. Our work
therefore sheds light on both the trafficking of an individual lysosome-related organelle
cargo protein as well as on the variety of mechanisms that cells utilize to send different
cargo proteins to the same organelle.

In order to put the work into context, this introduction will define lysosome-related
organelles and describe melanocytes and their melanosomes as model lysosome-related
organelles in greater detail. I then discuss the melanocytic proteins that are critical for
melanosome biogenesis, our current understanding of the mechanisms used for their
trafficking within cells, and how these mechanisms are disrupted in disease. Finally I
introduce the melanocytic protein OCA2 and describe what was known about the protein
prior to the work described in this thesis as well as the questions about its trafficking that
I wished to address with this body of work.

1.2 Lysosome-related organelles
Lysosome-related organelles (LROs) are a class of intracellular membrane-bound
organelles found only in certain cell types (Dell'Angelica et al., 2000; Raposo et al.,
2007). They are so named because they share some features in common with
conventional lysosomes, the cellular degradative compartment. Like lysosomes, LROs
are derived from the endocytic system, they have an acidic lumenal pH, and they can
contain a cohort of lysosomal resident proteins such as LAMPs (Lysosome-Associated
3

Membrane Proteins) or acid hydrolases. However, LROs are distinguished from
conventional lysosomes by their ability to carry out additional cell-type-specific functions
and by their unique morphologies. LROs are found in diverse tissues and include:
melanosomes in skin and choroidal melanocytes and the pigment epithelium of the retina,
iris, and ciliary body; dense granules in platelets; lamellar bodies in alveolar epithelial
cells; and secretory compartments of hematopoietic cells, including the lytic granules of
cytotoxic T cells and natural killer cells, several types of granules in basophils,
azurophils, and eosinophils, and the major histocompatibility class II compartments
(MIICs) in antigen presenting cells. The diverse morphologies and functions of these
LROs are reflections of the distinct cell-type specific resident proteins they harbor. Some
LROs, such as the cytotoxic T cell lytic granules, are considered modified lysosomes,
carrying out the degradative function in addition to their novel immune function
(Burkhardt et al., 1990; Peters et al., 1991). However a subset of LROs, including
melanosomes and platelet dense granules, are found to simultaneously coexist in cells
with conventional lysosomes, which implies that cells harboring this class of LROs must
make use of specialized sorting pathways to segregate LRO resident components away
from the general lysosomal delivery pathway and redirect them towards LROs (Raposo et
al., 2007). Indeed, melanosomes in melanocytic cells are inaccessible to fluid-phase
uptake markers, in contrast to the lysosomes (Fujita et al., 2001; Raposo et al., 2001), and
melanosomes of immortalized mouse melanocytes are relatively devoid of the lysosomal
marker protein LAMP-2 (Setty et al., 2008; Sitaram et al., 2009). While many of the
proteins that are involved in these segregating processes have been identified,
determining how they function and interact remains an active area of research.
4

Melanocytes constitute a model system that is widely used to study mechanisms of LRO
trafficking, and thus the following section will discuss melanocytes and melanosomes in
more detail.

1.3 Melanocytes and melanosomes - a model of LRO biogenesis
1.3.1 Melanocytes and albinism
Melanocytes are specialized cells that produce melanin pigments found in fish, mammals,
and other vertebrates (Seiji et al., 1963; Marks and Seabra, 2001; Raposo and Marks,
2007). In humans, these cells produce the melanin that serves an important lightabsorbing function in tissues of the inner eye and gives color and ultraviolet protection to
the skin, hair, and eyes. Defects in the biogenesis of melanosomes lead to the
hypopigmentation phenotype known as albinism (King, 1998). All types of albinism
include phenotypes in the eye (Summers, 2009). Lack of functional melanosomes in the
eye tissues causes poor vision and iris transillumination. For reasons that are not
completely understood, patients also demonstrate defects in the development of the visual
system, including foveal hypoplasia as well as misrouting of optic axons (Guillery et al.,
1975), which may underlie the elevated incidence of nystagmus and strabismus seen in
these patients. There are four types of oculocutaneous albinism (OCA), in which the eye
phenotypes are seen in conjunction with mild to severe hypopigmentation of the skin and
hair (King, 1998) (Figure 1.1). OCA patients have an increased risk of skin cancer due to
the deficiency of UV-protective melanin. The OCA subtypes are all recessive and linked
to different pigment-cell-specific genes important for melanin synthesis or melanosome
biogenesis. A distinct disease, X-linked ocular albinism, is caused by mutations in
5

Figure 1.1

Figure 1.1. Examples of human oculocutaneous albinism.
a) A Brazilian family with two children with normal pigmentation and three children
suffering from a form of oculocutaneous albinism.1 b) A Turkish man suffering from
oculocutaneous albinism type 4. Inset: a photo of the man as a youth.2

1

Reprinted with permission from Reuters.
Reprinted from The American Journal of Human Genetics, Vol. 69, Newton et al.,
Mutations in the Human Orthologue of the Mouse underwhite Gene (uw) Underlie a New
Form of Oculocutaneous Albinism, OCA4, p. 981–988, Copyright 2001, with permission
from Elsevier.
6
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GPR143 (also known as OA1), which encodes an unusual intracellular G protein coupled
receptor of unknown function (Schiaffino et al., 1999). No clinical skin phenotype is
observed in X-linked ocular albinism, although ultrastructural examination shows the
presence of enlarged melanosomes in pigment cells from skin and eyes (O'Donnell et al.,
1976; Cortese et al., 2005).

1.3.2 Melanin synthesis
The range of skin and eye coloration observed in humans can be attributed to differing
levels of two types of melanins, eumelanins and pheomelanins. Eumelanins are
responsible for black and brown pigmentation, whereas pheomelanins produce red and
yellow hues. All melanins are non-protein polymers of modified tyrosine subunits
(Figure 1.2a). The rate-limiting initial step in the synthesis of all types of melanin is
catalyzed by the pigment-cell-specific protein tyrosinase (Tyr). Mutations in the TYR
gene cause OCA type 1, the most common form of OCA in non-Hispanic Caucasians
(Hutton and Spritz, 2008). As Tyr is needed for all melanin synthesis, the most severe
OCA1 phenotype is a complete lack of pigment, leading to white hair and pale skin. The
increased visibility of blood vessels in the eyes causes them to appear pink. The same
phenotype is seen in the corresponding albino model mouse, mutated in Tyr, which maps
to the c locus (King, 1998). Tyr is a copper-dependent enzyme (Oetting et al., 2003) that
catalyzes the hydroxylation of tyrosine to L-DOPA and the further oxidation of L-DOPA
to dopaquinone. A series of subsequent oxidation and isomerization steps produces
colored indoles and finally a mixture of black and brown eumelanins. Tyr is the only
7

Figure 1.2

Figure 1.2. Melanin synthesis and melanosome maturation.
a) Eumelanin is a brown-black mixture of polymers of oxidized and cyclized tyrosine
subunits. The enzymes tyrosinase (TYR), tyrosinase-related protein (TYRP1), and
dopachrome tautomerase (DCT) catalyze the indicated steps of melanin synthesis within
the melanosome lumen. Integral membrane proteins including OCA2, SLC45A2, and
SLC24A5 are thought to bring about the lumenal conditions needed for melanin synthesis
(Braasch et al., 2007). b) Melanosome maturation progresses through four
morphologically distinct stages, as shown in an electron micrograph from a human
melanoma cell line. Stage II melanosomes are characterized by fibrils containing PMEL.
Delivery of Tyr and Tyrp1 to immature melanosomes initiates melanin synthesis and
progression to Stages III and IV (Raposo and Marks, 2002).
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melanocyte-specific protein needed for melanogenesis, as heterologous expression in
non-melanocytes is sufficient to induce melanin formation (Bouchard et al., 1989a; NiKomatsu and Orlow, 2006).

In melanocytes, two other enzymes can influence the mixture of eumelanins that are
produced. Dopachrome tautomerase (DCT, also known as tyrosinase-related protein 2)
can prevent auto-oxidation of dopachrome (an intermediate downstream of dopaquinone)
to the colored indole intermediate 5,6-dihydroxyindole and instead convert it into the 5,6dihydroxyindole-2-carboxylic acid, leading to different eumelanin products (Aroca et al.,
1990; Pawelek, 1991; Orlow et al., 1992). Mutations in Dct underlie the
hypopigmentation phenotype of the slaty mouse (Jackson et al., 1992; Tsukamoto et al.,
1992). Tyrosinase-related protein 1 (Tyrp1) can also influence the ratio of black and
brown eumelanins produced, as demonstrated by the corresponding brown mutant mouse
(Jackson, 1988). Tyrp1 has been proposed to catalyze the oxidation of DHICA, but this
hypothesis is controversial (Sarangarajan and Boissy, 2001). Nevertheless, Tyrp1 is
clearly important in melanosome function, as mutations in TYRP1 cause the more rare
OCA type 3 (Boissy et al., 1996; Manga et al., 1997). OCA type 3 has mostly been
studied in people of African descent and is sometimes called rufous albinism, due to the
yellowish or reddish hair seen in affected patients (Kromberg et al., 1990).

If sufficient cysteine is present, dopaquinone can be modified to cysteinyl L-DOPA, and
the resulting synthesis product is reddish-yellow pheomelanin rather than eumelanin. At
any given time, melanocytes produce primarily one type of melanin or the other; the
9

alternation between eumelanin production and pheomelanin production within a single
hair shaft produces the agouti banding pattern that gives the characteristic brushed
appearance to many mammalian coats (Robbins et al., 1993; Cone et al., 1996). The
choice of pigment to synthesize is regulated by a signal transduction pathway activated
by the binding of alpha melanocyte-stimulating hormone (alpha-MSH) to the
melanocortin-1 receptor (MC1R), the target of the murine extension locus e, on the
melanocyte surface (Geschwind, 1966; Tamate and Takeuchi, 1984). MC1R signaling via
alpha-MSH stimulation leads to the induction of eumelanogenesis. The agouti signaling
peptide, encoded by ASIP (Kwon et al., 1994; Wilson et al., 1995), is an inverse agonist
of MC1R, and its activity induces pheomelanogenesis (Lu et al., 1994). Mutations in
either POMC (Krude et al., 1998)—the gene that encodes the polyprotein that is
proteolytically processed to produce alpha-MSH—or MC1R (Valverde et al., 1995) are
associated with red-haired phenotypes as a consequence of the inactivation of the
eumelanogenesis initiation pathway. Conversely, the widely-used inbred mouse model
C57BL/6 is black because of a homozygous inactivation of the a locus, the murine
homolog of ASIP (Silvers, 1979; Bultman et al., 1992; Kwon et al., 1994). Initiation of
pheomelanogenesis causes the downregulation of several proteins crucial for
eumelanogenesis. These include Tyrp1, DCT, PMEL, and the putative transporter
OCA2, discussed in more detail below (Barber et al., 1985; Lamoreux et al., 1986;
Thody and Burchill, 1992; Kobayashi et al., 1995; Lamoreux et al., 1995; Hirobe et al.,
2011). As the vast majority of studies on melanosome biogenesis have focused on
eumelanosomes and eumelanogenesis, pheomelanin will not be discussed further. For the

10

remainder of this thesis, references to melanosomes should be understood to refer to
eumelanosomes.

1.3.3 Melanosome biogenesis and maturation
Melanin synthesis occurs within the lumen of the membrane-bound melanosome, the
melanocytic LRO. Melanosome biogenesis is considered to occur in four stages,
distinguishable on the basis of morphology and visualized by electron microscopy (Seiji
et al., 1963) (Figure 1.2b). A stage I melanosome is identified morphologically and
functionally as a coated vacuolar domain of an early endosome (Raposo et al., 2001). A
portion of the organelle is coated by cytoplasmic clathrin, and a few intralumenal vesicles
are visible. In this regard, a stage I melanosome resembles the classical vacuolar early
endosome from which multi-vesicular body formation is initiated (Hopkins and
Trowbridge, 1983). However, what distinguishes stage I melanosomes from typical
multivesicular early endosomes is the presence of proto-fibrils that radiate from the
surface of the intralumenal vesicles (Hurbain et al., 2008). These proto-fibrils are
composed primarily of proteolytically-cleaved lumenal fragments of the protein PMEL
(Berson et al., 2003). Continued polymerization produces the longitudinally-oriented
amyloid-like fibrillar sheets (Birbeck, 1963; Hurbain et al., 2008) that are characteristic
of a stage II melanosome (Seiji et al., 1963), a membrane-bound structure spatially and
compositionally distinct from the endosome. Melanin-synthesizing enzymes Tyr and
Tyrp1 and other proteins such as OCA2 and the copper transporter ATP7A are then
delivered to melanosomes (Seiji et al., 1963) from distinct domains of early endosomes
(Theos et al., 2005; Setty et al., 2007; Setty et al., 2008; Delevoye et al., 2009; Sitaram et
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al., 2009). Melanin synthesis is then initiated, giving rise to stage III melanosomes in
which the fibers appear darker and thicker due to the deposition of insoluble melanin
upon them (Seiji et al., 1963). As melanin synthesis continues, the internal fibril structure
becomes completely obscured, resulting in the black and fully melanized stage IV
melanosomes.

In skin melanocytes, which are situated at the basal epidermis, mature melanosomes are
trafficked to the cell periphery and transferred to neighboring keratinocytes in the
epidermis in a process that remains incompletely understood (Van Den Bossche et al.,
2006). The melanosomes in the keratinocytes are distributed in a protective cap that
shields the nucleus from UV exposure, and it is these melanosomes found in
keratinocytes that give humans their characteristic skin color. Interestingly, the racial
differences in skin color do not stem from different numbers of melanocytes (Staricco
and Pinkus, 1957); rather, melanocytes in people with darker skin seem to be more active
than melanocytes from people with lighter skin (Naeyaert et al., 1991; Iozumi et al.,
1993). More importantly, the distribution of melanosomes within host keratinocytes is
altered, such that melanosomes in Black keratinocytes are singly dispersed, while
melanosomes in Caucasian or Asian keratinocytes are clustered into bundles (Szabo et
al., 1969; Toda et al., 1972). Melanocytes in the skin and hair continually synthesize and
transfer their melanosomes to the neighboring keratinocytes, but in the pigmented tissues
of the eye, the melanosomal maturation process is thought to occur once during early
development, and then the melanosomes remain as permanent residents within the
pigment cell (Boissy, 1988). However, although temporally distinct, the molecular
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processes of melanosome biogenesis are thought to be the same in skin and eye pigment
cells.

1.3.4 Transporters that affect melanosome function
In addition to the melanosome contents outlined above, several additional pigment cellspecific proteins are known to be important for proper melanosome biogenesis and
function. Many of them are transporters. Mutations in the gene SLC45A2 cause OCA
type 4 (Newton et al., 2001) (Figure 1.1b), which is rare worldwide but common in Japan
(Inagaki et al., 2004; Inagaki et al., 2005), and the phenotypes in b medaka fish
(Fukamachi et al., 2001) and the underwhite mouse (Lehman et al., 2000; Newton et al.,
2001). The hypopigmentation in these models might be a consequence of defective
tyrosinase processing and trafficking (Costin et al., 2003). Surprisingly, the SLC45A2
protein (also known as Membrane-Associated Transport Protein or MATP, and Antigen
in Melanoma 1, or AIM-1) most closely resembles sucrose transporters in plants
(Fukamachi et al., 2001; Newton et al., 2001), yet humans do not express any known
sucrose transporters. Thus the potential transport substrate of SLC45A2 remains a
mystery. Another pigment cell-specific transporter, SLC24A5, is a K+-dependent
Na+/Ca2+ exchanger and is the most highly-expressed Na+/Ca2+ exchanger in melanocytes
(Ginger et al., 2008). The SLC24A5 homolog is mutated in the hypopigmented golden
zebrafish (Lamason et al., 2005), and the corresponding knockout mouse shows
hypopigmentation in the eye and skin (but surprisingly not in the coat) (Vogel et al.,
2008). Knockdown of SLC24A5 in a mouse melanoma cell line causes a reduction in
cellular melanin levels (Ginger et al., 2008). Single nucleotide polymorphisms in
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SLC45A2 and SLC24A5 are associated with normal human variations in skin, hair, and
eye color (Lamason et al., 2005; Sturm, 2006; Graf et al., 2007; Norton et al., 2007;
Branicki et al., 2008; Mengel-From et al., 2010), suggesting a critical modifying function
in melanogenesis.

Other more ubiquitously-expressed transporters are also thought to be critical for
regulating the function of melanosomes, in part by regulating lumenal pH (Fuller et al.,
2001). Melanosomes have long been considered to be acidic (Devi et al., 1987; Tripathi
et al., 1988; Bhatnagar et al., 1993), but the pH is not constant throughout melanosome
maturation. Acidification is necessary for proteolytic processing steps that generate
fibrillogenic fragments of PMEL (Berson et al., 2001), suggesting that early stage
melanosomes are likely acidic. Using quantitative immunoelectron microscopy to
quantify the accumulation of DAMP (which accumulates in acidic compartments in
proportion to acidity) in melanosomes and endosomal compartments of a human
melanoma cell line, Raposo et al. showed that early stage melanosomes are highly acidic,
but that melanosomes become less acidic as they mature (Raposo et al., 2001). Such
progressive alkalinization is likely necessary for melanization. Both human (Fuller et al.,
2001) and mouse tyrosinase (Saeki and Oikawa, 1983; Townsend et al., 1984) show
optimal function in vitro at a near-neutral pH, and melanin can form in neutral media into
which active Tyr is aberrantly secreted from mutant melanocytes (Potterf et al., 1998;
Manga and Orlow, 2001). Melanocytes from Caucasians appear to have lower tyrosinase
activity in situ and contain more acidic organelles than the more active melanocytes from
Blacks (Ancans et al., 2001b; Fuller et al., 2001), despite similar amounts of tyrosinase
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protein (Iozumi et al., 1993) and identical pH optima (Fuller et al., 2001) in both types of
melanocytes. Treatments that raise organellar pH stimulate tyrosinase activity in
Caucasian melanocytes without concomitant changes in tyrosinase abundance, but they
have little to no effect on Black melanocytes (Ancans et al., 2001b; Fuller et al., 2001).
Similar treatments cause human (Halaban et al., 2002) or murine melanoma cell lines to
become more pigmented, again without changes in tyrosinase protein levels (Saeki and
Oikawa, 1983; Oikawa et al., 1987; Ancans and Thody, 2000), and electron microscopy
confirmed that the induced melanin production takes place in previously immature
melanosomes (Saeki and Oikawa, 1983; Oikawa et al., 1987). These data indicate that
alkalinization is critical during progressive melanosome biogenesis in order to optimize
pigmentation.

How is acidity regulated during melanosome biogenesis? Inhibitors of the vacuolar
proton ATPase inhibit melanosome acidification (Bhatnagar and Ramalah, 1998; Ancans
et al., 2001b; Tabata et al., 2008) suggesting that this ubiquitous endosomal transporter is
necessary for acidification. However, since this complex is responsible for acidification
in the TGN and all endosomal compartments, its activity is likely regulated and/ or
complemented by other transporters. For example, treatments that inhibit Na+/H+
exchangers (NHEs) – transporters that are used by many cell types to regulate
intracellular and intraorganellar pH levels (Orlowski and Grinstein, 1997) - reduce the
tyrosinase activity of Black but not Caucasian melanocytes (Smith et al., 2004).
Expression analysis demonstrated that several NHE isoforms are expressed in Black and
Caucasian melanocytes and thus may normally act to bring the pH to the optimum level
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for tyrosinase activity (Sarangarajan et al., 2001; Smith et al., 2004). Since cytoplasmic
pH was not altered by the NHE inhibitor treatments, it was assumed that these NHE
proteins localize at the melanosome itself, in agreement with low-resolution indirect
immunofluorescence microscopy results (Smith et al., 2004). The regulation of
melanosomal pH probably also depends on other unidentified proteins, which likely
include some of the melanocyte-specific transporters discussed above and further below.

1.3.5 Transporter localization in melanocytes
Although the transporters described above influence melanosome function, it is not clear
whether these effects are direct – i.e. they regulate solute transport into or out of
melanosomes – or indirect by affecting precursor compartments, transport intermediates
from precursor compartments, or the cytosol. For example, melanocytes derived from
Slc45a2-deficient mice suggest that tyrosinase folding in the endoplasmic reticulum
might be defective (Costin et al., 2003), implying a potential indirect role for SLC45A2
in regulating the lumenal environment of the endoplasmic reticulum. Similar concerns
have been raised for OCA2, the topic of this thesis (see below). Indirect
immunofluorescence assays show that SLC24A5 partially localizes to the TGN and
partially to punctate structures that might represent melanosomes (Ginger et al., 2008).
Proteomic characterization of melanosome-containing fractions has led to proposals that
SLC45A2 and SLC24A5 are localized to melanosomes, but this has not been
conclusively demonstrated (Chi et al., 2006). Such a localization seems reasonable for
SLC24A5, as melanosomes are thought to store high amounts of calcium (Panessa and
Zadunaisky, 1981; Salceda and Sanchez-Chavez, 2000). Proteomics analyses of
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melanosome fractions have also identified several subunits of the vacuolar ATPase but
none of the NHE proteins (Basrur et al., 2003; Chi et al., 2006), although vacuolar
ATPase subunits and several NHE proteins have been suggested to be localized to the
melanosome by low-resolution indirect immunofluorescence microscopy (Smith et al.,
2004; Tabata et al., 2008).

In Chapter 2, I focus studies on the localization of another putative melanocyte
transporter, OCA2, for which localization and function in melanosome biogenesis have
been controversial. Before entertaining a discussion of what was known about OCA2
before I began my work, I will introduce known mechanisms by which melanosomes
acquire their protein contents.

1.4 Protein transport to melanosomes
As mentioned earlier, proper localization of proteins is critical for their ability to carry
out their functions. In order to generate functional melanosomes, melanosome contents
must be diverted within melanocytic cells from classical endocytic compartments, with
which melanosomes coexist. This is the main question addressed in this thesis.
Consequently, I will discuss below current models for melanosome protein delivery.

1.4.1 Biogenesis of and protein delivery to early stage melanosomes
The PMEL and GPR143 (OA1) proteins are known to localize to melanosomes but use
unusual sorting determinants for their trafficking. PMEL is the major component of the
internal fibrillar matrix of the melanosome lumen (Lee et al., 1996; Raposo et al., 2001).
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It is synthesized as an integral membrane protein that bears a C-terminal ER exit signal
with a critical valine residue and a conventional dileucine motif that serves as a signal
directing internalization from the plasma membrane. Disruption of these signals
underlies the defect in melanosomal sorting of PMEL in the silver mouse (Theos et al.,
2006a). Following endocytosis, PMEL is delivered to the intralumenal vesicles seen in
Stage I melanosomes (Berson et al., 2001). This internalization is required for the
proteolytic cleavage events that generate the fibrillogenic peptide of PMEL (Berson et
al., 2001; Berson et al., 2003). The sorting to the ILVs depends on a lumenal
determinant (Hoashi et al., 2006; Theos et al., 2006b) that overlaps with the fibrillogenic
determinant (Watt et al., 2009). Unlike most other proteins that are sorted to ILVs,
PMEL does not require ubiquitination or the activity of the ESCRT machinery for its
sorting (Theos et al., 2006b). It is on these ILVs that PMEL initiates fibril formation,
ultimately forming the fibrillar sheets that characterize stage II melanosomes (Hurbain et
al., 2008). While ILV formation and fibrillogenesis are initiated in stage I melanosomes
that are accessible to endocytic tracers, it is yet unknown how these compartments mature
into two distinct compartments – late endosomes and stage II melanosomes – with
distinct characteristics.

Two other components of early stage melanosomes are not limited to these compartments
but also present in other compartments within melanocytes. GPR143 localizes to late
endosomes, lysosomes, and melanosomes, especially early-stage melanosomes (Piccirillo
et al., 2006; Giordano et al., 2009), by virtue of the combined sorting activities of an
unusual dileucine motif and a tryptophan-glutamate doublet in the cytoplasmic C18

terminus of the protein (Piccirillo et al., 2006). These two signals are together necessary
and sufficient for lysosomal and melanosomal localization of the protein, but the
effectors that recognize these signals and effect GPR143 delivery are not known.
MART1 (also called melan-a) is an unusual small integral membrane protein with no
signal sequence. Like GPR143, MART1 localizes to multiple compartments, including
late endosomes and lysosomes, to which it is targeted by ubiquitylation and ESCRTdependent partitioning to lysosome-bound intralumenal vesicles (Levy et al., 2005; Theos
et al., 2006b). MART1 and GPR143 can be coimmunoprecipitated (Giordano et al.,
2009), and MART1 has also been suggested to associate with PMEL (Hoashi et al., 2005;
Giordano et al., 2009), but the consequences of these interactions are not known.

1.4.2 Trafficking of melanosomal proteins via the AP complexes
Once unpigmented stage II melanosomes are formed, they mature into pigmented stage
III and IV melanosomes by the delivery of melanogenic enzymes and transporters. This
set of melanosomal proteins is specifically sorted from endosomes towards Stage II
premelanosomes via the activity of more conventional sorting signals. These include Tyr
and Tyrp1 (Vijayasaradhi et al., 1995; Calvo et al., 1999; Simmen et al., 1999; Huizing
et al., 2001; Theos et al., 2005; Setty et al., 2007; Delevoye et al., 2009). Tyr and Tyrp1
are both type I single-pass transmembrane proteins with cytoplasmic acidic dileucine
sorting signals. These signals are short, linear peptide motifs in the cytoplasmic domains
of transmembrane proteins that have a consensus sequence of [D/E]XXXL[L/I]
(Bonifacino and Traub, 2003). Similar signals are found in a wide variety of
predominantly endosomal and lysosomal integral membrane proteins and often serve as
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independent, transferrable sorting signals for endocytosis and/or for subsequent
endosomal sorting. The acidic dileucine motif in the cytoplasmic domain of Tyr is
necessary and sufficient for protein localization to late endosomes and lysosomes in nonmelanocytes (Calvo et al., 1999; Simmen et al., 1999) and to synaptic vesicles in
neuronal cells (Blagoveshchenskaya et al., 1999), and is likely necessary for
melanosomal trafficking in melanocytes (Beermann et al., 1995). The Tyrp1 signal is
necessary and sufficient for targeting to intracellular compartments in melanocytic and
non-melanocytic cells (Winder et al., 1993; Vijayasaradhi et al., 1995).

Acidic dileucine signals effect protein sorting by binding to conserved sites on
heterotetrameric Adaptor Protein (AP) complexes. APs are a family of four related
complexes that have been extensively studied in their roles as soluble sorting adaptors
(Figure 1.3a). They are recruited to membranes, at least in part by binding to
phosphoinositides or other prevalent molecules (Gaidarov and Keen, 1999; Zhu et al.,
1999; Drake et al., 2000), and cluster integral membrane cargo proteins that contain AP
binding sites into coated membrane domains. AP-1, AP-2 and AP-3 also recruit clathrin,
and thus facilitate cargo incorporation into clathrin-coated vesicles that bud from these
domains at the trans-Golgi network, the cell surface, and endosomes (Boehm and
Bonifacino, 2001; Bonifacino and Traub, 2003; Robinson, 2004). Signal-bearing cargo
proteins are thus able to engage the vesicle trafficking machinery for directed sorting to
target membranes.
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Figure 1.3
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Figure 1.3. HPS-affected complexes and pigmentation phenotypes.
a) The AP complexes are a family of heterotetrameric soluble adaptors that are recruited
from the cytosol to membranes, where they bind signals in the cytoplasmic domains of
cargo proteins and cluster those proteins together for subsequent budding into transport
carriers (Dell'Angelica et al., 1999). b) The majority of genes affected in HermanskyPudlak Syndrome patients and mouse models encode subunits of five multisubunit
complexes: AP-3, HOPS, BLOC-1, BLOC-2, and BLOC-3. The color-coding indicates
the experimental basis for the interactions depicted between subunits. Subunits in red are
mutated in human subtypes of HPS. Subunits in yellow are mutated in additional mouse
models of HPS (Di Pietro and Dell'Angelica, 2005). c) The AP-3-deficient pearl
mouse—a model for HPS2—(bottom) is hypopigmented relative to a wild-type
C57BL/6J mouse (top) (Li et al., 2004). d) Mice deficient in each of the BLOCs show
varying degrees of hypopigmentation.3

3

Reprinted from Current Opinion in Cell Biology, Vol. 16, Dell’Angelica EC, The
building BLOC(k)s of lysosomes and related organelles, p. 458–464, Copyright 2004,
with permission from Elsevier.
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In melanocytes, AP-1, AP-2 and AP-3 have been implicated in cargo trafficking to
melanosomes. The signal in the Tyr cytoplasmic domain interacts with AP-1, AP-2, and
AP-3 in vitro (Honing et al., 1998; Theos et al., 2005; Chaudhuri et al., 2009). Tyr can be
localized to endosomal buds and tubules that are decorated with AP-1 or AP-3 (Honing et
al., 1998; Theos et al., 2005; Chaudhuri et al., 2009), and a significant cohort of Tyr is
mislocalized in melanocytes that are genetically deficient in AP-3 (Huizing et al., 2001;
Richmond et al., 2005; Theos et al., 2005). By contrast, the Tyrp1 sorting signal interacts
with AP-1 but not AP-3 in vitro (Theos et al., 2005) and Tyrp1 can be crosslinked to and
co-immunoprecipitated with AP-1 in melanoma cells (Delevoye et al., 2009).
Consistently, Tyrp1 is correctly localized to melanosomes in AP-3-deficient melanocytes
(Huizing et al., 2001; Setty et al., 2007). Melanocytes that are genetically deficient in
AP-1 are not available since the knockout is embryonic lethal in mice (Zizioli et al.,
1999; Meyer et al., 2000), but knockdown of AP-1 in a human melanoma cell line by
siRNA causes the majority of Tyrp1 to be mislocalized to vacuolar recycling endosomal
domains (Delevoye et al., 2009). AP-1 is also important for the peripheral positioning of
endosomes in melanocytes to appose melanosomes, since in the absence of AP-1
recycling endosomes are abnormally shifted to a perinuclear distribution. This is due to
the failure of endosomal recruitment of the AP-1 cargo and microtubule motor KIF13A.
AP-1 likely regulates the delivery of other cargoes to melanosomes, since its knock down
by siRNA leads to a reduction in cellular melanin content (Delevoye et al., 2009).
Finally, AP-2 has been implicated in enhancing the delivery of PMEL to endosomal
compartments in melanocytes (Robila et al., 2008), likely by interacting with the
previously-mentioned acidic dileucine signal in its cytoplasmic domain (Theos et al.,
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2006a). From these results it is clear that dileucine motifs and AP complexes play a
major role in melanosomal trafficking.

An additional pigment cell-specific protein, OCA2, also bears a putative acidic dileucine
motif (Lee et al., 1995), but the trafficking of this protein—before the beginning of this
thesis—had not been characterized. OCA2 trafficking will be discussed extensively
below.

1.5 Diseases of melanosome biogenesis and trafficking
As mentioned previously, melanosomes and some other LROs coexist with conventional
lysosomes in their host cells (Raposo et al., 2007), suggesting that specialized sorting
pathways are used to segregate LRO cargo from the lysosomal pathway. Some
components of this sorting machinery, including AP-3, have been identified by the
discovery of human patients in whom LRO function is disrupted (Raposo et al., 2007;
Huizing et al., 2008). Genetic diseases in which defective LRO biogenesis is implicated
include Chediak-Higashi Syndrome, Griscelli Syndrome, and Hermansky-Pudlak
Syndrome (HPS), discussed below. Much of the work that has been performed to
characterize these syndromes has been performed in melanocytic models (Raposo and
Marks, 2007). As we will see, the genes that are affected in HPS play particularly
important roles in trafficking of proteins to melanosomes.

1.5.1 Hermansky-Pudlak Syndrome
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Hermansky-Pudlak Syndrome is a set of genetic diseases characterized by phenotypes
arising from the loss of LRO function (Di Pietro and Dell'Angelica, 2005; Huizing et al.,
2008). The syndrome is divided into several subtypes. All exhibit oculocutaneous
albinism and prolonged bleeding, due to the loss of melanosomes and platelet dense
granules, respectively. Some HPS subtypes additionally involve lung fibroses that most
likely arise due to defective lamellar body function, leading to death in midlife. Some
subtypes also exhibit immune deficiencies because of the defect in the biogenesis of
LROs in cells of the adaptive and innate immune system, including lytic granules in T
lymphocytes and natural killer cells (Clark and Griffiths, 2003; Fontana et al., 2006) and
signaling endosomes in plasmacytoid dendritic cells (Blasius et al., 2010; Sasai et al.,
2010). It is worth emphasizing that HPS affects several cell types, unlike the primary
OCA diseases in which the defects are in genes that are restricted in expression to
pigment cells and in which phenotypes are restricted to processes affected only by
pigment synthesis. The appearance of multifaceted phenotypes arising from a single
defective gene in a given HPS subtype indicates that LRO trafficking has common
features conserved across different cell types, but the distinct phenotypes seen in different
HPS subtypes also point to some cell-type-specific variations in trafficking.

The eight subtypes are each caused by a defect in a different gene (Di Pietro and
Dell'Angelica, 2005; Wei, 2006; Huizing et al., 2008). Although the clinical phenotypes
of the disease arise specifically within tissues that harbor LROs, the genes are
ubiquitously expressed. There are mouse models of each HPS subtype with defects in the
homologous genes, and at least six additional mouse models of the disease for which
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patients with defects in the homologous human genes have not been found (Li et al.,
2004; Di Pietro and Dell'Angelica, 2005). The majority of the proteins encoded by the
affected genes are subunits of five completely distinct multisubunit complexes (Figure
1.3b). These include the Class C Vps complex (a.k.a. homotypic fusion and vacuole
sorting complex, or HOPS), AP-3, and the Biogenesis of Lysosome-Related Organelles
Complexes-1, -2, and -3 (BLOC-1, -2, and -3).

1.5.1a HPS-associated multisubunit complexes
The yeast HOPS complex comprises the core VPS-C complex (shared with another
multisubunit complex) and two distinct subunits Vps39 and Vps41 (Figure 1.3b). These
proteins are a guanine nucleotide exchange factor (Wurmser et al., 2000) and an effector
(Brett et al., 2008), respectively, for the yeast vacuolar Rab Ypt7, and HOPS is involved
in regulating membrane fusion events at the vacuole (Raymond et al., 1992). HOPS acts
as a tethering complex that interacts with Ypt7 and acidic phospholipids in the vacuole
membrane, and its interaction with SNARE complexes promotes trans-SNARE complex
assembly and selectivity (Stroupe et al., 2006; Hickey et al., 2009). The mammalian
HOPS complex is less well studied but appears to also be involved in late endosomal and
lysosomal fusion events and function in association with the late endosomal SNARE
syntaxin 7 (Caplan et al., 2001; Kim et al., 2001; Poupon et al., 2003). None of the
HOPS complex subunits are identified as human HPS genes, but a point mutation in the
Vps33a subunit underlies the HPS model mouse buff, and mutations in several VPS-C
subunit genes in Drosophila melanogaster (including the Vps33a mutant carnation)
result in abnormal eye color due to defects in the biogenesis of pigment granules in the
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eye (Lloyd et al., 1998; Sevrioukov et al., 1999; Sriram et al., 2003; Richardson et al.,
2004; Pulipparacharuvil et al., 2005). Mutations in genes encoding other HOPS subunits
in Caenorhabditis elegans cause defects in birefringent gut granules, LROs found in the
intestine (Hermann et al., 2005).

The heterotetrameric AP-3 complex (Figure 1.3a, b) has been discussed previously. It
consists of one each of beta3, mu3, sigma3, and delta subunits (Robinson, 2004). Beta3A,
mu3A, sigma3A or sigma3B, and delta assemble into a ubiquitously-expressed complex,
while the neuron-specific beta3B (Darnell et al., 1991; Newman et al., 1995; Gurkan et
al., 2005) and mu3B (Pevsner et al., 1994; Gurkan et al., 2005) subunits assemble with
sigma3A or sigma3B and delta into a neuron-specific complex. The beta3A subunit is
mutated in HPS2 patients and the pearl mouse (Feng et al., 1999; Zhen et al., 1999; Yang
et al., 2000; Peden et al., 2002) (Figure 1.3c), and the delta subunit, present in all AP-3
complexes, is mutated in the mocha mouse (Lane and Deol, 1974; Noebels and Sidman,
1989; Kantheti et al., 1998). The mocha mouse has the pigmentation phenotype seen in
pearl mice but additionally suffers from neurological disorders such as hyperactivity,
seizures, and deafness (Noebels and Sidman, 1989; Swank et al., 1991), presumably
because in pearl mice the neuronal beta3B isoform can compensate for the loss of the
ubiquitous beta3A subunit, but in mocha mice the loss of the single-isoform delta subunit
causes the loss of all AP-3 complexes. C. elegans gut granule defects are linked to
mutations in the genes for two subunits (Hermann et al., 2005) and Drosophila eye color
mutants have been linked to mutations in all four AP-3 subunits (Ooi et al., 1997;
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Simpson et al., 1997; Mullins et al., 1999; Mullins et al., 2000). HOPS and AP-3 are both
conserved from yeast to mammals (Dell'Angelica, 2004).

The majority of the HPS-affected genes encode subunits of the BLOC complexes (Figure
1.3b) and were thought to be found only in higher eukaryotes, although more recent low
stringency homology searches have revealed potential homologs of BLOC-1 and BLOC3 in Dictyostelium and S. cerevisiae (Cheli and Dell'Angelica, 2010; Hayes et al., 2011).
The subunits of each BLOC complex are not homologous to proteins of known function,
and thus the functions of the BLOCs are still not clear. However, a handful of potential
interactions with other proteins have been identified and provide some clues regarding
function (Di Pietro and Dell'Angelica, 2005). For example, the pallidin subunit of BLOC1 interacts with the endosomal SNARE syntaxin 13 (Huang et al., 1999; Moriyama and
Bonifacino, 2002; Ghiani et al., 2010), and the snapin subunit might interact with the
exosomal SNAREs SNAP23 and SNAP25 (Ilardi et al., 1999; Vites et al., 2004); these
interactions have been replicated for the complete BLOC-1 (Ghiani et al., 2010),
suggesting that the complex might regulate LRO trafficking by affecting endosomal
membrane fusion events. As discussed below, data from our laboratory suggest that
BLOC-1 and BLOC-2 function during cargo delivery from endosomes to maturing
melanosomes, supporting such a role.

BLOC-3 is composed of the HPS1 and HPS4 proteins (Figure 1.3b), mutated in human
HPS type 1 and type 4 patients and in the pale ear and light ear mice (Dell'Angelica et
al., 2000). Loss of BLOC-3 in the mouse models has a mild effect on coat and eye color
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but does cause lightening of the hairless skin of the ears and tail (Figure 1.3d), indicating
differences in melanosome biogenesis and development in follicular versus interfollicular
melanocytes (Gautam et al., 2006; Nguyen and Wei, 2007). Unique among the BLOCs,
loss of BLOC-3 causes melanosomes to become enlarged in the choroid of the eye
(Gardner et al., 1997; Feng et al., 2002; Suzuki et al., 2002). Moreover, the lung fibrosis
phenotype of HPS is especially prevalent in patients suffering from defects in BLOC-3
(Anderson et al., 2003) and lung function is uniquely affected in mice with mutations in
both BLOC-3 and other complexes (Guttentag et al., 2005; Gautam et al., 2006). The
heightened severity of LRO phenotypes in double mutants of BLOC-3 in combination
with BLOC-2 or AP-3 suggest that BLOC-3 works in a separate pathway from those
complexes and perhaps from BLOC-1 as well (Feng et al., 2002; Di Pietro et al., 2006;
Gautam et al., 2006). The molecular function of BLOC-3, however, is not clear.
Knockdown of BLOC-3 subunit expression in fibroblasts results in altered distribution of
late endosomes/lysosomes, suggesting a potential primary role for BLOC-3 in organelle
motility (Falcon-Perez et al., 2005), consistent with defects in melanosome transfer
observed in hair follicles of pale ear and light ear mice (Nguyen et al., 2002; Nguyen and
Wei, 2004).

BLOC-2 comprises HPS3, HPS5, and HPS6 (Figure 1.3b), defective in human HPS types
3, 5 and 6 and the cocoa, ruby-eye 2, and ruby-eye mice, respectively (Di Pietro and
Dell'Angelica, 2005). The orthologue to the HPS5 gene is also defective in the
Drosophila eye color mutant pink (Falcon-Perez et al., 2007). BLOC-2-deficient mice
are more hypopigmented than BLOC-3-deficient mice (Figure 1.3d), and loss of this
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complex (but not the other BLOCs) causes choroidal melanosomes to become clumped
into multi-melanosomal structures (Zhang et al., 2003; Gautam et al., 2004).
Melanocytes from BLOC-2-deficient patients accumulate tyrosinase-containing vesicular
structures in the cytoplasm (Boissy et al., 2005; Helip-Wooley et al., 2007), suggesting
that BLOC-2 might play some role in vesicular fusion during melanosome biogenesis.
We will discuss this potential role further below.

BLOC-1 comprises at least eight subunits (Di Pietro and Dell'Angelica, 2005) (Figure
1.3b). The dysbindin subunit is mutated in HPS7 and the sandy mouse and the BLOS3
subunit is mutated in HPS8 and the reduced pigmentation mouse. Another three HPS
mouse models—pallid, muted, and cappuccino—are defective in the pallidin, muted, and
cappuccino subunits. Of the three BLOC complexes, BLOC-1 mutant mice are the most
severely hypopigmented (Dell'Angelica, 2004) (Figure 1.3d) and BLOC-1 is epistatic to
BLOC-2 and BLOC-3 in pigmentation (Di Pietro et al., 2006; Gautam et al., 2006).

1.5.1b Other HPS-associated genes and proteins
The remaining murine HPS-associated genes are presented briefly here for the sake of
completeness. Slc7a11, mutated in the subtle gray (sut) mouse, encodes a cystine
transporter that is critical for cystine import and maintenance of cellular glutathione
levels in cultured melanocytes and other cell types (Chintala et al., 2005). Accordingly,
pheomelanin but not eumelanin production is drastically reduced in sut mice. Dense
granule numbers are also reduced in platelets from these mice (Swank et al., 1996).
Rab38 is mutated in the chocolate mouse (Loftus et al., 2002). In melanocytes, Rab38 is
30

associated with melanosomes and is needed for proper Tyrp1 trafficking (Loftus et al.,
2002; Wasmeier et al., 2006), consistent with the similarity of the coat color phenotypes
in chocolate and Tyrp1-deficient brown mice (Loftus et al., 2002). Rabggta, mutated in
the gunmetal mouse, encodes Rab geranylgeranyltransferase alpha, required for the
prenylation and membrane-anchoring of several Rabs (Detter et al., 2000). Rabggta
deficiency leads to phenotypes in multiple tissues (Seabra et al., 2002). One target of
Rabggta prenylation is Rab27a. Together with its effector protein melanophilin,
melanosome-associated Rab27a recruits myosin VA, enabling transfer of melanosomes
from microtubules onto the peripheral actin network for subsequent transfer to
keratinocytes (Wu et al., 2001; Hume et al., 2002). Mutations in the genes encoding the
subunits of the Rab27a/melanophilin/myosin VA complex lead to perinuclear clustering
of melanosomes and give rise respectively to the hypopigmentation phenotype of ashen,
leaden, and dilute mice, models of the three subtypes of Griscelli Syndrome, another
LRO biogenesis disorder (Pastural et al., 1997; Menasche et al., 2000; Menasche et al.,
2003).

1.5.2 Interactions among BLOCs and AP-3
How do the HPS complexes interact? A portion of BLOC-1 and BLOC-2 can be coimmunoprecipitated with each other from detergent extracts of membranes from
fibroblasts and neuronal cell lines (Di Pietro et al., 2006; Salazar et al., 2006), suggesting
that they functionally interact. A separate cohort of BLOC-1 can also be
coimmunoprecipitated from membrane extracts with AP-3 (Di Pietro et al., 2006), and
BLOC-1 can be isolated from immunoaffinity purified neuronal subcellular fractions
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enriched in AP-3 complexes (Salazar et al., 2006) as well as from clathrin-coated vesicle
fractions of HeLa cells (Borner et al., 2006). This suggests that a cohort of BLOC-1
might function together with AP-3, consistent with data from AP-3- and BLOC-1deficient neurons that show similar patterns of cargo trafficking defects (Newell-Litwa et
al., 2009; Salazar et al., 2009). However, this has to be reconciled with data in
melanocytes that AP-3 and BLOC-1 localize to distinct domains of early endosomes
(Theos et al., 2005; Di Pietro et al., 2006; Setty et al., 2007), and with functional data
discussed below that implicate BLOC-1 and AP-3 in distinct cargo trafficking pathways
to melanosomes (Theos et al., 2005; Setty et al., 2007; Setty et al., 2008). Data presented
in this thesis will attempt to clarify this controversy.

1.5.3. HPS complexes and melanosome biogenesis
Melanocytes have proven to be an excellent model in which to dissect the function of the
BLOCs and AP-3 in cargo trafficking to LROs. This has been supported by the
availability of primary melanocytes from both HPS patients and HPS mouse models, as
well as immortalized melanocytes from HPS mouse models. Studies in primary
melanocytes derived from human HPS patients suggest that Tyr is mislocalized in AP-3deficient cells (Richmond et al., 2005). As discussed earlier, studies in mouse
melanocytes showed that Tyr was largely mislocalized to late endosomes and vacuolar
early endosomes in AP-3-deficient melanocytes (Theos et al., 2005), but a cohort of Tyr
was present in melanosomes. By contrast, in BLOC-1-deficient cells 60% of the wildtype cohort of Tyr is correctly localized to melanosomes. In contrast, whereas Tyrp1
appears to be localized normally to melanosomes in AP-3-deficient cells (Huizing et al.,
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2001; Setty et al., 2007), nearly all Tyrp1 in BLOC-1-deficient melanocytes is depleted
from melanosomes and instead redistributed largely to vacuolar domains of early
endosomes, demonstrating a degree of cargo selectivity by BLOC-1 (Setty et al., 2007).
Analysis of the dynamics of Tyrp1 in these cells indicates that Tyrp1 exit from these
vacuoles in melanosome-bound transport carriers is defective, such that instead Tyrp1 is
“stuck” in an endless recycling loop to the plasma membrane. Interestingly, the
compartments in which Tyrp1 becomes entrapped in BLOC-1-deficient cells are positive
for the early endosomal SNARE syntaxin 13 (Setty et al., 2007). Like Tyrp1, the copper
transporter ATP7A, defective in the hypopigmented mottled mouse (Levinson et al.,
1994) and in patients suffering from Menkes disease (Tumer and Moller, 2010), is also
largely mislocalized to vacuolar early endosomes in BLOC-1-deficient cells but correctly
localized in AP-3-deficient cells (Setty et al., 2008). These data suggest that both Tyrp1
and ATP7A are cargoes of an AP-3-independent, BLOC-1-dependent transport pathway
to melanosomes.

Interestingly, the effects of BLOC-1 deficiency on Tyrp1 trafficking and on pigmentation
are similar to those observed in a human pigmented melanoma cell line upon knockdown
of the AP-3-related adaptor, AP-1 (Delevoye et al., 2009). As discussed earlier, AP-1 –
like AP-3 -- also binds to many melanosomal targeting signals, and in other cell types has
been implicated in cargo delivery to or from endosomes. Like BLOC-1, AP-1 has been
localized to tubulovesicular structures in proximity to melanosomes (Theos et al., 2005;
Delevoye et al., 2009). Because of these similarities, it has been thought that AP-1 and
BLOC-1 might work together in Tyrp1 trafficking to melanosomes. How such
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cooperation might occur is unclear, as a biochemical interaction between these two
complexes has not been seen (Salazar et al., 2009).

Several studies in primary melanocytes derived from human HPS patients have also
suggested that Tyr and Tyrp1 are mislocalized in the absence of BLOC-2 (Boissy et al.,
2005; Richmond et al., 2005; Helip-Wooley et al., 2007; Huizing et al., 2009). BLOC-2
also seems to regulate Tyrp1 trafficking in mouse melanocytes, and it may act from an
endosomal intermediate downstream of BLOC-1 (Setty et al., 2007). Immunoelectron
microscopy in these cells has demonstrated that both BLOC-1 and BLOC-2 localize to
tubulovesicular elements that are closely associated with melanosomes (Di Pietro et al.,
2006; Setty et al., 2007). The presence of transferrin in these tubules after long periods
of uptake identifies them as deriving from recycling endosomal domains. Importantly,
such domains have been shown to be involved in the formation of direct tubular contacts
between vacuolar endosomes and maturing melanosomes (Delevoye et al., 2009),
suggesting that BLOC-1 and BLOC-2 might play critical roles in either the formation of
these domains or the integration of cargoes into them. Like in BLOC-1-deficient cells,
Tyrp1 is largely redistributed to STX13-containing early endosomes and to the plasma
membrane in BLOC-2-deficient cells (Setty et al., 2007). However, Tyrp1 in BLOC-2deficient melanocytes is also aberrantly delivered to lysosomes (Setty et al., 2007) and
transported in a retrograde manner to the Golgi (A. Mantegazza, M. Dennis, D. Tenza
and G. Raposo, unpublished data), suggesting that BLOC-2 may help direct where the
Tyrp1-containing tubules deliver their cargo. BLOC-1/BLOC-2 double mutant mice
show the more severe hypopigmented phenotype of BLOC-1-deficient mice, also
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consistent with BLOC-2 working downstream of BLOC-1 (Di Pietro et al., 2006; Gautam
et al., 2006).

1.6 A model for melanosomal trafficking
The differential effect of loss of AP-3 or BLOC-1 on trafficking of Tyr versus Tyrp1 and
ATP7A suggests a model by which two distinct pathways, one controlled by each
complex, exist for anterograde trafficking of integral membrane proteins to melanosomes
(Raposo and Marks, 2007; Setty et al., 2007). Specifically, the model describes an AP-3mediated pathway taken by a large cohort of Tyr, and a BLOC-1-dependent pathway
taken by nearly all of the Tyrp1 and ATP7A proteins and by a portion of Tyr (Figure
1.4). The Tyrp1 trafficking studies suggest that the BLOC-1-dependent pathway also
utilizes AP-1 and BLOC-2. This model of distinct BLOC-1 and AP-3 pathways is
consistent with the observation that a mouse that is doubly homozygous for BLOC-1 and
AP-3 mutations is more hypopigmented in the coat, choroid, and retinal pigment
epithelium and has more pronounced lamellar body abnormalities than either the BLOC1 or AP-3 single mutant mouse (Di Pietro et al., 2006; Gautam et al., 2006).

The model of distinct BLOC-1-mediated and AP-3-mediated trafficking pathways is at
odds with data showing a robust biochemical interaction between BLOC-1 and AP-3 in
primary mouse neurons, a neuronal cell line, and mouse melanocytes, and with the ability
of one to affect the membrane recruitment of the other (Di Pietro et al., 2006; Salazar et
al., 2006; Newell-Litwa et al., 2009; Salazar et al., 2009), unpublished results from our
lab). AP-3 helps generate synaptic vesicles from endosomes in neurons
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Figure 1.4

Figure 1.4. Current model of melanosomal trafficking from endosomes.
Fluid phase cargoes (green arrows) follow the classical endocytic pathway through the
early endosome (EE)/stage I coated endosome (St I/CE) to late endosomes (LE) and
finally to lysosomes (Lys), but do not access maturing melanosomes. The model of
directed endosome-to-melanosome trafficking is derived from studies of the trafficking of
tyrosinase (orange arrows) and Tyrp1 (pink arrows). Tyrp1 utilizes a BLOC-1-dependent
and AP-3-independent pathway for trafficking from endosomes to melanosomes. A
minor cohort of tyrosinase may also use this pathway, while the majority of tyrosinase
uses a BLOC-1-independent, AP-3-dependent pathway for trafficking to Stage II and III
melanosomes (St II, St III). Melanin synthesis in Stage II melanosomes leads to melanin
accumulation and melanosome maturation through Stages III and IV (St III, St IV).
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(Faundez et al., 1998), and a subset of AP-3-dependent cargo is selectively enriched in
synaptic vesicles from brain tissues from BLOC-1-deficient mice (Newell-Litwa et al.,
2009), though trafficking in these cells is more complex due to the presence of the
additional neuronal AP-3 complex. AP-3-dependent CD63 and VAMP7-T1 trafficking
appear to be altered in fibroblasts lacking BLOC-1, but there are also conflicting data as
to whether the trafficking of AP-3-dependent LAMP1 is altered in BLOC-1-deficient
cells (Di Pietro et al., 2006; Salazar et al., 2006). It is also possible that increases in the
surface levels of AP-3-dependent cargo in BLOC-1 deficient cells reflect indirect effects
of the saturation of the internalization machinery due to the mislocalization of BLOC-1
cargo (Setty et al., 2007) rather than a direct requirement for BLOC-1 in the trafficking
of the AP-3 cargo proteins. Thus although the possibility of a common trafficking
pathway mediated by both BLOC-1 and AP-3 has been proposed in other cell types, the
studies of Tyr, Tyrp1, and ATP7A have not provided direct evidence of such a pathway
in melanocytic trafficking. Moreover, no evidence exists for such a pathway in
trafficking to other LROs.

Further investigation of anterograde melanosomal trafficking pathways will require the
characterization of additional melanosomal cargo proteins. As mentioned earlier, the
pigment-cell-specific protein OCA2 has a putative acidic dileucine sorting motif in its
cytoplasmic domain and thus appears poised to use AP-1 and/or AP-3 for trafficking to
post-Golgi organelles. As such, it was an ideal candidate to be a melanosomal cargo
protein that could be utilized to characterize trafficking mediated by HPS-associated
complexes. In the next section we describe OCA2 in greater detail.
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1.7 OCA2
1.7.1 The OCA2 gene and mutant phenotypes
The OCA2 protein is the product of the OCA2 gene (Brilliant, 2001). Recessive
mutations in the gene cause oculocutaneous albinism type 2, the most common form of
albinism among people of African heritage and worldwide (King, 1998). It has a reported
incidence of 1:17,000 in Blacks or 1:30,000 in Caucasians in the United States (Witkop,
1985) to as high as 1:2000 among the Navajo (Yi et al., 2003) and 1:669 in Tuvalu
(Johanson et al., 2010). Whereas OCA1 stems from a deficiency in tyrosinase and
therefore displays a complete lack of pigment, OCA2 is often referred to as tyrosinasepositive albinism, since hypopigmented hairbulbs plucked from these patients, but not
ones with OCA1, will become pigmented when incubated with the tyrosinase substrates
L-tyrosine or L-DOPA (Kugelman and Van Scott, 1961; Witkop et al., 1973). Indeed,
OCA2 patients can exhibit light to moderate pigmentation. They are born with light skin
and lightly pigmented blond, reddish, or brown hair (King, 1998; King et al., 2003)
(Figure 1.5a), consistent with the finding that OCA2 deficiency affects production of
black-brown eumelanin but not yellow-red pheomelanin (Rinchik et al., 1993; Lamoreux
et al., 1995; Hirobe et al., 2011). The hair may darken throughout life and some tanning
is possible (Brilliant, 2001). They may also develop pigmented lentigines or nevi
(Bothwell, 1997). Like all other OCA subtypes, OCA2 patients present phenotypes that
are restricted to tissues involving dysfunction due to loss of pigment. For example,
platelet dense granules are normal in patients with tyrosinase-positive albinism (OCA2)
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Figure 1.5

Figure 1.5. OCA2 disease phenotypes and OCA2 protein structure.
a) Fraternal twin girls born to a couple of Congolese origin. One girl has normal
pigmentation while the other has oculocutaneous albinism type 2 and shows the typical
hypopigmentation phenotype.4 b) Defects in the murine Oca2 gene give rise to the pinkeyed dilution mouse. On a non-agouti background, these mice have light gray coats and
pink eyes5 (Silvers, 1979). c) The proposed structure of OCA2 is that of a 12transmembrane domain glycoprotein with a long N-terminal cytoplasmic domain and
short C-terminal cytoplasmic domain. The sequence shows homology with transporters in
a superfamily with members expressed from bacteria to humans (Sitaram et al., 2009).

4

Reprinted by permission from Macmillan Publishers Ltd: Claas, M.J., Timmermans, A.,
and Bruinse, H.W. (2010). Case report: a black and white twin. J Perinatol 30, 434-436.
5
Reprinted with kind permission of Springer Science+Business Media.
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(Witkop et al., 1973). This is consistent with the pigment cell-restricted expression of
OCA2 and the other OCA-associated genes (Gardner et al., 1992).

The mutations identified within the OCA2 gene in OCA2 patients and in controls are
informative regarding the function of the OCA2 protein. While a high percentage of
people of African heritage who suffer from OCA2 have a homozygous 2.7-kb deletion
allele (Durham-Pierre et al., 1994), many cases of OCA2 in Africans and other ethnic
groups are attributed to point mutations that result in small amino acid substitutions in the
protein. These substitutions are mostly found in the C-terminal half of the protein in
amino acid residues that are conserved in murine OCA2 (Lee et al., 1995). Nonpathological polymorphisms in human OCA2 and in the adjacent gene HERC2 are
thought to modify OCA2 gene expression, and are strongly linked to ethnic differences in
skin color and to the emergence of blue eye color in humans (Lao et al., 2007; Norton et
al., 2007; Sulem et al., 2007; Eiberg et al., 2008; Sturm et al., 2008; Branicki et al.,
2009; Mengel-From et al., 2010).

The OCA2 model mouse is named pink-eyed dilution, and the affected murine gene had
originally been named p but is now referred to as Oca2. Over 100 mutant alleles of the
murine gene have been isolated (Brilliant, 2001), and some are associated with
phenotypes besides hypopigmentation, such as cleft palate, male sterility, and
neurological disorders. However these alleles were induced by radiation treatment and
the additional phenotypes derive from effects on physically-linked genes. The mutant
Oca2 allele found in the original pink-eyed dilution mice arose spontaneously
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(Gruneberg, 1952) and produces no transcript (Brilliant, 2001). These mice, when bred
on a black, non-agouti background, have pink eyes and light gray coats, consistent with
the OCA phenotype observed in humans (Figure 1.5b). Immortalized melan-p1 skin
melanocytes used for cell culture experiments are derived from the pcp/p25H mouse; pcp
homozygotes have cleft palates and die soon after birth (Silvers, 1979), while p25H
homozygotes have abnormal reproduction (Hunt and Johnson, 1971), but the mixed
heterozygotes are not documented as having these phenotypes (Lyon et al., 1992).
Neither OCA2 allele produces a transcript, and melan-p1 cells cultured from this mouse
have very few mature, pigmented melanosomes, but instead display an abundance of
small, hypopigmented compartments morphologically resembling Stage II melanosomes
(Sidman et al., 1965; Rosemblat et al., 1998). The hypopigmentation phenotype indicates
that Tyr activity in intact Oca2-/- cells is reduced compared to controls. Surprisingly, in
vitro Tyr activity levels in these cells are similar to or even higher than in wild-type cells
(Manga et al., 2001; Chen et al., 2002; Toyofuku et al., 2002). Localization of Tyr
activity in situ by DOPA histochemical assays and electron microscopy shows that a
significant amount of Tyr correctly localizes to the non-pigmented melanosomes but is
apparently inactive in vivo. In this regard OCA2 deficiency resembles the
hypopigmentation phenotype seen in BLOC-1 and BLOC-2 mutant cells, in which a
significant amount of Tyr is correctly localized to melanosomes yet inactive (Boissy et
al., 2005; Helip-Wooley et al., 2007; Setty et al., 2007; Setty et al., 2008), suggesting
that the defect in OCA2-deficient cells might be due to failure to raise the lumenal pH or
facilitate copper transport. Tyr activity in OCA2-deficient melanocytes is also
abnormally localized to 50-nm cytoplasmic vesicles distributed throughout the cell, and
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particularly near the plasma membrane (Manga et al., 2001). Again, this phenotype is
reminiscent of the increased number of Tyr-containing cytoplasmic vesicles found in
BLOC-2-deficient melanocytes cultured from HPS-3 and HPS-5 patients (Boissy et al.,
2005; Helip-Wooley et al., 2007). Consistently, Tyr in OCA2-deficient cells appears to
be aberrantly cleaved and secreted from cells, as is shown by a shift in Tyr protein and
activity from the detergent phase to the aqueous phase and by immunoprecipitation of
cleaved Tyr from the culture media, and the media itself contains an unusually high
amount of melanin (Potterf et al., 1998; Manga et al., 2001; Manga and Orlow, 2001;
Chen et al., 2002; Toyofuku et al., 2002; Chen et al., 2004). These data suggest that the
loss of OCA2 function causes defects in the lumenal melanin-synthesizing environment
as well as in delivery or retention of Tyr at the immature melanosomes.

1.7.2 The OCA2 protein – controversial function and localization
The OCA2 gene encodes a 12-transmembrane domain protein (Rinchik et al., 1993) that
is highly conserved throughout vertebrate evolution (Gardner et al., 1992; Rinchik et al.,
1993; Fukamachi et al., 2004; Protas et al., 2006) (Figure 1.5c), such that the C-terminal
two-thirds of the human and mouse homologues share >90% amino acid sequence
identity (Lee et al., 1995). The sequence shows homology to the ArsB/NhaD superfamily
of permeases, with members expressed from bacteria to humans that transport a variety of
substrates including arsenate and Na+/H+ exchange. No transport substrate has been
identified for OCA2. It had been hypothesized that the protein might serve as a
melanosomal tyrosine transporter supplying the tyrosine substrates for melanin
production, and that loss of this activity contributed to the hypopigmentation of OCA242

deficient melanocytes. Consistent with this interpretation, supplementation of the culture
media of these cells with extra tyrosine stimulated melanin synthesis (Sidman et al.,
1965; Rinchik et al., 1993; Potterf et al., 1998). However, tyrosine uptake was found to
be comparable across the plasma membrane of OCA2-deficient and wild-type
melanocytes, as well as into melanosome-containing granular fractions from these cells
(Gahl et al., 1995; Potterf et al., 1998), suggesting that the effect of tyrosine
supplementation was indirect. Saccharomyces cerevisiae expressing exogenous OCA2
become more susceptible to chemicals typically detoxified by glutathione, owing to
localization of the transgene to the vacuolar membrane and an increase in vacuolar
delivery and degradation of glutathione (Staleva et al., 2002). Direct involvement of
OCA2 in glutathione transport was not assayed in the yeast, and although mouse
melanocytes expressing endogenous OCA2 are also more sensitive to these toxic
chemicals than OCA2-deficient cells, cellular glutathione levels are not different between
the two types of melanocytes (Staleva et al., 2002). The protein has also been proposed
to control melanin synthesis by directly regulating the lumenal pH of melanosomes (Puri
et al., 2000). Consistent with this hypothesis are several studies in which treatment of
OCA2-deficient pigmented cells with lysosomotropic agents or vATPase inhibitors
causes an increase in melanin content, leading to the suggestion that OCA2 functions to
raise melanosomal pH for optimal tyrosinase activity (Ancans et al., 2001b; Manga and
Orlow, 2001; Chen et al., 2004; Ni-Komatsu and Orlow, 2006). Others have claimed that
OCA2 functions to acidify melanosomes, based on the observation that Tyrp1-containing
compartments in Oca2-deficient melanocytes accumulate less DAMP, a marker of
acidification, than those in wild-type melanocytes (Puri et al., 2000). However, this
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hypothesis is complicated by the fact that Tyrp1 is apparently mislocalized in OCA2deficient cells (Manga et al., 2001).

Not only is the function of the OCA2 protein unclear, but its subcellular site of action has
also been debated. There are several pieces of evidence that OCA2 is a bona fide
melanosomal protein. A putative acidic dileucine sorting signal present within the long,
cytoplasmically exposed N-terminal domain of OCA2 was predicted to serve a
melanosomal sorting function (Lee et al., 1995), analogous to the signals in the
cytoplasmic C-terminal domains of Tyr and Tyrp1 (Peng et al., 1994; Vijayasaradhi et
al., 1995; Calvo et al., 1999; Simmen et al., 1999). In addition, OCA2 co-fractionated
with Tyrp1 and Tyr in wild-type cultured melanocytes (Rosemblat et al., 1994), and lowresolution immunofluorescence microscopy analysis was interpreted to show some
colocalization with the early stage melanosomal protein PMEL (Toyofuku et al., 2002).
Moreover, like PMEL, OCA2 was difficult to extract from heavily melanized cells using
non-ionic detergents, suggesting a close association with melanin (Rosemblat et al.,
1994; Donatien and Orlow, 1995). However, other data were interpreted to suggest that
OCA2 localizes to and functions within the endoplasmic reticulum. OCA2 cofractionated with ER markers as well as melanosomal markers, and exogenously
expressed OCA2 displayed some colocalization with ER markers by indirect
immunofluorescence microscopy in melanocytes and non-melanocytes (Chen et al.,
2002). The shift of steady-state Tyr to more immature, endoglycosidase H-sensitive
glycoforms in OCA2-deficient cells has been interpreted to indicate that OCA2
modulates Tyr folding within and consequent exit from the endoplasmic reticulum (Chen
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et al., 2002; Toyofuku et al., 2002; Chen et al., 2004; Ni-Komatsu and Orlow, 2006); this
would be consistent with a role for OCA2 in modifying cellular glutathione levels.
However, none of these data were definitive in identifying the functional cellular
localization for OCA2 in wild-type melanocytes, or in testing whether OCA2, like other
melanosomal proteins, was mislocalized in melanocytes derived from models of
trafficking disorders such as Hermansky-Pudlak syndrome. Thus the question of where
precisely OCA2 localizes and functions within melanocytes required further, definitive
investigation.

1.8 Goals of this thesis
As discussed, previous work in the literature had not resolved the question of the
subcellular localization and site of function of OCA2 in promoting melanin synthesis,
suggesting either the ER or the melanosome as the putative site. In Chapter 2, I describe
how biochemical analysis indicates that OCA2 must function in a post-ER compartment,
consistent with the acquisition of resistance to endoglycosidase H treatment. The OCA2
protein localizes to late endosomes/lysosomes when exogenously expressed in nonmelanocytes or to the mature melanosome in melanocytes, as expected for a
melanosomal protein. Furthermore, similar to findings in Tyr and Tyrp1, I find that
melanosomal localization depends on an acidic dileucine motif in the cytoplasmic
domain, and that this motif is a binding site for the adaptor protein complexes AP-1 and
AP-3.
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We have previously described how studies with Tyrp1 and Tyr have led to a model of
endosome-to-melanosome trafficking mediated by two largely distinct pathways. One is
mediated by AP-3 and is utilized by a large cohort of Tyr, while another pathway, used
by Tyrp1, is mediated by BLOC-1, with contributions from AP-1 and BLOC-2. But
questions still remain regarding how distinct these two pathways are. Following our
discovery that OCA2 binds both AP-1 and AP-3, I exploited OCA2 as a useful tool to
dissect the relative roles of each complex in melanosomal trafficking and to interrogate
our trafficking model. In Chapter 3, I describe how I characterized the dependence of the
localization and AP-interacting activity of the OCA2 acidic dileucine motif on primary
sequence rather than position within the protein. I also describe the isolation of two point
mutations in the acidic dileucine motif that differentially affect binding of AP-1 or AP-3.
I determined the localization of these mutants in wild-type, AP-3-deficient, and BLOC-1deficient melanocytes. My results suggest that OCA2 exploits an anterograde trafficking
pathway that requires both AP-3 and BLOC-1, suggesting the existence of a third as yet
unappreciated pathway for melanosome cargo delivery and providing a functional
correlate for the AP-3-BLOC-1 interaction previously observed. The results also show
that chimeric expression of the acidic dileucine motif from a BLOC-1-independent
protein does not confer BLOC-1 independence on OCA2, suggesting that the
determinants of BLOC-1 dependence are distinct from those of AP complexes.
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CHAPTER 2: LOCALIZATION TO MATURE MELANOSOMES BY VIRTUE
OF CYTOPLASMIC DILEUCINE MOTIFS IS REQUIRED FOR HUMAN OCA2
FUNCTION
2.1 Abstract
Oculocutaneous albinism type 2 is caused by defects in the gene OCA2, encoding a
pigment cell-specific, 12-transmembrane domain protein with homology to ion
permeases. The function of the OCA2 protein remains unknown, and its subcellular
localization is under debate. Here, we show that endogenous OCA2 in melanocytic cells
rapidly exits the endoplasmic reticulum (ER) and thus does not behave as a resident ER
protein. Consistently, exogenously expressed OCA2 localizes within melanocytes to
melanosomes, and, like other melanosomal proteins, localizes to lysosomes when
expressed in nonpigment cells. Mutagenized OCA2 transgenes stimulate melanin
synthesis in OCA2-deficient cells when localized to melanosomes but not when
specifically retained in the ER, contradicting a proposed primary function for OCA2 in
the ER. Steady-state melanosomal localization requires a conserved consensus acidic
dileucine-based sorting motif within the cytoplasmic N-terminal region of OCA2. A
second dileucine signal within this region confers steady-state lysosomal localization in
melanocytes, suggesting that OCA2 might traverse multiple sequential or parallel
trafficking routes. The two dileucine signals physically interact in a differential manner
with cytoplasmic adaptors known to function in trafficking other proteins to
melanosomes. We conclude that OCA2 is targeted to and functions within melanosomes
but that residence within melanosomes may be regulated by secondary or alternative
targeting to lysosomes.
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2.2 Introduction
Melanin pigments are synthesized by specialized cell types, including dermal and
epidermal melanocytes and retinal pigment epithelial cells, within unique organelles
known as melanosomes (Raposo and Marks, 2007). Melanosomes are members of a class
of tissue-specific “lysosome-related organelles” characterized by an acidic lumenal pH
and the presence of some lysosomal proteins (Dell'Angelica et al., 2000; Griffiths, 2002).
Among lysosome-related organelles, melanosomes represent a subclass that coexists with
bona fide lysosomes in their host cells (Raposo and Marks, 2007). Melanosomes are
distinguished from lysosomes by the presence of cell-type-specific cargo proteins that
confer unique functional and morphological properties. How these cargo proteins are
diverted from traditional lysosomes and delivered to and maintained within melanosomes
is incompletely understood, and the degree of cargo cross-talk between melanosomes and
lysosomes is not known.

Melanosomes undergo a program of maturation within melanocytes by the ordered
delivery of cargoes to nascent melanosomes via specialized trafficking pathways (Raposo
and Marks, 2007). Some components of the melanosomal trafficking machinery are
known, largely from analyses of the sorting of well-characterized cargo proteins, such as
the melanogenic enzyme tyrosinase (Tyr) and tyrosinase-related protein 1 (Tyrp1), in
both wild-type melanocytes and melanocytes derived from patients or mouse models of
genetic hypopigmentary diseases such as Hermansky–Pudlak Syndrome (HPS) (Di Pietro
and Dell'Angelica, 2005; Wei, 2006). Tyr and Tyrp1 contain cytoplasmic acidic dileucine
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motifs that are required for melanosomal sorting (Vijayasaradhi et al., 1995; Calvo et al.,
1999; Simmen et al., 1999) and that are bound within endosomal intermediates by
heterotetrameric adaptor proteins (APs) AP-1 or AP-3. AP-1 and AP-3 each bind the Tyr
sorting signal (Honing et al., 1998; Theos et al., 2005), but they participate in distinct
delivery pathways toward melanosomes (Theos et al., 2005). Consistently, Tyr is largely
(but not completely) missorted in melanocytes derived from human HPS type 2 patients
and HPS model pearl mice that bear mutations in the gene encoding the β3A subunit of
AP-3 (Huizing et al., 2001; Theos et al., 2005). By contrast, the acidic dileucine-based
sorting signal in Tyrp1 has been shown to bind AP-1 but not AP-3 (Huizing et al., 2001;
Theos et al., 2005), and accordingly Tyrp1 accumulates normally on melanosomes in
AP-3-deficient melanocytes (Huizing et al., 2001; Setty et al., 2007) (although an
unusually large cohort cycles through the plasma membrane; (Di Pietro et al., 2006)).
These results corroborate the dependence on AP-1 and AP-3, respectively, for in vitro
budding of Tyrp1 and tyrosinase from Golgi/endosomal membrane fractions (Chapuy et
al., 2008). Interestingly, both lysosomal and melanosomal proteins depend on AP-1 and
AP-3 for their trafficking, and it is not known how trafficking to these distinct organelles
in melanocytes is distinguished. Additional components that influence Tyr and Tyrp1
trafficking to melanosomes include the biogenesis of lysosome-related organelles
complex (BLOC)-1 and BLOC-2, subunits of which are defective in other forms of HPS,
and the tissue-specific Rab proteins Rab32 and Rab38 (Richmond et al., 2005; Di Pietro
et al., 2006; Wasmeier et al., 2006; Helip-Wooley et al., 2007; Setty et al., 2007). Tyrp1
and Tyr trafficking toward melanosomes or lysosomes is also regulated by lumenal
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interactions with glycosphingolipid-dependent membrane microdomains, presumably on
endosomes (Sprong et al., 2001; Groux-Degroote et al., 2008).

The mechanisms regulating the delivery of other melanosomal proteins to melanosomes
are less understood. Pmel17, a component of the fibrillar melanosome matrix on which
melanins deposit, becomes incorporated into early stage melanosomes in a manner that
seems to be unaffected in most, if not all, forms of HPS. Pmel17 is first delivered to
endosomes by a dileucine-based internalization motif (Theos et al., 2006a) and is
subsequently sorted to the internal membranes of multivesicular endosomes in a step that
precedes and is required for fibril formation (Hoashi et al., 2006; Theos et al., 2006b).
This latter step requires a lumenal determinant within Pmel17 but does not require
components of the classical multivesicular body sorting machinery such as Hrs and
endosomal sorting complex required for transport subunits (Theos et al., 2006b). The G
protein-coupled receptor OA1 is targeted to melanosomes by a distinct class of sorting
signal (Piccirillo et al., 2006), but the effectors that regulate its sorting are not known.

OCA2, also called pink-eyed dilution or P protein, is an enigmatic protein with a critical
function in pigmentation. The OCA2 gene is mutated in oculocutaneous albinism (OCA)
type 2, one of the most common forms of human albinism (Brilliant, 2001). In addition,
nonpathological polymorphisms in both coding and noncoding regions of the OCA2 gene
have been implicated as major determinants of skin color (Lao et al., 2007; Norton et al.,
2007; Sulem et al., 2007), and variation in OCA2 expression through a polymorphism in
an adjacent gene, HERC2, is thought to underlie blue eye color in humans (Eiberg et al.,
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2008; Sturm et al., 2008). OCA type 2 patients exhibit severe hypopigmentation of the
skin, hair, and eyes. Defects in the corresponding murine gene (p) give rise to the pinkeyed dilution mouse (Rinchik et al., 1993), which has similar eye and coat
hypopigmentation. Melanocytes from this model mouse contain melanosomes that are
small, immature, and hypopigmented relative to normal melanosomes (Sidman et al.,
1965; Rosemblat et al., 1998). Although these features clearly implicate OCA2 as being
critical for pigmentation, the molecular function of OCA2 is still unclear. Its sequence
predicts that OCA2 is a 12-transmembrane domain protein with homology to a
superfamily of permeases (Rinchik et al., 1993; Lee et al., 1995). However, no transport
substrate has yet been identified.

Not only is OCA2 function not known, but its subcellular site of action is also debated.
OCA2 was originally thought to localize predominantly to mature melanized
melanosomes based on subcellular fractionation of melanocytes (Rosemblat et al., 1994),
poor extraction by detergent from melanized melanocytes relative to nonmelanized
melanocytes (Donatien and Orlow, 1995), and interpretation of results from confocal
immunofluorescence microscopy (IFM) analyses (Toyofuku et al., 2002). Tyrp1containing compartments in melanocytes from OCA2-deficient mice are less acidic than
in wild-type melanocytes, suggesting that OCA2 not only localizes to melanosomes but
also modulates their pH (Puri et al., 2000), although this interpretation is disputed
because Tyrp1 does not localize to melanosomes properly in OCA2-deficient
melanocytes (Manga et al., 2001). The possibility that melanosomal pH might be affected
by OCA2 deficiency is supported by an observed increase in melanin synthesis upon
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neutralization of organellar pH in otherwise hypopigmented OCA2-deficient melanocytes
(Ancans et al., 2001b). Other evidence, however, suggests that OCA2 localizes to and
functions from the endoplasmic reticulum (ER). OCA2-immunoreactive subcellular
fractions from melanocytes contain ER markers as well as melanin, and OCA2
colocalized extensively with ER markers by indirect IFM (Chen et al., 2002). Moreover,
cells that lack OCA2 show a reduction in terminal glycosylation of Tyr (Chen et al.,
2002; Toyofuku et al., 2002), suggesting that OCA2 activity might provide an optimal
environment within the ER to facilitate Tyr folding. Thus far, this controversy has not
been resolved.

To resolve this debate and extend our understanding of melanosomal protein trafficking,
we attempted to clarify the subcellular localization and site of action of OCA2 and to
define the determinants required for its localization. Our results demonstrate that human
OCA2 is rapidly processed by Golgi enzymes, suggesting that it is not a resident ER
protein. Consistently, ectopically expressed OCA2 localizes predominantly to
melanosomes in a manner that depends on a cytoplasmic dileucine-based sorting signal,
similar to those found in Tyr and Tyrp1. A second dileucine-based signal in human
OCA2 facilitates steady-state lysosomal but not melanosomal localization. We further
show that melanosomal localization of OCA2 correlates with its function in supporting
melanin synthesis. These results strongly suggest that OCA2 is active in melanosomes
and raise the possibility that OCA2 activity may be limited by additional sorting to
lysosomes.
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2.3 Results
OCA2 Transits to a Post-ER Compartment and Becomes Terminally Glycosylated.
Analysis of the primary sequence of human OCA2 reveals three evolutionarily conserved
consensus N-glycosylation sites within the first predicted lumenal loop (at Asn residues
214, 218, and 273) and additional sites elsewhere, but mouse OCA2 was suggested to be
nonglycosylated based on lack of a mobility shift in tunicamycin-treated cells (Rosemblat
et al., 1994). We thus tested whether human OCA2 was in fact N-glycosylated using
endoglycosidase treatment in a metabolic pulse/chase and immunoprecipitation
experiment. MNT-1 human melanoma cells that endogenously express OCA2 or HeLa
cells transiently transfected with OCA2 were pulse-labeled with 35S-cysteine/methionine,
chased for various times, and then lysed and subjected to immunoprecipitation with the
NOCA2 anti-OCA2 antibody. Immunoprecipitates were mock treated or digested with
endoH or PNGase F. Endogenous OCA2 from pulse-labeled MNT-1 cells is entirely
sensitive to digestion by both endoH and PNGase F, indicating that it is modified by the
addition of core N-linked oligosaccharides. By 1 h of chase, a cohort of OCA2 becomes
resistant to cleavage by Endo H (Figure 2.1a, compare M and D, arrows), indicating
modification by N-acetylglucosamine transferase in the medial Golgi. By 4 h of chase, all
detectable OCA2 is resistant to endoH. As a control, PNGase F digestion increases the
mobility of OCA2 at all time points. Similar results were obtained in transiently
transfected HeLa cells expressing OCA2, although processing in the Golgi seemed to be
faster (Figure 2.1b). Note that processed OCA2 disappeared rapidly from detergent
lysates in melanocytes, consistent with earlier results, suggesting close association with
melanin (Donatien and Orlow, 1995), but much less rapidly in transfected HeLa cells.
53

Figure 2.1

Figure 2.1. Human OCA2 is N-glycosylated and is not an ER resident protein.
(a and b) Endogenous OCA2 in MNT-1 human melanoma cells (a) or transfected OCA2
in HeLa cells (b) was immunoprecipitated after metabolic labeling and indicated chase.
Immunoprecipitates were digested with endoglycosidases, fractionated by SDS-PAGE,
and analyzed by phosphorimaging. M, fully mature protein; P, precursor protein with
incomplete glycosylation; D, deglycosylated protein; -, mock treatment; H, endoH
treatment; F, PNGase F treatment; *, nonspecific band. All markers are indicated in
kilodaltons.
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The reduction in Mr resulting from PNGase F or endoH treatment of OCA2 was ~7 kDa,
consistent with loss of two N-linked oligosaccharide chains. Consistently, the Mr of
OCA2 isolated from normal human melanocytes or OCA2-transfected COS-7 cells was
reduced if cells were first treated with the N-glycosylation inhibitor tunicamycin or the
mannosidase inhibitor deoxymannojirimycin (data not shown). Together, these results
indicate that OCA2 is a glycoprotein and is not a resident of the ER but rather traffics to
at least the medial Golgi.

OCA2 Localizes to Melanosomes in Melanocytes and Lysosomes in Nonmelanocytes.
Because OCA2 is largely exported from the ER and thus does not behave like an ER
resident protein, we next sought to determine the steady-state localization of OCA2 in
melanocytes and nonmelanocytic HeLa cells. Endogenous OCA2 in human melanocytic
cells could not be detected by IFM (data not shown), but a full-length human OCA2
transgene product, with or without a triple HA epitope tag inserted in-frame within the
first lumenal loop of the protein (OCA2-HA; see Figure 2.5a) could be detected in
several melanocytic cell lines after transient transfection. The HA tag did not affect
OCA2 function (see Figure 2.3) and permitted detection of the OCA2-HA transgene with
an anti-HA antibody. When expressed in pigmented melan-Ink4a mouse melanocytes,
both OCA2 and OCA2-HA were distributed in either a reticular or vesicular pattern as
revealed by labeling with NOCA2 or anti-HA antibodies and analysis by IFM and image
deconvolution (Figure 2.2a; data not shown). The reticular pattern was similar to that
observed with antibodies to ER markers (data not shown). Qualitative observations of
transfected cells did not reveal an obvious correlation between transgene expression level
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Figure 2.2

Figure 2.2. OCA2 localizes to melanosomes in melanocytes and to lysosomes in
nonmelanocytes.
(a–c) Melan-Ink4a melanocytes were transfected with human OCA2-HA and stained with
anti-HA antibodies (a; magenta in the merge, c). The bright field image of pigmented
melanosomes (b) is inverted and colored green in the merge (c). (d–f) HeLa cells
transfected with human OCA2-HA were treated with 50 µg/ml cycloheximide for 3 h
before fixation. Cells are stained with antibodies to HA (d; magenta in the merge, f) and
the lysosomal marker LAMP-1 (e; green in the merge, f). Insets, 3X magnification of
boxed regions. Arrows point to regions of overlap between OCA2-HA and melanosomes
(a–c) or lysosomes (d–f). Asterisk indicates an overexpressing cell. Bar, 10 µm.
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and the subcellular distribution of the protein. In cells with vesicular labeling, the antiOCA2 or anti-HA label overlaps almost entirely with that of the melanosomal marker
Tyrp1 (data not shown), as well as with pigment granules visualized by bright field
microscopy (Figure 2.2, b and c). These data suggest that although a cohort of
exogenously expressed OCA2 accumulates in the ER, OCA2 that exits the ER is targeted
to melanosomes.

Most melanosomal proteins localize to late endosomes or lysosomes when expressed in
nonmelanocytic cells (Bouchard et al., 1989b; Vijayasaradhi et al., 1995; Calvo et al.,
1999; Simmen et al., 1999; Berson et al., 2001). We therefore tested the localization of
OCA2-HA expressed in nonmelanocytic HeLa cells. As with melanocytes, OCA2 or
OCA2-HA was distributed either in a predominantly reticular pattern, characteristic of
the ER, or a predominantly vesicular pattern (30.4 and 69.5% of transfected cells,
respectively; Figure 2.2d; data not shown). The vesicles overlapped nearly completely
with labeling for LAMP-1, a membrane protein that accumulates in late endosomes and
lysosomes (Figure 2.2, e and f). Treatment of HeLa cells for 3 h with the protein
synthesis inhibitor cycloheximide increased the percentage of cells displaying
predominantly vesicular HA staining to 81.7%. Additionally, the fraction of cells
exhibiting vesicular localization increased with increasing time after transfection (data
not shown). A similar cycloheximide treatment in transfected melan-Ink4a melanocytes
did not alter the ratio of cells with predominantly ER or vesicular staining, although it did
significantly reduce the fraction of cells with any detectable labeling (data not shown).
This is likely a consequence of the rapid degradation of OCA2 observed in melanocytic
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cells (Figure 2.1a), such that OCA2 fails to accumulate to detectable levels without
continuous biosynthetic input. We therefore interpret these results to suggest that the ERlocalized pool of OCA2 is transient and that OCA2 traffics to melanosomes in
melanocytes and to lysosomes in nonmelanocytes. We cannot exclude the possibility that
microheterogeneity in our cell culture system contributes to differential rates of ER exit
or stability within melanosomes.

ER-localized OCA2 Cannot Rescue Pigmentation of OCA2-deficient Melanocytes.
Because a significant cohort of exogenously expressed OCA2 resides in the ER at steady
state, we tested whether OCA2 in the ER is functional. We took advantage of the fact that
expression of human OCA2 in nonpigmented, OCA2-deficient mouse melan-p1
melanocytes can restore melanin synthesis and consequent pigmentation (Sviderskaya et
al., 1997), and we asked whether purposeful retention of OCA2 in the ER is compatible
with this function.

We first constructed two OCA2 mutants that are constitutively localized to the ER.
OCA2-HMGCR was created by fusing the C-terminal cytoplasmic domain of human
HMG CoA reductase (HMGCR), containing a canonical dilysine ER retrieval signal
(Jackson et al., 1990), to the cytoplasmic C terminus of OCA2-HA (Figure 2.3a). OCA2HMGCR was effectively retained in the ER when expressed in MNT-1 melanoma cells,
as judged by colocalization with calnexin by IFM (Figure 2.4, a–c). As controls, we
constructed two mutants in which the lysine residues were mutagenized to alanine
(OCA2-HMGCR-AATA) or in which the targeting signal was deleted (OCA2-HMGCR58

Figure 2.3
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Figure 2.3. OCA2 function correlates with localization to melanosomes.
(a) Scheme of HA-tagged, chimeric, and truncated OCA2 proteins as described in the
text. Added sequences in fusion proteins are indicated at the N or C termini. All
constructs bear a triple HA epitope tag (3xHA, indicated by a black bar). Gray boxes
indicate predicted transmembrane domains, and N-glycosylation sites are indicated by
branching. (b–m) OCA2-deficient melan-p1 mouse melanocytes were transfected with
human OCA2-HA (b–d), MHRRROCA2-ΔN91 (e–g), MHAAA-OCA2-ΔN91 (h–j), or
OCA2-AA123 (k–m; see Figure 3.4a). Transfected cells were identified by anti-HA
staining (b, e, h, and k) and visually inspected for the presence of pigmented
melanosomes by bright field microscopy (c, f, i, and l). In the merged images (d, g, j, and
m), the bright field image is inverted and colored green and anti-HA is colored magenta.
Insets, 5X magnification of boxed regions. Arrows point to regions of overlap between
OCA2-HA and melanosomes (b–d, h–j). Bar, 10 µm. (n) Bar graph of pigmentation
rescue by each OCA2 construct. Shown is the percentage of transfected cells expressing
each indicated construct that contained pigmented melanosomes (% pigmented cells).
The degree of rescue induced by any construct bearing an ER targeting signal or lacking
endogenous dileucine sorting signals was significantly different from rescue induced by
wild-type OCA2-HA. *, p < 0.05; ***, p < 0.001.
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Figure 2.4

Figure 2.4. ER targeting signals alter localization of OCA2 chimeras.
MNT-1 human melanoma cells were transfected with OCA2-HMGCR (a-c), OCA2ΔN91 (d-f) or MHRRR-OCA2-ΔN91 (g-i), and analyzed for colocalization between each
OCA2 construct, visualized by anti-HA staining (a, d, g), and either the ER marker
calnexin (b, h) or pigmented melanosomes (bright field, e). c, f, and i are merged images
in which anti-HA is colored green and anti-calnexin (c, i) or the inverted bright field
image (f) is colored magenta. Arrows indicate colocalization between OCA2-ΔN91 and
pigmented melanosomes (g-i). Bar = 10 µm.
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ΔKKTA) (Figure 2.3a); these mutants were weakly and strongly localized to
melanosomes, respectively (data not shown). Another OCA2 chimeric construct bore an
N-terminal cytoplasmic ER-targeting arginine motif, MHRRR, derived from the p35
form of human Invariant chain (Schutze et al., 1994). This signal did not confer ER
retention when fused to full-length OCA2 (data not shown). However, when appended to
a deletion mutant that lacked the first 91 amino acids of OCA2 (OCA2-ΔN91) and that
localized by IFM in pigmented MNT-1 melanoma cells to melanosomes like fulllength
OCA2-HA (Figure 2.4, d–f), the resultant MHRRR-OCA2-ΔN91 fusion protein was
effectively retained in the ER (Figure 2.4, g–i); the Δ91 deletion presumably brought the
N-terminal ER retention signal near enough to the membrane anchor to allow for
interactions with membrane-proximal effectors. By contrast, when the triple arginine
signal was mutagenized to a triple alanine (MHAAA-OCA2-ΔN91), melanosomal
localization in melan-Ink4a was restored (data not shown, but see Figure 2.3).

To test whether ER-retained OCA2 is functional, each of these mutants was expressed in
hypopigmented, OCA2-deficient mouse melan-p1 cells and restoration of pigmentation
was scored by bright field microscopy. As expected, expression of human OCA2-HA was
sufficient to rescue pigmentation in 80% of transfected melan-p1 cells (Figure 2.3, b–d,
n), indicating that the addition of the lumenal triple HA tag does not negatively affect
OCA2 function. Likewise, the level of rescue induced by OCA2-ΔN91, 69%, was not
significantly different from wild-type, indicating that the first 91 amino acids of OCA2
are not essential for protein function (Figure 2.3n). Strikingly, expression of OCA2HMGCR or MHRRR-OCA2-ΔN91, both of which localized in melan-p1 cells to a
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reticular pattern characteristic of ER as in MNT-1 cells (Figure 2.3, e–g; data not shown),
rescued pigmentation in only 16 and 17% of transfected cells, respectively (Figure 2.3n).
The corresponding fusion proteins with mutated ER targeting signals—MHAAA-OCA2ΔN91 and OCA2-HMGCR-ΔKKTA—showed restored vesicular/melanosomal
localization (Figure 2.3, h–j; data not shown) and induced pigmentation in a fraction of
melan-p1 cells that was not significantly different from that induced by wild-type OCA2HA (Figure 2.3n); OCA2-HMGCR-AATA rescued more efficiently than OCA2HMGCR but not as efficiently as OCA2-HMGCR-ΔKKTA, consistent with its partial
restoration of melanosome localization. This might reflect misfolding induced by the
elongated C-terminal domain, as similar observations were made with other C-terminally
extended OCA2 variants (data not shown). Overall, our results demonstrate that OCA2 is
unable to promote melanin synthesis from the ER of melanocytes and therefore must
function in a post-ER compartment.

OCA2 Localization Requires Cytoplasmic Dileucine Motifs.
To begin to understand the mechanism by which OCA2 is sorted to melanosomes, we
next investigated the cis-acting signals required for OCA2 localization. The cytoplasmic
Cterminal domains of the melanosomal proteins Tyr and Tyrp1 contain sequences
conforming to the [D/E]XXXL[L/I] consensus for acidic dileucine motifs that are
necessary for sorting of these proteins to melanosomes (Vijayasaradhi et al., 1995; Calvo
et al., 1999; Simmen et al., 1999). Mutagenesis of the two leucine residues within these
motifs results in mislocalization to the cell surface. Three sequences conforming to the
acidic dileucine consensus are present in the human OCA2 cytoplasmic N-terminal
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domain (Figure 2.5a). We tested whether these motifs are required for steady-state
localization of OCA2-HA to melanosomes by simultaneously mutagenizing the leucine
residues in all three motifs to alanine and examining the localization of the resultant
mutant, expressed transiently in wild-type melan-Ink4a melanocytes, by IFM. Whereas
wild-type human OCA2-HA localizes to melanosomes in these cells (Figure 2.5, b–d),
the triple dileucine mutant (OCA2-AA123) localizes to the cell periphery (Figure 2.5, e–
g). HA-positive structures within the cell perimeter did not colocalize with melanosomes
(Figure 2.5g), but rather they seemed to correspond to surface projections. As with wildtype OCA2, the labeling pattern of OCA2-AA123 in transiently transfected melanocytes
was heterogeneous, in that some cells showed a reticular pattern rather than peripheral
protein localization. Similarly, whereas wild-type OCA2 localized to lysosomes in HeLa
cells, OCA2-AA123 localized to the cell periphery in these cells as well (Figure 2.6). To
confirm localization to the cell surface, wild-type OCA2-HA or OCA2-AA123 was
transiently expressed in pigmented melan-Ink4a melanocytes and incubated at 4°C with
anti-HA antibodies to detect the lumenally exposed (extracellular) triple HA tag on the
cell surface. Cells were then washed, fixed, permeabilized, and stained with NOCA2 to
identify all transfected cells (NOCA2 binding is not affected by mutagenesis of the Nterminal dileucine motifs). Cells expressing OCA2-AA123 were labeled with the anti-HA
antibody, whereas cells expressing wild-type OCA2-HA were not (Figure 2.7, a–f).
Together, these data show that the dileucine motifs in the N-terminal cytoplasmic domain
of human OCA2 are necessary for melanosome/lysosome localization and that in their
absence OCA2 localizes by default to the plasma membrane.
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Figure 2.5

Figure 2.5. OCA2 melanosomal sorting requires intact dileucine motifs.
(a) Topology of human OCA2 and sequence of the cytoplasmic N terminus with putative
acidic dileucine motifs indicated in magenta. (b–g) Wild-type OCA2-HA (b–d) or the
triple dileucine mutant OCA2-AA123 (e–g) were expressed in pigmented melan-Ink4a
melanocytes. Transfected cells are identified by anti-HA staining (b and e; colored
magenta in merged images, d and g). Bright field images (c and f) were inverted and
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colored green in merged images (d and g). Insets, 4X magnification of boxed regions.
Arrows point to regions of overlap between OCA2-HA and melanosomes (b–d). Bar, 10
µm.
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Figure 2.6

Figure 2.6. Overexpression of OCA2 intact dileucine motifs induces lysosomal swelling
and clustering in HeLa cells.
a-f) HeLa cells were transfected with either human OCA2-HA (a-c) or the OCA2-AA123
mutant (d-f) and transgenic proteins were visualized by staining with anti-HA antibodies
(a, d). Lysosomes were identified by staining of the marker LAMP-1 (b, e). c and f are
merged images in which anti-HA labeling is colored green and anti-LAMP-1 is colored
magenta. Note the swelling and perinuclear clustering of lysosomes only in cells
expressing OCA2-HA (insets 2) relative to untransfected cells (insets 1). g-i) HeLa cells
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were transfected with OCA2-TfR and stained with NOCA2 to identify transgenic
proteins (g) and with anti-LAMP-1 (h). Merged image (i) shows anti-OCA2 in green and
anti-LAMP-1 in magenta. Note lysosomal clustering in transfected cells (inset 2) but not
in untransfected cells (inset 1). Bar = 10 µm.
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Figure 2.7

Figure 2.7. Surface localization of OCA2-AA123.
Pigmented melan-Ink4a melanocytes expressing human OCA2-AA123 (a-c) or OCA2HA (d-f) were incubated with anti-HA antibodies at 4°C to label surface-localized OCA2
proteins (a, d) and then washed, fixed, permeabilized, and stained with NOCA2 (b, e) to
mark all transfected cells. Bright field images show melanosomes in c, f. Bar = 10 µm.
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To determine whether sorting to melanosomes was required for OCA2 function, we
tested whether the cell surface localized OCA2-AA123 could restore pigmentation upon
expression in melan-p1 cells. As with cells expressing the ER-localized OCA2 fusion
proteins, only 3% of melan-p1 cells expressing OCA2-AA123 were pigmented (Figure
2.3, k–n). This indicates that OCA2 cannot function on the cell surface and must function
from an intracellular, post-ER compartment. Interestingly, lysosomes in HeLa cells that
overexpressed OCA2-HA tended to be unusually clustered around the nucleus and
swollen compared with untransfected cells (Figure 2.6, compare insets 1 and 2); a similar
phenomenon has been seen in HeLa cells expressing tyrosinase (Calvo et al., 1999). By
contrast, lysosomes in HeLa cells expressing the surface-localized OCA2- AA123
seemed similar to those in untransfected cells (Figure 2.6). These results suggest that
overexpression of the intact OCA2 cytoplasmic sorting signals can alter late
endosome/lysosome function or morphology, further supporting a functional role for
these motifs in sorting to lysosome-like organelles.

OCA2 Dileucine Motifs Are Sufficient for Lysosomal Localization in Nonmelanocytes and
Intracellular Targeting in Melanocytes.
To determine whether the OCA2 dileucine motifs were sufficient to cause trafficking to
lysosomes or melanosomes, we assessed their ability to direct the localization of a
reporter molecule. We generated chimeric proteins in which the Nterminal cytoplasmic
domain of either wild-type human OCA2 or the dileucine mutant, OCA2-AA123, was
fused to the transmembrane and lumenal domains of human transferrin receptor (hTfR) to
generate OCA2-TfR and AA123-TfR, respectively (Figure 2.8a). hTfR, which normally
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Figure 2.8
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Figure 2.8. OCA2 dileucine motifs are sufficient for lysosomal localization in
nonmelanocytes.
(a) Schematic of OCA2-transferrin receptor chimeras. Green, hTfR sequences; blue,
cytoplasmic N terminus of human OCA2; TM, hTfR transmembrane domain; green
circles, intact OCA2 dileucine motifs; white X’s, disrupted dileucine motifs. Binding
regions of relevant antibodies are indicated. The NOCA2 epitope does not overlap the
dileucine motifs. (b–j) Chinese hamster ovary cells were transfected with hTfR (b–d),
OCA2-TfR (e–g), or AA123-TfR (h–j), and the transgenic proteins were localized at
steady-state by anti-hTfR staining (b, e, and h). The lysosomal marker LAMP-1 is stained
in c, f, and i, and images are merged in d, g, and j with anti-hTfR in green and antiLAMP-1 in magenta. Insets, 4X magnification of boxed regions. (k–p) Chinese
hamster ovary cells were cotransfected with wild-type OCA2-HA (k and n) and OCA2TfR (l and o) and incubated with (n–p) or without (k–m) 50 mM NH4Cl before fixation in
order to inhibit lysosomal degradation. Lysosomes are marked by LAMP-1 staining (m
and p). Insets show 3X magnifications of two-color merged images of OCA2-HA
(green), OCA2-TfR (red), and LAMP-1 (blue). Arrows point to regions of overlap among
the three proteins (n–p). Bar, 10 µm.
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cycles between the plasma membrane and early endosomes, was chosen as a fusion
partner because it is a type II integral membrane protein and thus allowed us to maintain
the proper orientation of the OCA2 N-terminal domain. hTfR or the chimeric proteins
were transiently expressed in CHO cells, which do not endogenously express human
OCA2 or hTfR, and localization was determined by IFM. As expected, heterologously
expressed hTfR localized to the cell surface and to peripheral intracellular puncta that did
not overlap with the late endosome/lysosome marker LAMP-1 and that likely represent
early endosomes (Figure 2.8, b–d). By contrast, OCA2-TfR localized exclusively to
intracellular compartments that were predominantly accumulated in the perinuclear area
(Figure 2.8, e–g). Mutagenesis of the three dileucine motifs in AA123-TfR restored cell
surface localization (Figure 2.8, h–j). Surprisingly, the puncta to which OCA2-TfR
localized did not appreciably overlap with LAMP-1. We reasoned that the hTfR lumenal
domain, to which the antibody was directed, might be degraded within LAMP-1containing late endosomes and lysosomes. To test this possibility, CHO cells that were
cotransfected with both the OCA2-TfR chimera (Figure 2.8, l and o) and full-length
OCA2-HA (Figure 2.8, k and n) were analyzed by IFM after treatment with 50 mM
NH4Cl to neutralize lysosomes and interfere with proteolysis. Whereas neither protein
colocalized with LAMP-1 in untreated cells (Figure 2.8, k–m), both OCA2-TfR and
OCA2-HA redistributed to vesicular structures that colocalized with LAMP-1 in NH4Cltreated cells (Figure 2.8, n–p). Consistently, OCA2-TfR localized to LAMP-1-positive
compartments in HeLa cells even without lysosomal inhibition, and induced enlargement
and perinuclear clustering like full-length OCA2-HA (Figure 2.6). These results confirm
that the OCA2 dileucine motifs are sufficient to direct trafficking to lysosomes in
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nonmelanocytes. Moreover, the enlargement and clustering of LAMP-1-positive
compartments in HeLa cells induced by expression of OCA2-TfR indicates that these
effects are a consequence of overexpression of the cytoplasmic sorting signals and not of
OCA2 ion transport activity. Similar observations were made upon overexpression of a
chimeric protein with the tyrosinase cytoplasmic domain (Calvo et al., 1999). It is unclear
why this effect on lysosome morphology is not seen in transfected CHO cells, but it may
reflect the apparently heightened sensitivity of lysosomally-localized OCA2 constructs to
degradation in this cell type.

When expressed in melanocytic cells, OCA2-TfR was detected intracellularly on
perinuclear vesicular structures that overlapped minimally with pigment granules and the
melanosome marker Tyrp1 (Figure 2.9). We were unable to alter its distribution by
treatment with inhibitors of lysosomal proteases or deacidification reagents; however,
similar results were obtained with other chimeras that target to lysosomes in other
melanocytic cells (data not shown), suggesting that lysosomal proteolysis might be more
difficult to disrupt in melanocytes than in other cell types. We thus could not directly
determine whether the dileucine motifs were sufficient for localization to melanosomes.
However, by labeling transfected melan-Ink4a cells with anti-hTfR antibodies without
permeabilization at 4°C, we tested whether the dileucine motifs confer steady-state
intracellular localization. Whereas intact cells expressing full-length hTfR (Figure 2.10,
a–c) or AA123-TfR (Figure 2.10, g–i) were strongly labeled at the cell surface by antihTfR antibodies, cells expressing OCA2-TfR were not (Figure 2.10, d–f). These data
indicate that the N-terminal OCA2 dileucine motifs are sufficient to confer intracellular
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Figure 2.9

Figure 2.9. OCA2-TfR is not detectable in melanosomes at steady state.
Wild-type melan-Ink4a melanocytes were transfected with OCA2-TfR and stained
with antibodies against hTfR (a) and the melanosomal marker Tyrp1 (b). Images are
merged in c (anti-hTfR, green; anti-Tyrp1, magenta). Bar = 10 µm.
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Figure 2.10

Figure 2.10. OCA2 dileucine motifs confer internal localization in melanocytes.
Wild-type melan-Ink4a melanocytes were transfected with hTfR (a–c), OCA2-TfR (d–f),
or AA123-TfR (g–i) and incubated at 4°C with antibodies to the extracellular region of
hTfR (b, e, and h). After subsequent washing, fixation, and permeabilization, cells were
labeled with NOCA2 antibody (c, f, and i) to identify transfected cells expressing
chimeric proteins. Bright field images are shown in a, d, and g. Bar, 10 µm.
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localization in melanocytes, and they are consistent with the notion that they may confer
melanosome localization.

Individual OCA2 Dileucine Motifs Are Not Functionally Equivalent.
To determine whether individual OCA2 dileucine motifs had distinct or redundant
functions, we mutagenized each of the three motifs individually or in all possible
combinations within the context of OCA2-HA (Figure 2.11a). The three motifs are
designated LL1, LL2, and LL3, with LL1 being the most N-terminal and LL3 the most Cterminal. The corresponding OCA2 mutant proteins are designated OCA2-AA1, -AA2,
and -AA3. Mutants were expressed in wild-type melan-Ink4a melanocytes and
localization was determined by IFM. Disruption of LL3 (OCA2-AA3) did not affect
steady-state localization of OCA2-HA to melanosomes (data not shown), whereas
disruption of LL1 and LL2 together—leaving only LL3 intact (OCA2-AA12)—ablated
localization to melanosomes and resulted in surface expression as seen with the triple
mutant (Figure 2.11, c–e). Therefore, LL3 is dispensable for OCA2 trafficking.
Strikingly, mutants in which LL2 alone (OCA2-AA2) or both LL2 and LL3 (OCA2AA23) were mutagenized, leaving LL1 intact, were as efficiently localized at steady state
to melanosomes as the wildtype protein (Figure 2.11, f–h; data not shown). This indicates
that, within the context of full-length OCA2, LL1 is sufficient to confer melanosomal
localization. Moreover, LL1 is necessary for steady-state melanosomal localization,
because mutants in which LL2 was present but LL1 was disrupted (OCA2-AA1 and
OCA2-AA13) did not colocalize with pigment granules (Figure 2.11, i–k; data not
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Figure 2.11
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Figure 2.11. Localization and function of OCA2 dileucine mutants.
(a) Schematic of the panel of human OCA2 dileucine mutants with the relevant Nterminal region of OCA2 highlighted. A green circle indicates the presence of LL1, LL2,
or LL3, and a white X indicates its absence. (b) Dileucine mutants were expressed in
melan-p1 cells, and transfected cells were visually inspected for the presence of
pigmented melanosomes. Shown is the percentage of transfected cells expressing each
indicated construct that contained pigmented melanosomes (% pigmented cells).
Columns with asterisks were significantly different from rescue by OCA2-HA. **,
p < 0.01. (c–n) IFM analysis of melan-Ink4a cells expressing selected mutant OCA2
variants. Melan-Ink4a melanocytes were transfected with OCA2-AA12 (c–e), OCA2AA2 (f–h), or OCA2-AA1 (i–n). Transgenes were visualized with anti-HA antibodies (c,
f, i, and l), melanosomes were visualized by bright field (BF) microscopy (d, g, j, and m),
and late endosomes/lysosomes were visualized by labeling with anti-LAMP-2 antibody
(n). e, h, and k are merged OCA2-HA (magenta) and inverted bright field (green) images.
All insets show 3.5X magnified images of the boxed region, and insets in l–n show paired
merged images of anti-HA (green), anti-LAMP-2 (red), and inverted bright field (blue).
Arrows point to regions of overlap of OCA2 constructs with melanosomes (f–h) or with
LAMP-2 (l–n). Bars, 10 µm.
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shown). Rather, these mutants localized at steady state to nonpigmented, cytoplasmic
vesicles that were also labeled by antibodies to LAMP-2 (Figure 2.11, l–n; data not
shown), a lysosomal marker (Granger et al., 1990) that is largely excluded from pigment
granules in melan-Ink4a cells. Together, these data indicate that LL1 is necessary and
sufficient for melanosomal trafficking in the context of full-length OCA2, whereas LL2
confers steady-state localization to lysosomes, but not to melanosomes, in a manner that
is masked by LL1 function. In HeLa cells, which do not have a separate melanosomal
trafficking pathway, the presence of either LL1 or LL2 was sufficient to confer lysosomal
localization of full-length OCA2 mutants, whereas the simultaneous loss of both motifs
caused accumulation on the cell surface similar to that seen with the triple mutant (data
not shown).

To determine whether melanosomal localization correlated with OCA2 function, we next
tested how mutagenesis of distinct dileucine motifs affected the ability of OCA2 to
rescue pigmentation when expressed in melan-p1 cells (Figure 2.11b). Transfected cells
expressing a mutant in which LL1 was disrupted (AA1, AA12, and AA123) showed a
significant reduction in the percentage of pigmentation, suggesting that melanosomal
localization is needed for maximal OCA2 function in pigmentation. By contrast,
disruption of either LL2 (AA2) or LL3 (AA3) had no significant effect, and a mutant in
which only LL1 was intact (AA23) rescued pigmentation as efficiently as the wild-type
protein. The surface-localized OCA2-AA12 mutant, lacking both LL1 and LL2, was as
inefficient as the triple mutant in restoring pigmentation. These results corroborate the
finding that of the three dileucine motifs in the N terminus of OCA2, LL1 is the most
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important for both localization to melanosomes and function. Interestingly, mutants
lacking LL1 but retaining LL2 (OCA2-AA1 and -AA13) were able to partially restore
pigmentation to melan-p1 cells. Because these mutants localize at steady state to
lysosomes, one possible interpretation of this result is that a cohort of melanosomelocalized OCA2 that is below the limit of detection is sufficient to rescue pigmentation in
these cells. Alternatively, OCA2 might either transiently traverse melanosomes en route
to late endosomes/lysosomes or function from late endosomal compartments.

OCA2 Binds Adaptors AP-1 and AP-3 in a Dileucine-dependent Manner.
Previous studies have shown that acidic dileucine signals bind to members of the
clathrin-associated heterotetrameric adaptor protein family (Bonifacino and Traub, 2003;
Janvier et al., 2003; Chaudhuri et al., 2007; Doray et al., 2007). The acidic dileucine
signal in Tyr mediates an interaction with both AP-3 and AP-1 (Honing et al., 1998;
Theos et al., 2005), whereas the corresponding signal in Tyrp1 has been shown to interact
with AP-1 only (Theos et al., 2005). We therefore used an affinity “pull-down” assay to
test whether the dileucine motifs in the OCA2 cytoplasmic domain can be recognized by
heterotetrameric adaptors. Recombinant fusion proteins consisting of GST fused to the
cytoplasmic N terminus of wild-type (GST-OCA2NT) or mutagenized human OCA2 were
purified, immobilized onto glutathione-Sepharose beads, and then incubated with MNT-1
or HeLa cell lysates. Bound proteins were analyzed by immunoblotting. As shown in
Figure 2.12a, GST-OCA2NT bound the adaptor proteins AP-1, AP-2, and AP-3 but not
the unrelated proteins β-actin, α-tubulin, Rab5, or the BLOC-1 subunit pallidin. We did
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Figure 2.12

Figure 2.12. OCA2 cytoplasmic dileucine-based motifs differentially bind AP proteins.
(a) GST alone (GST) or fused to the N-terminal cytoplasmic domain of human OCA2
(GST-OCA2NT) was bound to glutathione-Sepharose and then incubated without (No
Lys) or with MNT-1 cell lysates. Bound proteins were fractionated by SDS-PAGE and
immunoblotted with antibodies to the proteins indicated at left. The first lane includes
lysate before incubation (1% of the total used for the pulldowns). (b) GST fused to wildtype (OCA2NT) or the indicated mutants of the N-terminal cytoplasmic region of human
OCA2, or to the C-terminal cytoplasmic domain of OA1 as a negative control (OA1CT5),
were bound to glutathione-Sepharose, incubated without (No Lys) or with HeLa cell
lysate, and then analyzed by immunoblotting. Arrows point to the relevant bands in the
immunoblot. Arrowheads point to cross-reactivity of the anti-AP-3 µ3A antibody with
GST-fusion proteins. Shown at bottom is a Coomassie-stained gel of identical reactions
showing the GST-fusion proteins.
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not detect binding of AP-1 or AP-3 to GST fused to the C-terminal cytoplasmic domain
of the melanosomal/ lysosomal protein OA1 (GST-OA1CT5). This domain contains an
unrelated sorting signal that does not conform to any canonical AP-binding consensus
sequences (Figure 2.12b) (Piccirillo et al., 2006). These data suggest that the cytoplasmic
domain of OCA2 interacts specifically with AP-1, AP-2, and AP-3.

To determine whether adaptor binding was mediated by the dileucine-based motifs, the
experiment was repeated using GST fused to OCA2 cytoplasmic domain mutants in
which one or more dileucine motifs were disrupted by dileucine-to-dialanine mutations
(Figure 2.12b). Whereas AP-2 binding to different mutants was detected inconsistently
over multiple trials (data not shown), AP-3 was consistently bound to GST-OCA2NT
fusions containing an intact LL1 (OCA2-AA2, -AA3, and -AA23) but not with fusions
containing a disrupted LL1 (OCA2-AA1, -AA12, -AA13, and -AA123). Although low
levels of bound AP-1 were observed even with a GST-OCA2NT fusion protein bearing
mutations in all three dileucine motifs (OCA2-AA123), much higher levels of bound AP1, as for AP-3, were observed with fusion proteins containing an intact LL1.
Interestingly, intermediate binding to AP-1 was observed with a mutant bearing only an
intact LL2 (OCA2-AA13). Detection of all AP complexes was dependent on incubation
with cell lysates (Figure 2.12b, “No Lys”), and identical results were observed using
lysates derived from MNT-1 cells (data not shown). These data suggest that LL1
mediates strong binding to AP-1 and AP-3, whereas LL2 mediates moderate binding to
AP-1 and LL3 has no appreciable affinity for the adaptors we tested. Thus, strong binding
to AP-1 and AP-3 correlates with steady-state localization to melanosomes and with
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OCA2 function, and modest binding to AP-1 correlates with steady-state lysosomal
sorting. These data further corroborate the different roles of the dileucine motifs and
implicate AP-1 and/or AP-3 in regulating the trafficking of OCA2.

2.4 Discussion
OCA2-deficient melanocytes have clear defects in melanosome morphology and
function, but previous reports have ascribed functions for OCA2 within different
subcellular locations. Recent reports suggest that melanosome malformation in OCA2deficient melanocytes results from misfolding of melanosomal proteins in the ER, and
that OCA2 localizes to the ER (Chen et al., 2002). Our data indicate that endogenous
OCA2 in melanocytic cells and OCA2 transgene products in nonmelanocytic cells reside
only transiently within the ER and that spatial restriction of OCA2 to the ER or to the cell
surface impairs the function of OCA2 in melanogenesis. IFM and deconvolution analyses
show that exogenously expressed OCA2 localizes to pigmented structures in mouse
melanocytes that bear markers of mature melanosomes. Moreover, like other
melanosomal proteins, the targeting of OCA2 to melanosomes is dependent on
cytoplasmic dileucine-based motifs that bind to AP-3 and AP-1 adaptors and mediate
lysosomal sorting in nonmelanocytic cells. These data indicate that OCA2 traverses
intracellular sorting pathways common to other melanosomal proteins. We conclude that
OCA2 localizes to and functions primarily within melanosomes.

The molecular function of the OCA2 protein is not yet known, but it is predicted to be a
transmembrane ion transporter based on sequence homology to the ArsB/NhaD family of
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permeases. Our results suggest that this proposed activity would be required to regulate
the intralumenal ion concentration within melanosomes to promote melanin synthesis.
The lack of melanin synthesis in OCA2-deficient cells is thus likely a direct consequence
of the dysregulation of ion content. This model is consistent with in vitro data showing
that tyrosinase activity is sensitive to pH and redox state (Townsend et al., 1984). Ion
dysregulation could in turn have indirect consequences on other processes in OCA2deficient cells. For example, alterations in intralumenal ion balance or pH can affect
cellular membrane fusion events (Peters and Mayer, 1998; Ungermann et al., 1999; Pryor
et al., 2000), perhaps explaining the accumulation of melanosomal cargo in vesicular
structures in OCA2-deficient melanocytes (Manga et al., 2001). Moreover, disruption of
OCA2 transport activity across the melanosomal membrane may indirectly alter ion
concentrations or pH in the cytosol; for example, exogenous expression of OCA2 in
Saccharomyces cerevisiae led to a depletion of cytoplasmic glutathione due to
glutathione transport into the vacuole (Staleva et al., 2002). Alterations in substrate levels
could in turn have downstream effects on ion transport between the cytosol and other
compartments, such as the ER. Such effects might alter folding or disulfide bond
formation of proteins such as tyrosinase in the ER, perhaps explaining the reduced rate of
processing and ER exit of tyrosinase in OCA2-deficient melanocytes (Toyofuku et al.,
2002). Tyrosinase contains 15 lumenal Cys residues and many intramolecular disulfide
bonds (Wang and Hebert, 2006), so changes in the disulfide bonding capacity of the ER
could have a significant effect on tyrosinase maturation. A similar indirect effect on
cellular ion levels and consequent tyrosinase missorting has been hypothesized to
underlie the pigmentation defects in cells bearing a mutated form of SLC24A5, a pigment
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cell-specific potassium-dependent sodium-calcium exchanger that was suggested to
localize to the trans-Golgi network (Ginger et al., 2008).

OCA2 is unique among melanosomal proteins by virtue of having multiple functional
dileucine-based trafficking signals. The three motifs we identified in the N terminus of
OCA2 are the only cytoplasmic sequences in the protein that conform to the acidic
dileucine consensus. Of these, only the first motif (LL1) has been specifically noted in
the past (Lee et al., 1995). The cytoplasmic N terminus of OCA2 is poorly conserved
across species, and LL1 is the only one of the three consensus dileucine signals in the
human homologue that is conserved in the mouse. This raises the question of how human
and murine OCA2 trafficking might differ. No posttranslational modifications of OCA2
(other than N-glycosylation) have been reported, but the N terminus contains many serine
residues that could be potential sites of regulatory phosphorylation. It is also possible that
the combined activities of both human dileucine signals are incorporated into the single
mouse dileucine signal, which differs in specific sequence from human LL1.
Consistently, the single dileucine signal of tyrosinase seems to be sufficient to target
tyrosinase to either of two distinct pathways to the melanosome (Theos et al., 2005; Setty
et al., 2007). Although dileucine-based signals clearly play crucial roles in melanosomal
trafficking, it is worth noting that none of the documented pathological point mutations in
human Tyr, Tyrp1, or OCA2 occur in the acidic dileucine motifs of the proteins. The
ability of the dileucine motifs to direct lysosomal localization of the OCA2-TfR chimera
in nonmelanocytes suggests that these motifs are likely sufficient for OCA2 trafficking,
but the existence of additional and/or potentially interacting melanosomal trafficking
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determinants cannot be ruled out because we could not visualize OCA2-TfR on
melanosomes in melanocytes.

The change in steady-state localization that arises from mutation of individual dileucine
motifs raises the possibility that different motifs mediate different steps of the trafficking
itinerary of human OCA2. IFM data suggest that LL2 confers steady-state localization to
lysosomes but is dominated by LL1, which confers steady-state localization to
melanosomes. The existence of two signals suggests either of two possible models for
OCA2 trafficking within melanocytes. One model posits that distinct cohorts of OCA2
use LL1 and LL2 for melanosomal and lysosomal trafficking, respectively. Mutagenesis
of either motif would thus render the mutant protein subject to the direction of the
remaining signal. Because LL1 mutants localize at steady state to lysosomes and yet
stimulate substantial melanin synthesis in melan-p1 cells, this model would require that
OCA2 be able to support optimal melanin synthesis in the melanosome either from late
endosomes/lysosomes but not from the ER or the cell surface, or via a cohort of
melanosome-localized OCA2 that is below the level of detection by IFM. A second
model posits that OCA2 traffics through both melanosomes and lysosomes sequentially
by virtue of sequential utilization of LL1 and LL2. In this case, LL2 would function as a
timer to limit the residence of OCA2 within melanosomes by targeting it to lysosomes for
subsequent degradation. OCA2 mutants that lack the strong melanosomal targeting of
LL1 but still stimulate significant melanin synthesis might be targeted inefficiently to
melanosomes via the weak AP-1-binding activity of LL2 and subsequently travel more
efficiently to lysosomes, which would constitute the predominant accumulation at steady
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state. This model would explain the short half-life of OCA2 in melanocytes and can
potentially be vigorously tested by live cell imaging experiments. In either case, the
differential localization of OCA2 mutants with only LL1 or LL2 intact indicates that
cytoplasmic targeting signals, irrespective of potential integral membrane or lumenal
targeting determinants, can be differentially decoded to confer steady-state localization to
lysosomes or melanosomes. This contrasts with the targeting of Tyrp1, in which lumenal
determinants seem to be required to distinguish these two fates (Groux-Degroote et al.,
2008).

LL1 and LL2 have differing abilities to bind adaptor proteins, thus suggesting a potential
mechanism behind the complex trafficking pathway of OCA2. Like that of tyrosinase, the
OCA2 cytoplasmic domain binds both AP-1 and AP-3. This binding depends critically on
the presence of LL1. LL2 binds AP-1 more weakly and does not bind significantly in our
assay to AP-3. Thus, steady-state localization of OCA2 to melanosomes, seen with all
constructs containing an intact LL1, correlates well with either AP-3 binding or highaffinity binding to either AP protein, similar to the situation for tyrosinase. By contrast, a
weak affinity for AP-1 alone may be sufficient to drive targeting of constructs containing
LL2 but lacking LL1 toward lysosomes, either directly from endosomes or secondarily
from melanosomes. Interestingly, lysosomal enlargement is seen in nonmelanocytes that
overexpress fusion proteins containing the wildtype dileucine motifs from OCA2 or Tyr,
which possess both AP-1 and AP-3 binding ability; enlargement is not seen when the
fusion protein contains the dileucine motif of Tyrp1, which binds only AP-1 (data not
shown). Thus, in this case a functional alteration of the target organelle seems to correlate
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with the cargo protein’s capacity for interaction with multiple AP proteins. How
differences in affinity might distinguish melanosomal from lysosomal targeting in
melanocytes remains to be elucidated. Moreover, whether the two adaptor proteins
distinguish the dileucine motifs by virtue of differences in their sequence or in their
position within the protein is not clear. Future experiments will more closely probe the
sequence of events in the trafficking of OCA2 to define the relationship between
melanosomal and lysosomal targeting and the role each plays in OCA2 function.
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CHAPTER 3: DIFFERENTIAL SEQUENCE PREFERENCES FOR AP-1 AND
AP-3 IN AN ACIDIC DILEUCINE-BASED SORTING SIGNAL REVEAL A
REQUIREMENT FOR BOTH BLOC-1 AND AP-3 IN DELIVERY OF OCA2 TO
MELANOSOMES
3.1 Abstract
Cell types that harbor unique lysosome-related organelles (LROs) require specialized
intracellular trafficking pathways to divert cargoes from conventional endocytic
organelles toward nascent LROs. In melanocytes, cargo delivery to melanosomes – the
LRO in which melanin pigments are synthesized and stored – correlates with cargo
binding via cytoplasmically exposed targeting signals to either of two clathrin-associated
adaptors, AP-1 or AP-3. Some cargoes, such as tyrosinase, have acidic dileucine-based
sorting signals that can bind either adaptor, but how binding to each adaptor functions
during melanosome delivery of such cargoes is not clear. Moreover, analyses of
melanocytes from mouse models of Hermansky-Pudlak syndrome suggest that AP-3 and
BLOC-1 function in mutually exclusive cargo transport pathways, whereas in other cell
types they appear to function together. Here, we use the pigment cell-specific putative
transporter, OCA2, to dissect the relative roles of AP-1 and AP-3 and their cooperativity
with BLOC-1 in melanosome transport. We show that interaction of the OCA2 acidic
dileucine-based melanosome targeting motif with AP-1 or AP-3 depends on the primary
sequence and not the position of the motif within the cytoplasmic domain. Directed
mutagenesis of the motif led to the isolation of mutants that show preferred binding to
either AP-1 or AP-3 by yeast two-hybrid analysis. Each mutant was able to traffic
toward melanosomes when expressed in wild-type melanocytes and rescue melanin
synthesis in OCA2-deficient melanocytes, but robust AP-3 binding was necessary for
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steady-state melanosome localization. Importantly, despite its dependence on AP-3,
OCA2 trafficking to melanosomes required BLOC-1. This dependence on BLOC-1 was
observed even when the endogenous OCA2 sorting motif was replaced with that of
tyrosinase, a single membrane-spanning domain enzyme that traffics to melanosomes in
an AP-3-dependent/ BLOC-1-independent fashion. The dependence of OCA2 on both
AP-3 and BLOC-1 for melanosomal localization indicates that BLOC-1 can cooperate
with either of several adaptors during cargo transport, thus reconciling melanosome cargo
transport with previously reported physical and functional interactions between AP-3 and
BLOC-1.

3.2 Introduction
Lysosome-related organelles (LROs) are cell type-specific organelles that share some
characteristics with lysosomes, such as an acidic lumenal pH, the presence of some
lysosomal proteins, and derivation from the endocytic system (Dell'Angelica et al., 2000;
Raposo et al., 2007), but are distinguished from true lysosomes in that they also contain
unique cargo proteins that confer distinct morphological and functional characteristics.
Some cell types simultaneously harbor LROs and lysosomes and consequently must
utilize unique sorting and trafficking pathways to divert specific cargo proteins from the
general endocytic pathway and deliver them to LROs (Dell'Angelica et al., 2000; Raposo
and Marks, 2007; Raposo et al., 2007). For example, melanocytes contains LROs called
melanosomes, organelles that serve as the site of synthesis of the melanin pigments that
give color to the skin, hair, and eyes (Marks and Seabra, 2001; Hearing, 2005).
Melanosomal cargoes are biosynthetically transported from endosomes to melanosomes
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(Raposo and Marks, 2007), but fluid-phase cargoes and the endosomally recycling
transferrin receptor are both excluded from melanosomes, consistent with the idea that
the melanosomal cargoes must be specifically sorted from endosomes into trafficking
pathways that are targeted to these organelles (Raposo et al., 2001; Delevoye et al.,
2009). Several studies have implicated both the AP-1 and AP-3 heterotetrameric adaptors
as being important for the trafficking of melanosomal cargo proteins from endosomes
(Huizing et al., 2001; Theos et al., 2005; Setty et al., 2007; Setty et al., 2008; Delevoye
et al., 2009). These complexes seem to regulate distinct LRO cargoes, but what
determines this selectivity is still unclear. Moreover, other components that facilitate
cargo delivery during or after AP-mediated sorting have not been clarified.

The AP complexes are a family of cytosolic trafficking adaptors that couple clathrin
recruitment to clustering of integral membrane cargo via interactions with short sorting
signals in the cytoplasmic domains of the target proteins (Boehm and Bonifacino, 2001;
Bonifacino and Traub, 2003; Robinson, 2004). One class of signals recognized by the AP
complexes is the acidic dileucine motifs, with the consensus [D/E]XXXL[L/I]
(Bonifacino and Traub, 2003). The melanosomal sorting of tyrosinase (Tyr) and
tyrosinase-related protein 1 (Tyrp1), two enzymes that carry out the synthesis of melanin,
depends on critical acidic dileucine sorting motifs in their cytoplasmic domains
(Vijayasaradhi et al., 1995; Calvo et al., 1999; Simmen et al., 1999; Huizing et al., 2001;
Theos et al., 2005; Setty et al., 2007; Delevoye et al., 2009). As expected, these two
motifs interact with adaptors, but they show differing levels of dependence on AP-1 and
AP-3. AP-1 binds the signals in the cytoplasmic domains of both Tyr and Tyrp1 in vitro
92

while AP-3 binds only the signal in Tyr (Honing et al., 1998; Theos et al., 2005). Those
features of acidic dileucine-based sorting signals that distinguish between AP-1 and AP-3
binding have not been identified. While a crystal structure has identified the interaction
site between the AP-2 core complex and an acidic dileucine-like signal from CD4 (Kelly
et al., 2008), comparable structures of AP-1 or AP-3 with signals have not been described
and thus the molecular basis for distinctive interaction patterns is not known.

Consistent with the in vitro binding, both Tyr and Tyrp1 are localized to AP-1-coated
endosomal buds and tubules that accumulate near melanosomes in melanocytic cells,
whereas only Tyr is found in the AP-3-coated structures in similar subcellular regions
(Raposo et al., 2001; Theos et al., 2005; Delevoye et al., 2009). In hypopigmented AP-3deficient pearl mouse melanocytes or melanocytes derived from AP-3-deficient human
patients, Tyr is largely mislocalized to early endosomes and multivesicular late
endosomes, suggesting that AP-3 is required to efficiently sort Tyr out of the classical
endosomal degradation pathway and toward melanosomes (Huizing et al., 2001;
Richmond et al., 2005; Theos et al., 2005). However, the amount of Tyr that localizes to
AP-1-coated buds also increases in these cells, suggesting that AP-1 might be able to
partially substitute for AP-3 under certain circumstances (Theos et al., 2005). By contrast
to Tyr, Tyrp1 (and another melanosome resident, ATP7A; (Setty et al., 2008)) is not
mislocalized like Tyr in AP-3-deficient melanocytes but is correctly delivered to
melanosomes (Huizing et al., 2001; Setty et al., 2007). By contrast, depletion of AP-1
from a pigmented human melanoma cell line causes substantial mislocalization of Tyrp1
to vacuolar domains of recycling endosomes and a reduction in cellular melanin content.
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At least part of AP-1 function is mediated by its interaction with a kinesin motor,
Kif13A, which is required for the generation of tubules that emerge from recycling
endosomes, make direct contacts with melanosomes, and correlate with cargo transfer
(Delevoye et al., 2009). Thus AP-1 and AP-3 each functon in the delivery of distinct
cargoes from endosomes toward melanosomes, but how they discriminate among cargo
proteins, cooperate in the delivery of cargoes that are recognized by both complexes, and
interface with other components of the trafficking machinery are not well understood.

The importance of AP-3 in melanosomal trafficking is further underscored by mutations
in the beta3A subunit that underlie the LRO biogenesis defect of Hermansky-Pudlak
Syndrome (HPS) type 2 and the pearl mouse (Feng et al., 1999). HPS is a group of
genetic diseases that result from impaired LRO biogenesis in multiple cell types (Di
Pietro and Dell'Angelica, 2005; Huizing et al., 2008). Phenotypes common to all HPS
subtypes include oculocutaneous albinism and prolonged bleeding, due respectively to
defects in the biogenesis of melanosomes and of platelet dense granules, and LRO defects
in other tissues lead to additional phenotypes in some HPS subtypes. Mutations in any of
at least 15 genes give rise to murine models of HPS, eight of which correspond to those
affected in human HPS subtypes (Di Pietro and Dell'Angelica, 2005; Wei, 2006). Most of
these genes encode subunits of five distinct multisubunit protein complexes, at least four
of which are thought to regulate endosomal membrane dynamics required for LRO
biogenesis. Among the murine HPS gene products are two subunits of AP-3 as well as
five of at least eight subunits of the Biogenesis of Lysosome-Related Organelles
Complex 1 (BLOC-1). AP-3 has been well-characterized as a cargo adaptor complex,
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but BLOC-1 has not been successfully demonstrated to physically interact with any
melanosomal cargo proteins. In fact, the function of BLOC-1 is still unknown, although
its demonstrated interactions with several SNARE proteins suggest a potential role in
regulating membrane fusion events (Huang et al., 1999; Ilardi et al., 1999; Moriyama and
Bonifacino, 2002; Vites et al., 2004; Ghiani et al., 2010). While AP-3 is detected
primarily on buds of sorting endosomal tubules, BLOC-1 has been localized primarily on
tubular domains of early endosomes (Di Pietro et al., 2006; Setty et al., 2007).
Consistently, BLOC-1 deficiency leads to mislocalization of distinct melanosomal
cargoes from those affected by AP-3 deficiency. For example, in BLOC-1-deficient
melanocytes from pallid or muted HPS model mice, Tyr was only partially mislocalized,
with a large cohort capable of accessing melanosomes, but Tyrp1 and ATP7A failed to
access melanosomes at all, and Tyrp1 was largely trapped in an endocytic recycling loop
(Setty et al., 2007; Setty et al., 2008). Based on this differential sensitivity of
melanosomal proteins to perturbations in AP-3 and BLOC-1 expression, melanosomal
transmembrane cargoes have been proposed to follow one of two pathways from early
endosomes to melanosomes, one controlled by AP-3 and another by BLOC-1 (Raposo
and Marks, 2007; Setty et al., 2007). Moreover, the similarity of the Tyrp1 trafficking
phenotypes seen with AP-1 knockdown or genetic deficiency of BLOC-1 has led to the
additional proposal that AP-1 and BLOC-1 act together to promote Tyrp1 trafficking to
melanosomes via recycling endosomal tubules (Delevoye et al., 2009).

A model in which AP-1 and BLOC-1 cooperate in one dedicated cargo delivery pathway
to melanosomes and AP-3 functions in a separate dedicted pathway fails to account for
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several published observations. First, a robust physical interaction has been detected
between AP-3 and BLOC-1 in detergent extracts of membranes from fibroblasts, brain,
and liver (Di Pietro et al., 2006; Salazar et al., 2006); our lab has also observed this
interaction in lysates from melanocytes (S. Gangi Setty, unpublished observation). By
contrast, despite several efforts, AP-1 has not been demonstrated to biochemically
interact with BLOC-1 (Salazar et al., 2009). Moreover, in neurons, AP-3 and BLOC-1
appear to cooperate in the delivery of a set of cargoes (Newell-Litwa et al., 2009; Salazar
et al., 2009). Indeed, although AP-3 and BLOC-1 localize to distinct domains of early
endosomes in melanocytes, BLOC-1 has been consistently detected in immunoaffinity
purified AP-3-coated vesicles from neurons (Newell-Litwa et al., 2009; Salazar et al.,
2009), as well as in clathrin-coated vesicles from HeLa cells (Borner et al., 2006). As
mentioned, it is also unclear how signals such as those in tyrosinase that are capable of
binding either AP-3 or AP-1 «choose» between the two distinct pathways.

In order to further dissect models for melanosomal protein sorting, we turned to an
additional melanosomal protein, OCA2, also known as pink-eyed dilution or P protein
(Rinchik et al., 1993). OCA2 is a 12-transmembrane domain protein that is expressed
only in pigment cells and that bears homology to a superfamily of transporters (Rinchik
et al., 1993; Lee et al., 1995). Mutations in the OCA2 gene underlie oculocutaneous
albinism (OCA) type 2, the most common form of OCA worldwide (King, 1998). We
have previously shown that OCA2 localizes to melanosomes by virtue of one of three
acidic dileucine sorting signals in the cytoplasmic N-terminal domain (Sitaram et al.,
2009). As for the Tyr sorting signal, the OCA2 sorting signal binds to both AP-1 and AP96

3, as shown using a GST pulldown assay. Here, we sought to define those features of the
OCA2 acidic dileucine-based sorting signal that confer the ability to bind AP-1 or AP-3,
and then to exploit mutants that only bind to one of these complexes to dissect the
respective role of each adaptor in OCA2 melanosome transport. Our results define
sequence features of acidic dileucine-based sorting signals that can distinguish between
AP-1 and AP-3 binding, show that OCA2 absolutely requires AP-3 interaction for stable
localization to melanosomes, and provide evidence for two distinct AP-3-dependent
melanosomal transport pathways in melanocytes – one that is independent of BLOC-1
and one that requires BLOC-1. Together, these data suggest that BLOC-1 can cooperate
with multiple adaptors to effect cargo delivery to cell type-specific LROs.

3.3 Results
The OCA2 Acidic Dileucine-based Melanosome Targeting Signal Binds to AP-1 and AP3 Hemicomplexes in a Yeast Three-Hybrid Assay
The N-terminal cytoplasmic domain of human OCA2 contains three consensus acidic
dileucine-based sorting motifs termed LL1, LL2 and LL3 (Figure 3.1a). We have
previously shown that substitution of the two critical leucines of LL1 for alanine (AA1N)
resulted in a loss of steady state localization to melanosomes, implicating LL1 as the
critical sorting signal for melanosome delivery. Moreover, a fusion protein consisting of
the OCA2 N-terminal cytoplasmic domain fused to glutathione S-transferase (GST) was
capable of binding to both AP-1 and AP-3 from human melanoma or HeLa cell cytosol,
and this interaction required intact LL1 (Sitaram et al., 2009). We first sought to
determine those features of LL1 that permitted its interaction with AP-1 and/or AP-3 and
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Figure 3.1
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Figure 3.1. The cytoplasmic domain of OCA2 shows dileucine-dependent interaction
with adaptor proteins in a yeast three-hybrid system.
(a) Sequences of the three acidic dileucine sorting motifs in the cytoplasmic N-terminus
of human OCA2 and the single acidic dileucine motif in the cytoplasmic C-terminus of
human tyrosinase. (b) Schematic of OCA2 N-terminal domain Gal4 fusion constructs
used in the assay. GAL4 BD, Gal4 binding domain; green square, intact dileucine motif;
white X, disrupted dileucine motif. Black numbers within the green square indicate
whether the primary sequence of the LL1, LL2, or LL3 motif is inserted at the indicated
position within the domain. Below, a yeast three-hybrid assay of various OCA2
constructs co-expressed with hemicomplexes of the AP-1 (gamma/sigma1A), AP-2
(alpha/sigma2), and AP-3 (delta/sigma3A) complexes. A protein-protein interaction leads
to expression of HIS3, allowing growth on His-deficient media. All transformed yeast
grow on His-containing control media. (c) Schematic of OCA2 constructs used in the
assay. Below, yeast three-hybrid assay of the OCA2 constructs in which dileucine motif
sequences are re-positioned within the OCA2 cytoplasmic domain.
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thus distinguished it from the nearly inactive LL2 and completely inactive LL3. In order
to more effectively assay in parallel the interaction between various OCA2 mutants and
adaptor protein complexes, we adapted a yeast three-hybrid (Y3H) assay that was
previously used to study acidic dileucine motifs in the melanogenic enzyme tyrosinase
and the HIV protein Nef (Janvier et al., 2003; Theos et al., 2005; Chaudhuri et al., 2007;
Chaudhuri et al., 2009). The assay involves coexpression of Gal4 fusion proteins of the
test cytoplasmic domain with two of the four subunits of each AP complex, namely the
small subunit (sigma1A, sigma2, or sigma3A) and the corresponding large subunit
(gamma, alpha, or delta) for AP-1, -2, and -3, respectively, which comprise the surface
that interacts with acidic dileucine sorting motifs (Janvier et al., 2003; Doray et al., 2007;
Kelly et al., 2008) (note that the sigma4/epsilon hemicomplex of AP-4 has not been
demonstrated to bind an acidic dileucine motif). The full cytoplasmic N-terminal region
of human OCA2 (amino acids 1-173) was fused to the C-terminus of the yeast Gal4
binding domain. One of the three sigma subunits was expressed from the MET5
promoter within a second transcription unit in the same plasmid, and the gamma, alpha,
or delta subunits were fused to the C-terminus of the Gal4 activation domain in a separate
plasmid. The Saccharomyces cerevisiae strain HF7c was co-transformed with both
plasmids and grown on Met-deficient selective media to express all three proteins. An
interaction between the OCA2 cytoplasmic domain and an AP hemicomplex activates
Gal4-dependent expression of HIS3 and allows for growth on His-deficient media. The
cytoplasmic domain of human tyrosinase (from amino acid 499 through the C-terminus),
previously shown to interact with all three AP hemicomplexes in this assay (Janvier et
al., 2003; Chaudhuri et al., 2009), served as a positive control.
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As expected, the tyrosinase cytoplasmic domain interacted with hemicomplexes from
AP-1, AP-2 and AP-3, as indicated by growth of all three sets of transformants on Hisdeficient media (Figure 3.1b). The full-length human OCA2 cytoplasmic N-terminal
domain also interacted with all three AP hemicomplexes, confirming previous results
obtained with GST-cytoplasmic domain fusion proteins (Sitaram et al., 2009); consistent
with previous results, the strength of interaction with the AP-2 alpha/sigma2
hemicomplex varied among experiments (not shown). Also consistently, the interaction
was ablated when all three acidic dileucine motifs were mutagenized to substitute the
three dileucine pairs to dialanines (OCA2-AA123N), and the restoration of the critical
LL1 motif (OCA2-AA23N) was sufficient to restore the interaction with the AP
hemicomplexes. These data confirm that the Y3H assay robustly recapitulates the ability
of LL1 to interact with AP complexes.

Acidic dileucine motif position does not affect AP binding or sorting activity.
Our previous analyses of immortalized melanocytes that transiently express full-length
OCA2 mutant constructs revealed that neither the second nor third acidic dileucine motif
(LL2 or LL3) alone could support steady-state localization of OCA2 to melanosomes in
wild-type melanocytes or fully restore melanin synthesis when expressed in OCA2deficient melanocytes (Sitaram et al., 2009). Moreover, GST fusion proteins with
cytoplasmic domains in which LL1 was ablated by mutagenesis showed impaired binding
to AP complexes. To determine why these motifs were inactive in melanosome sorting
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and AP binding, we considered two parameters: position within the cytoplasmic domain
and sequence of the intervening “X” residues within the EXXXLL consensus.

Because proximity to the membrane has previously been reported to affect the ability of a
consensus sorting motif to function and to bind adaptors (Rohrer et al., 1996; Geisler et
al., 1998; White et al., 1998), we used the Y3H assay to determine whether the inability
of the LL2 or LL3 motif to bind APs was due to its placement within the cytoplasmic
domain. We made variants of the OCA2-AA23N construct in which the sequence of the
active LL1 signal was replaced in situ by that of LL2 (OCA2-AA23N LL1-2) or LL3
(OCA2-AA23N LL1-3) (Figure 3.1c). Whereas all three AP hemicomplexes interact
with OCA2-AA23N bearing intact LL1, no AP interacted with either the LL1-2 or LL1-3
mutant, indicating that the sequences of the LL2 and LL3 motifs were inherently
inactive. We then performed the complementary experiment in which the LL1 sequence
was placed in the position of the second or third motif (in the context of an inactivated
LL1 motif at position 1 in construct OCA2-AA1N). Whereas the disruption of the LL1
motif in OCA2-AA1N ablates the interaction with all three AP hemicomplexes,
reintroduction of the LL1 sequence into the second position (OCA2-AA1N LL2-1) or the
third position (OCA2-AA12N LL3-1) within the cytoplasmic domain restores this
interaction. These data indicate that the LL1 motif is active in AP binding regardless of
its position within the cytoplasmic domain, implicating specific sequence elements as
critical to its AP binding activity.
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To determine whether motif position affected the activity of the sorting signal, the
mutations described above were engineered into the full-length, HA-tagged human
OCA2 and transiently expressed in wild-type pigmented melan-Ink4a mouse
melanocytes. By indirect immunofluorescence microscopy (IFM) analysis in these cells,
OCA2-AA1 LL2-1 – in which LL1 is placed in position 2 - distributes largely in HApositive rings that surround pigmented structures (Figure 3.2, a-c), similar to the staining
pattern seen with expression of wild-type HA-tagged or native OCA2 (Sitaram et al.,
2009). To determine whether this construct retained function, we expressed it in nonpigmented OCA-2-deficient melan-p1 mouse melanocytes; we have previously shown
that OCA2 function correlates with melanosomal localization, since expression of
melanosomally-localized but not surface-localized human OCA2 constructs in melan-p1
melanocytes restores pigment synthesis (Sviderskaya et al., 1997; Sitaram et al., 2009).
Consistently, transiently-expressed OCA2-AA1N LL2-1 localized to vesicular structures
in melan-p1 cells as in wild-type cells (Figure 3.2, d-f), and rescued pigmentation in 54%
of transfected cells, compared to 69% of cells expressing wild-type OCA2 (Figure 3.2j).
By contrast, full-length OCA2 constructs bearing the LL1-2 and LL1-3 mutations were
mislocalized to the cell surface when expressed in wild-type melanocytes (see Figure 3.3j
and data not shown) or melan-p1 cells (Figure 3.2, g-i) and were incompetent to rescue
melanin synthesis in melan-p1 cells (Figure 3.2, g-j and data not shown). Together, these
data confirm that the LL2 and LL3 sequences are intrinsically poor at interacting with AP
complexes and at effecting melanosome localization, even when placed in a "favorable"
position within the protein. Conversely, the LL1 sequence is intrinsically competent to
bind AP complexes in a relatively position-independent manner.
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Figure 3.2

Figure 3.2. Localization and function of OCA2 dileucine motif position mutants.
a-i) IFM analysis of melan-Ink4a cells (a-c) or melan-p1 cells (d-i) expressing selected
mutant OCA2 variants. Melan-Ink4a melanocytes were transfected with OCA2-AA1
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LL2-1 (a-c) and melan-p1 cells were transfected with OCA2-AA1 LL2-1 (d-f) or OCA2AA23 LL1-2 (g-i). Transgenes were visualized with anti-HA antibodies (a, d, g) and
melanosomes were visualized by bright field microscopy (b, e, h). c, f, and i are merged
OCA2-HA (magenta) and inverted bright field (green) images. All insets show 5X
magnified images of the boxed region. Arrows point to regions of overlap of OCA2
constructs with melanosomes. Bar = 10 µm. (j) Dileucine mutants were expressed in
OCA2-deficient melan-p1 cells, and transfected cells were visually inspected for the
presence of pigmented melanosomes. Shown is the percentage of transfected cells
expressing each indicated construct that contained pigmented melanosomes (%
pigmented cells). All columns were significantly different from rescue by OCA2-HA.
***, p < 0.001
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Acidic dileucine motif sequence requirements for AP binding and melanosome targeting
activity.
To begin to dissect those primary sequence features of the OCA2 dileucine motifs that
conferred AP binding and sorting activity, we compared the sequence of the inactive LL3
motif in OCA2 to that of active acidic dileucine sorting signals. In particular, the sole
acidic dileucine sorting motif in human Tyr, EKQPLL, differs at only two positions from
L3 motif in human OCA2, EKGDLL (Figure 3.3a). Whereas AP hemicomplexes did not
interact with the OCA2-AA23N LL1-3 mutant, in which the LL3 sequence in position 1
is the only intact motif (Figures 3.1c, 3.3b), all three AP hemicomplexes interacted with
an OCA2-AA23N construct bearing the EKQPLL motif of human Tyr at position 1
(OCA2-AA23N hTyr; Figure 3.3b). However, constructs bearing either of the two single
amino acid substitions that change the middle residues of the Tyr signal to those in the
inactive LL3 motif (OCA2-AA23N TyrPD or OCA2-AA23N TyrQG) do not interact
with any AP hemicomplexes (Figure 3.3b). The AP binding ability of the motifs
correlated completely with sorting activity, since full-length OCA2-AA23 bearing
endogenous LL1 (Figure 3.3, d-f) and OCA2-AA23N hTyr bearing the intact tyrosinase
signal localize to melanosomes at steady-state when expressed in melan-Ink4a
melanocytes (Figure 3.3, d-i) and stimulate melanin synthesis in a high proportion of
transfected melan-p1 cells (Figure 3.3c), but neither of the two “LL3-like” single point
mutants chimeric constructs did. Rather, these mutants localized to the plasma
membrane (Figure 3.3, k and l). Taken together, our results indicate that the ''X'' amino
acids of the [D/E]XXXL[L/I] consensus can greatly affect AP binding and sorting
activity in the context of OCA2, and that neither glycine at position -2 nor an aspartate at
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Figure 3.3

Figure 3.3. Internal sorting signal residues affect AP complex interaction.
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(a) Comparison of the LL3 acidic dileucine motif from human OCA2 and the sole acidic
dileucine motif in human tyrosinase. OCA2-AA23N hTyr constructs were made in
which the first acidic dileucine motif of the OCA2 cytoplasmic domain was replaced with
the sequence from tyrosinase, with or without the indicated amino acid substitutions. (b)
Yeast three-hybrid analyses of AP hemicomplex interaction with the OCA2-AA23N hTyr
constructs. (c) Melan-p1 rescue assay performed as in Figure 3.2j. n.s., not significant. (dl) Melan-Ink4a mouse melanocytes were transiently transfected with full-length HAtagged OCA2-AA23 (d-f), OCA2-AA23 hTyr (g-i), OCA2-AA23 LL1-3 (j), OCA2AA23 hTyrPD (k), or OCA2-AA23 hTyrQG (l) constructs bearing the identical
mutations used in the yeast three-hybrid assay. Cells were stained with anti-HA
antibodies (d, g; colored magenta in merged pictures f, i-l) and subjected to indirect
immunofluorescence microscopy. Bright field images (e, h) were inverted and colored
green in merged pictures. Arrows point to regions of overlap between OCA2 constructs
and melanosomes. Bar = 10 µm.
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position -1 (relative to the first leucine) can support either activity.

OCA2 Interactions With AP-1 and AP-3 are Separable
To further define the sequence requirements for AP binding and for melanosome
targeting, we compared LL1 to acidic dileucine-based sorting signals from other
melanocytic proteins. The LL1 motif in human OCA2 is the only one of the three human
motifs that has a counterpart in OCA2 homologs in the mouse, Japanese medaka fish, or
Mexican cavefish. Although the general consensus for acidic dileucine motifs is
[D/E]XXXL[L/I], the three nonhuman OCA2 homologs and the LL1 (but not LL2 or
LL3) motif of human OCA2 share a more restricted consensus of EXXPLL (Figure
3.4a). Moreover, the sequences of the cytoplasmic sorting motifs found in Tyr and Tyrp1
also correspond to the more restricted motif, suggesting the specific importance of a -4
glutamate and -1 proline for sorting to melanosomes. We tested the effect of a
conservative Glu-to-Asp mutation of the OCA2 LL1 motif (OCA2-AA23N E96D) and of
a non-conservative Pro-to-Ala mutation (OCA2-AA23N P99A; Figure 3.4b). The E96D
mutant ablated the interaction of OCA2-AA23N with AP-3 hemicomplexes by Y3H
assay (Figure 3.4c). Its interactions with AP-1 and AP-2 hemicomplexes were reduced
but not eliminated; this manifested as variability in yeast growth over several trials
(compare Figure 3.6b). Conversely, the P99A mutation abolished interaction of OCA2AA23N with AP-1 hemicomplexes, but, although reduced, the interaction with AP-3
hemicomplexes was consistently retained. The P99A mutation consistently impaired the
interaction with AP-2 hemicomplexes (data not shown). These data suggest that AP-1
but not AP-3 is tolerant of an aspartate residue at position -4, whereas AP-3 but not AP-1
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Figure 3.4

Figure 3.4. AP-1 and AP-3 interaction with the OCA2 LL1 motif are separable.
a) Comparison of sequences of acidic dileucine motifs in OCA2 isoforms from human,
mouse, Japanese medaka fish, and Mexican cavefish. All motifs are underlined, and gray
boxes highlight conserved elements in the OCA2 motifs as well as in motifs from human
and mouse tyrosinase and Tyrp1. b) Single amino acid substitutions were made in the
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OCA2-AA23N construct in order to test for changes in interaction with AP complexes. c)
Yeast three-hybrid analyses of AP interaction with OCA2 sorting motif mutants.
Transformants were spotted in 5-fold serial dilutions. E96D and P99A show reciprocal
interaction with AP-1 and AP-3.
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is tolerant of an alanine at position -1.

To determine what features at position -4 were necessary for binding to AP-1
hemicomplexes, we further mutagenized the -1 Pro residue to test the suitability of a
range of side groups for the residue in that position (Figure 3.5a). Of Ala, Asp, Asn, Lys,
Phe, and Ser, only the serine substitution interacted with AP-3 hemicomplexes at a level
that was comparable to that of the wild-type OCA2 LL1 motif; importantly, like the
alanine substitution, the serine substitution did not interact with AP-1 hemicomplexes
(Figure 3.5b). The phenylalanine substitution also interacted variably with both AP-1
and AP-3 hemicomplexes. Together, these data suggest that interaction of an acidic
dileucine motif with AP-1 requires a proline or perhaps a large hydrophobic amino acid
residue at position -1, whereas AP-3 binding can tolerate small, uncharged residues such
as serine or alanine at this position. As predicted by the individual mutations,
incorporation of both the E96D and P99S mutations together within the LL1 motif of
OCA2-AA23N ablated the interaction with either AP-1 or AP-3 hemicomplexes (Figure
3.6a, b). Although each individual mutant retained the ability to bind to the AP-2
hemicomplex, the combined mutant also ablated this interaction (Figure 3.6b).

OCA2 Interaction with AP-3 is Required for Melanosomal Localization But Not Function
As we had isolated OCA2 constructs that showed contrasting preferences for AP-1 or
AP-3 binding—E96D for AP-1 interaction and P99S or P99A for AP-3 interaction—we
next tested the role of each complex in melanosomal trafficking of OCA2 by determining
whether the changes in interactions with AP complexes affected localization of OCA2.
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Figure 3.5

Figure 3.5. AP-3 is more tolerant than AP-1 of substitutions at the -1 position in the
OCA2 LL1 sorting motif.
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a) Schematic of OCA2-AA23N constructs containing a range of amino acid substitutions
at the conserved proline of the LL1 sorting motif of human OCA2. b) Yeast three-hybrid
analyses of the interaction of OCA2-AA23N proline substitution constructs with AP-3 or
AP-1.
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Figure 3.6

Figure 3.6. The E96DP99S combined dileucine mutant is nonfunctional.
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(a) The OCA2 LL1 motif was subjected to two amino acid substitutions in the OCA2AA23N yeast three-hybrid construct to create the OCA2-AA23N E96DP99S mutant. (b)
Yeast three-hybrid results show that the E96DP99S construct does not interact with the
three AP complexes. (c) Full-length OCA2-AA23 E96DP99S was transiently transfected
into melan-Ink4a melanocytes. The transgene is visualized by anti-HA antibodies
(magenta) and pigmented melanosomes are visualized by Bright field microscopy
(inverted and colored green). Bar = 10 µm. (d) OCA2-AA23 E96DP99S was transiently
transfected into melan-p1 melanocytes and assayed for rescue of melanin synthesis as in
Figure 3.2j. The graph shows the results from three independent transfections.
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Each sorting motif mutation was placed into full-length HA-tagged human OCA2 and
transiently expressed in melan-Ink4a melanocytes. In these cells, most of the visualized
OCA2-AA23 localizes to rings, and approximately 49% of these structures surround
pigmented melanosomes (Figure 3.3, d-f; 3.7g). When transiently expressed in these
cells, the AP-3-biased OCA2-AA23 P99S or P99A constructs consistently showed a
significant amount of steady-state staining at the surface of the cell, reminiscent of the
staining seen with OCA2-AA123, which contains no functional dileucine motifs (Figure
3.7, a-c). However, this construct also showed a variable ability to localize properly to
rings, about 40% of which enclose pigmented structures (Figure 3.7g). The ability of the
P99A and P99S constructs to form the HA-positive rings suggests that OCA2 interaction
with AP-1 might not be absolutely required for trafficking. By contrast, the AP-1-biased
OCA2-AA23 E96D construct localized to structures that formed partial coats around
pigmented melanosomes (Figure 3.7, d-f). These structures showed a reduced amount of
overlap with melanin, approximately 25%, suggesting that an ability to bind AP-3 rather
than AP-1 might be necessary for a late step of melanosomal trafficking of OCA2. As
expected for a mutant that was unable to bind to any of the adaptors, full length OCA2AA23N bearing the double E96DP99S mutation localized to the cell surface when
expressed in wild-type melan-Ink4a melanocytes (Figure 3.6c).

To confirm the role of AP-3 in melanosomal trafficking of OCA2, we also expressed the
constructs in AP-3-deficient melan-pearl mouse melanocytes. These cells are
significantly pigmented, but they exhibit mislocalization of a large cohort of tyrosinase
(Theos et al., 2005). Melanosomal localization of Tyrp1 is largely intact, consistent with
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Figure 3.7

Figure 3.7. Localization of dileucine motif point mutants in wild-type melanocytes.
a-i) IFM analysis of melan-Ink4a cells expressing selected mutant OCA2 variants.
Melan-Ink4a melanocytes were transfected with OCA2-AA23 (a-c), OCA2-AA23 P99A
(d-f), or OCA2-AA23 E96D (g-i). Transgenes were visualized with anti-HA antibodies
(a, d, g) and melanosomes were visualized by bright field microscopy (b, e, h). c, f, and i
are merged OCA2-HA (magenta) and inverted bright field (green) images. All insets
show 5X magnified images of the boxed region. Arrows point to regions of overlap of
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OCA2 constructs with melanosomes. Bar = 10 µm. (j) Deconvolved IFM images of each
mutant were converted to binary images and analyzed for marker overlap. Cells
transfected with OCA2-AA23 P99A or OCA2-AA23 P99S were combined in the
analysis. Each data point represents one cell. Shown is the percentage of
punctate/vesicular HA staining that overlapped with pigment in each cell (% of OCA2
with pigment). Each point mutant was compared to OCA2-AA23. n.s., not significant.
****, p < 0.0001
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an interaction of Tyrp1 with AP-1 but not AP-3 in the yeast three-hybrid assay (Theos et
al., 2005; Setty et al., 2007). In melan-pearl cells, transiently expressed OCA2-AA23
localized to punctate structures that were near or adjacent to pigmented melanosomes
(Figure 3.8, a-c). About 25% of these structures overlapped with pigment (Figure 3.8j), a
level similar to the overlap seen with the AP-1-biased E96D construct in wild-type cells.
This result is consistent with a model in which AP-3 is necessary for melanosomal
delivery of OCA2 from adjacent endosomal structures. Both the E96D and P99S
constructs are also found on structures near pigmented melanosomes (Figure 3.8, d-i),
and the amount of co-localization of either mutant with pigment was not statistically
different from that of OCA2-AA23 (Figure 3.8j). Thus in all cases, the lack of AP-3
appeared to prevent efficient melanosomal delivery of OCA2.

We next tested whether changes in steady-state localization of the mutants affected
function by utilizing the melan-p1 pigmentation rescue assay. Expression of OCA2AA23 leads to rescue in 86% of transfected cells, while the expression of the surfacelocalized OCA2-AA123 and OCA2-AA23 E96DP99S mutants led to a minimal increase
in pigmentation (Figure 3.8k and Figure 3.6d). The expression of the AP-3-biased P99S
construct stimulated pigment synthesis as well as OCA2-AA23, despite the reduced
efficiency of melanosomal delivery compared to OCA2-AA23. Since the E96D mutant
is defective in melanosomal localization in wild-type cells, we expected it would be less
able to rescue melanin synthesis in melan-p1 cells. Surprisingly, the AP-1-biased E96D
was only slightly less efficient than OCA2-AA23. The high amount of rescue effected by
the E96D construct suggests that OCA2 may in fact be able to function from within the
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Figure 3.8

Figure 3.8. Localization of dileucine motif point mutants in AP-3-deficient melanocytes.
(a-i) IFM analysis of AP-3-deficient cells expressing selected mutant OCA2 variants.
Melan-pearl melanocytes were transfected with OCA2-AA23 (a-c), OCA2-AA23 P99S
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(d-f), or OCA2-AA23 E96D (g-i). Transgenes were visualized with anti-HA antibodies
(a, d, g) and melanosomes were visualized by bright field microscopy (b, e, h). c, f, and i
are merged OCA2-HA (magenta) and inverted bright field (green) images. All insets show
5X magnified images of the boxed region. Bar = 10 µm. (j) Deconvolved IFM images of
each mutant were converted to binary images and analyzed for marker overlap. Each data
point represents one cell. Shown is the percentage of punctate/vesicular HA staining that
overlapped with pigment in each cell (% of OCA2 with pigment). Neither point mutant
was significantly different (n.s.) from OCA2-AA23. (k) OCA2-deficient melan-p1
melanocytes were rescued as in Figure 3.2j. All columns were compared to OCA2AA23. n.s., not significant. *, p < 0.05, ***, p < 0.001
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endosomal structures adjacent to melanosomes to which the construct localizes.

OCA2 Trafficking to Melanosomes is Dependent on BLOC-1
Finally, melanosomal trafficking of Tyr and Tyrp1 show very different levels of
dependence on BLOC-1. In order to investigate the dependence of the melanosomal
trafficking of OCA2 constructs on the BLOC-1 complex, we examined their localization
following transient expression in BLOC-1-deficient melan-pallid mouse melanocytes.
We previously showed that Tyrp1 does not localize to melanosomes in these cells but is
instead mislocalized to vacuolar endosomes (Setty et al., 2007). In addition, there is
increased steady-state staining of Tyrp1 at the cell surface thought to be due to a shift into
a recycling loop as a result of the failure of BLOC-1-dependent siphoning towards
melanosomes. About 50% of OCA2-AA23 staining in the melan-pallid cells colocalizes
with internal Tyrp1 in melan-pallid cells (Figure 3.9, a-c; j), suggesting that melanosomal
trafficking of OCA2 is similarly BLOC-1-dependent. The AP-1-biased E96D construct
shows an equivalent amount of overlap with Tyrp1 (Figure 3.9, d-f; j). The AP-3-biased
P99S construct, however, appears to be mislocalized to the cell surface to a much greater
extent than Tyrp1 and consequently shows little overlap with the marker (Figure 3.9, g-i).
A possible explanation may be a combination of increased delivery of OCA2 from
endosomes to the surface in the same manner as Tyrp1 as well as potentially decreased
endocytosis of the P99S construct that could be a consequence of its decreased
interaction with AP-2 relative to the other OCA2 constructs. Interestingly, OCA2-AA23
hTyr, bearing the dileucine motif from human tyrosinase, is unable to traffic to
melanosomes in melan-pallid melanocytes, as shown by a lack of colocalization with
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Figure 3.9

Figure 3.9. Localization of dileucine motif point mutants in BLOC-1-deficient
melanocytes.
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(a-i) IFM analysis of BLOC-1-deficient cells expressing selected mutant OCA2 variants.
Melan-pallid melanocytes were transfected with OCA2-AA23 (a-c), OCA2-AA23 E96D
(d-f), or OCA2-AA23 P99S (g-i). Transgenes were visualized with anti-HA antibodies (a,
d, g) and endogenous Tyrp1 was visualized in b, e, and h. c, f, and i are merged OCA2HA (magenta) and Tyrp1 (green) images. All insets show 5X magnified images of the
boxed region. Bar = 10 µm. (j) Deconvolved IFM images of OCA2-AA23 and OCA2AA23 E96D were converted to binary images and analyzed for marker overlap. The P99S
mutant was not analyzed. Each data point represents one cell. Shown is the percentage of
punctate/vesicular HA staining that overlapped with Tyrp1 in each cell. (% of OCA2
with Tyrp1). E96D was not significantly different (n.s.) from OCA2-AA23.
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PMEL, a marker of the unpigmented melanosomes in these cells (Figure 3.10). This
result suggests that the transplantable dileucine motif from tyrosinase can confer APinteracting ability but not BLOC-1-independence on OCA2. Together, our data suggest
a model for melanosomal trafficking of OCA2 that is dependent on both AP-3 and
BLOC-1, complexes that were previously hypothesized to mediate distinct melanosomal
trafficking pathways.

3.4 Discussion
Based on the behaviour of model cargo proteins studied to date, two routes have been
proposed to regulate cargo delivery from endosomes towards maturing melanosomes in
melanocytic cells: one mediated by AP-3 and utilized largely by Tyr (Huizing et al.,
2001; Theos et al., 2005), and the other mediated by AP-1 and BLOC-1 and utilized by
Tyrp1 (Setty et al., 2007; Delevoye et al., 2009), the copper transporter ATP7A (Setty et
al., 2008), and perhaps a cohort of Tyr (Theos et al., 2005). By analyzing the behavior of
OCA2 and targeting signal mutants that bind selectively to AP-1 or AP-3, we now extend
this model by providing evidence for a pathway that requires both BLOC-1 and AP-3.
Our data confirm previous findings that OCA2 can bind to both AP-1 and AP-3 via a
critical acidic dileucine sorting motif, but show for the first time that the identity of
particular residues within the core motif--but not the placement of the motif within the
cytoplasmic domain--underlie binding specificity for each adaptor. The distinct
intracellular localization of mutants that interact by Y3H assay preferentially with either
AP-1 or AP-3 provide evidence that AP-3 mediates a final step in the delivery of OCA2
to melanosomes, highlighting an expanded role for this complex within the scope of LRO
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Figure 3.10

Figure 3.10. The dileucine motif does not determine BLOC-1 dependence.
The OCA2-AA23 hTyr construct was transiently transfected into BLOC-1-deficient
melan-pallid melanocytes. The transgene was visualized with anti-HA antibodies (a) and
hypopigmented melanosomes were visualized by antibodies to PMEL (b). OCA2
(magenta) and PMEL (green) images were merged in (c). All insets show 5X magnified
images of the boxed region. Bar = 10 µm.
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biogenesis.

The AP complexes are well known for their role in coupling clathrin coat recruitment to
cargo selection via recognition of cytoplasmic sorting motifs and consequent cargo
clustering into buds for directed vesicular trafficking within the endosomal system
(Bonifacino and Traub, 2003; Robinson, 2004). The cytoplasmic domains of a number of
melanosomal proteins, including Tyr and Tyrp1, contain acidic dileucine-based sorting
signals that have been shown to be necessary for melanosomal transport (Vijayasaradhi et
al., 1995; Calvo et al., 1999; Simmen et al., 1999). Human OCA2 has three consensus
acidic dileucine-based motifs, but only the most distal motif, LL1, confers melanosomal
localization and full function (Sitaram et al., 2009). Unlike acidic dileucine signals in
other melanosomal and lysosomal proteins, which tend to be positioned within 6-11
residues of the transmembrane domain, the LL1 motif of human OCA2 is located 70
amino acid residues from the transmembrane domain. Motifs at such a distance tend to be
limited for use in internalization rather than targeting to lysosomes or LROs (reviewed in
(Bonifacino and Traub, 2003)), as seems to be the case for an acidic dileucine signal in
the distal cytoplasmic domain of PMEL (Lepage and Lapointe, 2006; Theos et al., 2006a;
Robila et al., 2008), but in this case it is likely that protein:protein or protein:lipid
interactions bring the motif close enough to the membrane to engage AP-1 and AP-3.
Nevertheless, the data presented here demonstrate that the LL1 signal functions in a
position-independent manner – at least within the membrane proximal 100 amino acid
residues of OCA2 - and is capable of interacting with AP complexes and effecting
melanosome targeting when moved to sites harboring inactive LL2 and LL3 motifs. We
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conclude that the primary determinant of acidic dileucine-based targeting activity is
ultimately a property of its sequence rather than its context. In this regard, the LL1
sequence is different from other acidic dileucine motifs such as a CD4/CD3-gamma
chimera (Geisler et al., 1998), the distal motif of Iip31 (Pond et al., 1995), and the motif
of Vam3p (Darsow et al., 1998), all of which were affected by the residue immediately
upstream of the acidic residue. It may be that OCA2 folds in such a way that only the
core motif is presented in the correct orientation for AP binding, without the engagement
of nearby residues. Interestingly the LL1 sequence is exactly conserved in nearly all of
the predicted mammalian homologs of OCA2, with the exception of mouse and rat,
suggesting that the sequence may have evolved to optimize function.

While the adjacent residues do not seem to be important for LL1 interaction with AP
complexes, the so-called X residues within the core [D/E]XXXL[L/I] motif are. In our
mutagenic study with the human tyrosinase motif and the similar but nonfunctional
OCA2 LL3 motif, the mutation of the -2 Gln in the Tyr motif to the Gly of the LL3 motif
(OCA2-AA23 hTyrQG) completely abolished the interaction with all three AP
complexes and caused mislocalization of the full-length protein to the cell surface,
despite the fact that this motif still conforms to the EXXPLL consensus that seems to be a
hallmark of melanosomal sorting signals. Since the motifs were all placed in the same
position within the OCA2 domain, the difference in AP interaction between the Q-motif
and the G-motif must reflect differences in the direct interaction between the core motif
and the AP complexes. Our experiments with the Tyr motif and LL3 show that the
binding of the OCA2 acidic dileucine motifs to AP complexes can be extraordinarily
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sensitive to the identity of the X residues of the motif. There is not yet a crystal structure
of an acidic dileucine motif in complex with AP-1 or AP-3, but there is one for AP-2 with
the motif from CD4 (Kelly et al., 2008). The side chains for residues at the -2 and -3
positions of the motif point into the solvent in vitro and thus do not contribute
significantly to binding affinity, in stark contrast to the large effect on AP binding that we
observed upon mutation in the -2 position. AP-2 is used for endocytosis of a wide variety
of proteins from the cell surface and a less rigid binding orientation is thought to
contribute to its broad specificity as a cargo adaptor (Kelly et al., 2008). It may be that
AP-1 and AP-3 have more rigid binding surfaces that are more sensitive to the identities
of the X residues than AP-2.

The E to D mutation in OCA2 greatly reduced but did not eliminate AP-1 interaction and
had less of an effect on AP-2 interaction, consistent with mutagenesis results with the
distal acidic dileucine motif of LRP9 (Doray et al., 2007). Our data additionally show
that the conservative E to D mutation eliminates AP-3 interaction. Acidic residues
upstream of the dileucine pair are known to be necessary for AP-3 binding to LIMP-II
(Honing et al., 1998) and Vam3p (Darsow et al., 1998), but to our knowledge this study
represents the first report of specificity for the identity of the acidic residue. In contrast
to the E to D mutant, the P to A/S mutants of OCA2 eliminated AP-1 interaction and
greatly reduced AP-2 interaction, but maintained a significant level of AP-3 interaction.
Proline has been specifically noted as a common -1 residue in several acidic dileucine
motifs (Pond et al., 1995; Darsow et al., 1998; Honing et al., 1998; Doray et al., 2007).
Consistent with the importance of the -1 Pro for AP-1 and AP-3 interaction, mutagenesis
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of a -1 Pro in the distal motif of LRP9 eliminates binding to AP-1 and severely reduces
its interaction with AP-2, and CI-MPR can acquire the ability to interact with AP-1 and
AP-2 from a heterologous motif that includes a -1 Pro (Doray et al., 2008). The -1 Pro
does not seem to be required for AP-3 interaction since the same position could
accommodate alanine (with a small hydrophobic side chain), serine (polar uncharged side
chain), and phenylalanine (bulky hydrophobic side chain) in our yeast three-hybrid assay.
However, neither OCA2 LL1 (Figure 3.5) nor the OCA2-AA23 hTyrPD chimera (Figure
3.3) was able to tolerate an acidic residue (asparatate) in this position. In the AP-2 crystal
structure the -4 acidic residue binds in a pocket that has some flexibility, the two leucine
residues bind in a separate hydrophobic pocket, and the -1 position protrudes into the
solvent. It is again tempting to speculate that the differential requirements for the identity
of the acidic residue or the -1 Pro will be reflected in structural differences between AP-1
and AP-3 dileucine motif-interacting surfaces.

Although the E96D and P99S mutants show opposite preferences for AP interaction, fulllength OCA2 bearing either mutation was found to localize to post-endosomal structures
and to confer nearly complete function to OCA2-deficient melanocytes. This indicates
that either AP-1 or AP-3 alone is sufficient to direct proteins into the endosomal system
and into endosomal domains bound for melanosomes. However, steady-state
melanosomal localization of OCA2 seemed to critically depend on an OCA2/AP-3
interaction, because (a) the AP-1-biased E96D mutant localized to endosomal structures
closely apposed to melanosomes rather than properly to melanosomal “rings” in wildtype melanocytes, and (b) no construct expressed in AP-3-deficient melanocytes
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localized properly to melanosomes. The localization of the E96D mutant to endosomal
tubules that are physically continuous with melanosomes in wild-type cells and the high
amount of melanin synthesis induced by this construct in OCA2-deficient cells raise the
intriguing possibility that melanosomal localization of OCA2 may not be absolutely
required for function. OCA2 is thought to function as a transporter, and thus
mislocalization of OCA2 itself might be overcome by diffusion of its putative substrate
into melanosomes via passage through the tubules. Such a model would still be consistent
with studies that suggested the protein localized to the melanosome membrane on the
basis of subcellular fractionation, low-resolution immunofluorescence microscopy, and
effects on melanosomal lumenal pH (Rosemblat et al., 1994; Donatien and Orlow, 1995;
Puri et al., 2000; Sitaram et al., 2009) and still disfavor an alternate proposal that the
protein functions from the endoplasmic reticulum (Chen et al., 2002; Toyofuku et al.,
2002).

The trafficking of OCA2 differs from that of Tyrp1 in that it is AP-3 dependent.
However, like Tyrp1 and unlike Tyr, all OCA2 constructs were mislocalized in BLOC-1deficient melanocytes; indeed, OCA2 in these cells largely overlapped with Tyrp1, which
becomes entrapped primarily in early endosomal vacuoles (Setty et al., 2007). This
dependence on BLOC-1 differentiates OCA2 trafficking from that of Tyr, for which a
substantial cohort can be found in melanosomes in BLOC-1-deficient cells (Setty et al.,
2007; Setty et al., 2008). Thus we have identified a new mode of endosome-tomelanosome trafficking that is both BLOC-1-dependent and AP-3-dependent. This
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pathway provides a critical biological context in a LRO-generating cell type for a
previously described physical interaction between AP-3 and BLOC-1 (Di Pietro et al.,
2006; Salazar et al., 2006). Whether AP-3 functions independently of BLOC-1 – as for
tyrosinase – or dependent on BLOC-1 – as for OCA2 – likely reflects some feature of the
cargo. The failure of OCA2-AA23 hTyr, bearing the sorting motif of the largely BLOC1-independent tyrosinase, to localize to immature melanosomes in BLOC-1-deficient
melanocytes suggests that the dileucine motif is not the determinant of the BLOC-1dependence of a cargo. The identity of that feature will have to await further
experimentation. We speculate that the 12 membrane spanning domains might preclude
entry of OCA2 into early sorting endosomal domains from which tyrosinase accesses AP3 for the BLOC-1-independent pathway (Peden et al., 2004; Theos et al., 2005).

The unusual structures to which OCA2 localized in the absence of AP-3 or a strong AP-3
binding signal were adjacent to and partially overlapping with melanin. This pattern of
localization resembles that of AP-1 and recycling endosomal markers in a human
pigmented melanoma cell line, and correlates with tubular transport intermediates that
physically connect recycling endosomal domains with melanosomes (Delevoye et al.,
2009). This similarity thus suggests that OCA2 accumulates in such tubular extensions
when it is capable of binding to AP-1 but not to AP-3. By contrast, deficiency in either
AP-1 or BLOC-1 prevents tubular localization of Tyrp1 and instead causes its
mislocalization to vacuolar domains of recycling endosomes (Setty et al., 2007; Delevoye
et al., 2009). Based on these results, we proposed a model in which AP-1 and BLOC-1
work together to specify Tyrp1 entry into these tubules. Our results here suggest that
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OCA2 might also enter these tubules in a manner that is similarly dependent on BLOC-1,
but the successful delivery of the AP-3-biased P99S mutant to melanosomes in wild-type
cells suggests that entry of OCA2 into the tubules might not require direct interaction
with AP-1 and could instead be regulated by cooperation between BLOC-1 and AP-3.
This interpretation would align our previous model of distinct BLOC-1-mediated and
AP-3-mediated melanosomal trafficking pathways with observations in neurons that
suggest that BLOC-1 and AP-3 work together in cargo distribution (Newell-Litwa et al.,
2009; Salazar et al., 2009).
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CHAPTER 4. DISCUSSION

Prior to the start of this thesis, the localization of OCA2 was unclear, and the trafficking
of the protein had not been explored at all. My results have resolved to a large extent the
question of the site of action of OCA2 and defined important sorting determinants that
control trafficking of the protein. The protein also has proved useful as a model
melanosomal cargo and revealed new mechanisms for the trafficking of proteins from
endosomes to melanosomes, expanding our understanding of trafficking to these unique
organelles. Below I discuss the implications of some of these findings in more detail.

4.1 Sorting signals in OCA2
4.1.1 The LL1 motif
Although many of the initial reports characterizing OCA2 function suggested that the
protein localizes to melanosomes (Rosemblat et al., 1994; Donatien and Orlow, 1995;
Puri et al., 2000; Toyofuku et al., 2002), a competing hypothesis that OCA2 might
function from within the ER introduced a legitimate controversy within the field (Chen et
al., 2002). Previously published immunofluorescence microscopy and subcellular
fractionation analyses were inconclusive and could have been used to support either
interpretation (Rosemblat et al., 1994; Chen et al., 2002; Toyofuku et al., 2002). My
results presented in Chapter 2 demonstrate that although OCA2 can be detected primarily
in the ER of a substantial fraction of melanocytes, the steady-state localization of OCA2
to the ER is not compatible with its function in promoting melanin synthesis. Instead,
melanin synthesis induction correlated with localization of the protein to mature
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melanosomes. As expected for a melanosomal protein, this localization in turn depended
on intact acidic dileucine motifs that serve as binding sites for the AP complexes. Of the
three dileucine motifs found within OCA2, I found that the first motif alone is both
necessary and sufficient for steady-state localization of OCA2 to melanosomes. This
finding correlates well with the observation that the primary sequence of this motif—
ENTPLL—is nearly invariant among the predicted homologs of OCA2 in placental
mammals, the mouse and rat being notable exceptions. A less-restricted EXXPLL
consensus expands the conservation to nearly all the vertebrates, confirming the
importance of the LL1 motif. However, the role of acidic dileucine motifs in the
trafficking of OCA2 is more complex. For example, an LL3 EXXXLL motif, which is
neither necessary nor sufficient for melanosomal trafficking or function of human OCA2,
is conserved among the majority of predicted OCA2 homologs, so simple conservation is
not enough to determine which motifs are most critical.
We noted during the domain swap assays that the LL1 motif of human OCA2 is located
70 amino acid residues from the transmembrane domain, much longer in primary
sequence from the 6-11 residue distance that is more typical for lysosomal or LRO
targeting motifs (Bonifacino and Traub, 2003). We hypothesized that protein:protein or
protein:lipid interactions might bring the motif close enough to the membrane to engage
AP-1 and AP-3. This is consistent with our earlier study, in which an ER retention motif
added to the N-terminus of OCA2 functioned more efficiently when the first 91 amino
acids of OCA2 were first removed, bringing the signal very close to the LL1 motif
(Sitaram et al., 2009). I hypothesized that the OCA2 cytoplasmic domain might adopt a
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secondary structure that facilitates an interaction of that region with membrane-proximal
retention machinery. However, the domain swapping experiments demonstrated that the
LL1 signal functions in a position-independent manner – at least within the context of the
first 100 residues of OCA2 - and is capable of interacting with AP complexes and
effecting melanosome targeting when moved to sites previously harboring inactive LL2
and LL3 motifs.

Since acidic dileucine motif position within the cytoplasmic domain was not critical for
AP interaction, it follows that AP complex binding to the OCA2 LL1 sequence may be
relatively independent of contributions from residues outside the core motif, a property
that differs from some other acidic dileucine motifs. The addition of a basic arginine
immediately upstream of the acidic residue in a CD4/CD3-gamma chimera reduced the
internalization and degradation of the protein (Geisler et al., 1998). An asparagine
upstream of the distal motif of mouse invariant chain Iip31 was important for proper
internalization kinetics (Pond et al., 1995), and an asparagine upstream of the Vam3p
sorting motif was identified in a mutant screen as a residue that was important for
interaction with AP-3 (Darsow et al., 1998). The interaction was disrupted when the
asparagine was mutated to the hydrophobic isoleucine. The residues upstream of the
acidic residue in the OCA2 LL1 and LL3 positions--threonine and serine, respectively-are also polar uncharged residues like asparagine. However, the residue upstream of the
LL2 position is hydrophobic tryptophan, and an OCA2 construct with the LL1 sequence
in that position (OCA2-AA1 LL2-1) can still interact with AP-3 and localize properly to
the melanosome membrane, showing that an upstream polar residue is not necessary for
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LL1 interaction with AP complexes (though the tryptophan itself may be special, as
discussed below). In another instance, AP-1 and AP-2 could not bind to fusion proteins
consisting of GST fused to the cytoplasmic domains of LRP3 and LRP12 in which their
nonfunctional acidic dileucine motifs were mutagenized to the sequence found in the
functional AP-interacting motif from LRP9 (Doray et al., 2008). The authors speculated
that amino acids specific to the parent proteins and outside of the core motif might have
interfered with AP binding. In our mutagenic study with the human tyrosinase motif and
the nonfunctional OCA2 LL3 motif, we saw that a single point mutation in an X residue
was able to inactivate the tyrosinase motif embedded in OCA2, despite still conforming
to the EXXPLL melanosomal sub-consensus. Since the surrounding residues were the
same between the two different motifs, we can conclude that the difference in binding
stems from differences in the ability of the AP complexes to engage the core motif itself.
The experiment also demonstrates the importance of the so-called X residues. The only
crystal structure available of an AP complex bound to an acidic dileucine motif is that of
AP-2 with an acidic dileucine-containing peptide from CD4 (Kelly et al., 2008). There
was no interaction between the side chains of the -2 and -3 amino acids and the AP-2
complex, but the authors of that study hypothesized that their contribution to AP
interaction might be apparent in vivo (Kelly et al., 2008). The -3 position is occupied by
polar Asn in the LL1 motif of human OCA2, acidic Asp in the motif from mouse OCA2,
and basic Lys or Arg in the motif from predicted OCA2 homologs of birds, amphibians,
reptiles, and fish, suggesting that this position may indeed be relatively free. The -2
position is occupied by Thr in the majority of OCA2 homologs, and by Ser in the rest,
while in Tyr and Tyrp1 from human and mouse the position holds Gln, suggesting a need
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for a hydrophilic amino acid at this position. Interactions of the AP complex with other
peptide residues surrounding the motif in the crystal were not described.
The effect of the E to D mutation in LL1 on AP-1 and AP-2 interaction was consistent
with different mutagenesis assays of other proteins such as the acidic dileucine motif of
LRP9 (Doray et al., 2007). A similar E to D mutation in Iip31 (Pond et al., 1995) and
CD4/CD3-gamma chimeras (Geisler et al., 1998) had no effect on internalization,
consistent with a more minimal effect on AP-2 interaction. Whether this position
requires an acidic residue at all seems to depend on the individual motif; substitution by
alanine at this position within the endogenous Iip31 motif or a transferred CI-M6PR
motif within an Iip31 chimeric protein disrupted internalization (Pond et al., 1995), and a
similar E to A mutation within the CD3-gamma motif impairs internalization of a
CD4/CD3-gamma chimera (Geisler et al., 1998), but internalization of LIMP-II, Nef, or
native CD3-gamma was not impaired by a similar mutation (Letourneur and Klausner,
1992; Pond et al., 1995; Bresnahan et al., 1998; Sandoval et al., 2000). Although the E to
A mutation in the CD3 gamma motif in an Iip31/CD3-gamma chimera (Pond et al., 1995)
or in LIMP-II (Sandoval et al., 2000) did not disrupt interanalization, these mutants failed
to reach their proper compartments within the endosomal system. This suggested that
loss of the acidic residue affected another sorting pathway such as AP-1-mediated sorting
at the TGN (Sandoval et al., 2000). Our data show that the conservative E to D mutation
also eliminates interaction with AP-3. Though the importance of a -4 acidic residue for
AP-3 interaction has been previously described (Darsow et al., 1998; Honing et al.,
1998), to our knowledge ours is the first report of specificity for the acidic residue.
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Unlike the E-4 to D mutant, the P-1 to A/S mutants of the OCA2 LL1 motif eliminated the
interaction with AP-1 interaction and greatly reduced the interaction with AP-2, but only
modestly diminished or maintained interaction with AP-3. Proline has been specifically
noted as a common -1 residue in acidic dileucine motifs, including in Vam3p (Darsow et
al., 1998), LIMP-II (Honing et al., 1998), Iip31 (Pond et al., 1995), and LRP9 (Doray et
al., 2007). Consistent with our Y3H results, mutation of the -1 Pro to an alanine
eliminated binding of a GST fusion of LRP9 to recombinant AP-1 and severely reduced
interaction with recombinant AP-2; binding to AP-3 was not tested (Doray et al., 2008).
Although a cohort of the OCA2 LL1 proline mutants localize effectively to
melanosomes, they were also consistently enriched at the cell surface. The enriched
surface accumulation of these mutants is likely a consequence of the weakened
interaction with AP-2 for a cohort of OCA2 that accesses the plasma membrane either
through normal biosynthetic traffic like PMEL (Theos et al., 2006a) or post-melanosomal
fusion with the plasma membrane like Tyrp1 (Truschel et al., 2009). This hypothesis is
supported by observations that Ala substitution for the -1 Pro halves the internalization
rate of Iip31 bearing either its native motif or the LIMP-II motif (Pond et al., 1995). An
alternative explanation for the increased surface localization of the Pro mutants may be
that the loss of AP-1 interaction with OCA2 mimics the effect of the genetic loss of
BLOC-1 on Tyrp1 trafficking (Setty et al., 2007) or of AP-3 on LAMP1 trafficking
(Peden et al., 2004) in enhancing biosynthetic and endosomal recycling to the plasma
membrane as a consequence of the failure to divert the cargo towards
melanosomes/lysosomes. This hypothesis is consistent with the idea that AP-1 and
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BLOC-1 work together at an early step of melanosomal diversion of cargo proteins. The
importance of the -1 Pro for binding to AP-1 and AP-2 is supported by surface plasmon
resonance assays of GST-fusions of Ii showing a 70-80% reduction in binding to AP-1 or
AP-2-enriched cell fractions when the Pro was mutated (Kongsvik et al., 2002).
Furthermore, the mutagenized GGA-binding SDEDLL motif of CI-MPR acquired AP-1
and AP-2 binding when altered to EDEPLL (found naturally in LRP9), but not when
altered to EDEDLL lacking the P-1 (Doray et al., 2008). Unlike AP-1 and AP-2, the -1
Pro does not seem to be required for AP-3 interaction since the same position could
accommodate alanine, serine, or phenylalanine (but not aspartate) in our Y3H assay. That
this position in the OCA2 motif could be more flexible for AP-3 interaction is supported
by the fact that a mutagenesis screen in the Vam3p cytoplasmic domain identified every
residue in the acidic dileucine sorting motif as being critical for AP-3 interaction except
for the -1 Pro (Darsow et al., 1998).

4.1.2 The LL2 motif
The LL1 motif is not the only motif in OCA2 that confers sorting information to OCA2.
The OCA2-AA1 mutant, bearing an intact LL2 motif in its endogenous position in
combination with an inactivated LL1 motif, localizes at steady state to lysosomes in
melanocytes yet is still competent to restore pigment synthesis in a substantial and
statistically significant fraction of OCA2-deficient melan-p1 cells (Sitaram et al., 2009).
We hypothesized that OCA2-AA1 passes transiently through melanosomes and continues
trafficking towards lysosomes by virtue of a weak interaction between the intact LL2
motif and AP-1, as demonstrated in the GST pulldown assays. However, we could not
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confirm this interaction by Y3H assay. We also noted that the OCA2 constructs that
localize at steady state to the melanosome had in common strong binding to AP-3, in
contrast to the mislocalized OCA2-AA1 mutant with the weak AP-1-binding ability. This
differing ability of AP-1 and AP-3 to determine the steady-state localization
foreshadowed the results of the subsequent experiments described in Chapter 3.
In Chapter 3, we extended this investigation into acidic dileucine-mediated trafficking of
OCA2, ultimately analyzing the in vivo behavior of the AP-1-biased E96D construct and
the AP-3-biased P99A and P99S constructs. Analysis of the trafficking of these OCA2
mutants in wild-type melanocytes indicated that the E96D construct could localize to
structures that abut melanosomes and that likely represent the recycling endosomederived tubules that tether endosomes to melanosomes. As with the OCA2-AA1 mutant,
the E96D variant rescued pigmentation in a substantial fraction of melan-p1 cells without
localizing at steady state to melanosomes.

Why do the OCA2-AA1 and E96D mutants have differing steady-state localizations if
both exhibit weak binding to AP-1 and negligible binding to AP-3? We cannot exclude
the possibility that OCA2 interacts with other trans-acting trafficking determinants
besides the AP complexes. In particular, we noted that the steady-state lysosomal sorting
activity of LL2 is masked when the stronger LL1 melanosomal sorting signal is intact.
The glutamate of the LL2 motif is preceded by a tryptophan residue and thus may act as
an additional sorting signal analogous to the WE motif in the cytoplasmic domain of the
melanocytic G protein-coupled receptor GPR143; this signal has been shown to be
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sufficient to sort chimeric proteins to vesicular structures in a human melanoma cell line,
although the factors that recognize this signal are not known (Piccirillo et al., 2006). As
before, this sorting activity would be masked in the E96D mutant, in which the stronger
LL1 signal is altered but still functional and directs steady-state localization to the
endosomal tubules. The lack of the upstream tryptophan may also explain the apparent
position-dependence of the LL2 sequence, which can facilitate lysosomal localization
when in its endogenous position in OCA2-AA1, but is inactive when placed in the LL1
position in the OCA2-AA1 LL1-2 mutant. This position-dependence stands in contrast to
the position-independence of the LL1 sequence, which functions in both the LL2 position
and the LL3 position. Further support for the importance of the WE sequence stems from
the fact that a WEXXXLL motif is conserved in the LL2 position among nearly all
sequenced or predicted mammalian OCA2 homologs. (In mouse and rat the sequence is
WEXXXML, but a Met could substitute for Leu in this position, as seen in human Iip31).
Characterization of tryptophan substitution mutants should help resolve whether OCA2
utilizes this additional sorting mechanism.

4.2. OCA2 melanization-promoting function within the endocytic system
Despite the differences observed in the steady-state localization of the OCA2-AA1 and
E96D mutants, the differences in their ability to stimulate melanin synthesis in OCA2deficient melan-p1 cells were not statistically significant (data not shown), whereas
OCA2 lacking any endosomal sorting signals – such as in the AA123 or E96DP99S
mutants – were completely non-functional in “rescuing” OCA2 deficiency. Taken
together, the results suggest that OCA2 function may be generally required within the
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endocytic system if not at the melanosome itself. One possible explanation for this result
might be connectivity between the recycling endosomal domains and melanosomes,
which have been observed by electron tomography and by live cell imaging (Delevoye et
al., 2009); unpublished results, A. Mantegazza and M. E. Dennis). Because endosomal
tubules physically connect the lumenal environment of endosomes and melanosomes, the
passage of active OCA2 through the endocytic system may allow for its putative
substrate to access endosomes and diffuse into melanosomes despite its absence from the
melanosomal membrane. Alternatively, the steady state distribution might reflect a
transient presence within melanosomes, which might provide ample time to concentrate
the putative substrate within melanosomes directly.

A final alternative might be that the transport activity of OCA2 might be required within
the transport intermediates themselves, or within endosomes to generate the transport
intermediates. Could the endosomal tubules be the normal site of action for OCA2? The
indirect immunofluorescence assays (and unpublished immunoelectron microscopy) that
we have performed showing steady-state melanosomal localization of OCA2 were all
conducted in cells that were transiently overexpressing an epitope-tagged form of human
OCA2. Moreover, two proteomics studies of melanosome-enriched fractions from a
pigmented human melanoma cell line have not identified OCA2 (Basrur et al., 2003; Chi
et al., 2006). It is not clear whether this reflects a lack of melanosomal localization or if
the endogenous levels of OCA2 are too low to detect. Consistent with the latter
possibility, our antibody directed against a human OCA2 peptide can immunoprecipitate
the endogenous protein and can be used to detect the transiently overexpressed OCA2 by
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immunofluorescence microscopy in these cells but cannot detect the endogenous protein
by immunofluorescence microscopy (Sitaram et al., 2009). It may be that the
melanosomal localization in overexpressing wild-type cells represents spillover of extra
protein from the endosomal localization into the melanosomes, a possibility that is
supported by the behavior of a putative platelet dense granule protein when transiently
expressed in melanocytes (A. Sitaram, R. Meng and K. Skinner, unpublished data). Since
OCA2 is not detected on melanosomes in AP-3-deficient melanocytes or in wild-type
cells that express the E96D mutant, such spillover would necessarily be facilitated by
interaction with AP-3. Ultimately, this question will be difficult to address without a
means of detecting endogenous OCA2.

4.3 Expansion of the endosome-to-melanosome trafficking model
4.3.1 The addition of the BLOC-1- and AP-3-dependent pathway
What do the studies of OCA2 localization tell us about cargo sorting from endosomes to
melanosomes? Our model to date was based on studies of the trafficking of Tyr, Tyrp1,
and ATP7A in cells lacking the HPS-associated trafficking complexes AP-3 or BLOC-1.
The model posited one pathway of melanosomal trafficking from endosomes that relies
on AP-3 and is used by a large cohort of Tyr, while a second pathway used by a small
cohort of Tyr and the majority of Tyrp1 (and ATP7A) depends on BLOC-1. Since AP-1
deficiency phenocopies the BLOC-1-deficiency in terms of Tyrp1 localization, it had also
been proposed that BLOC-1 and AP-1 work together to promote Tyrp1 recruitment to the
recycling endosomal tubules that physically connect to melanosomes. Since Tyrp1 and
ATP7A are physically associated and could potentially thus traffic in concert (Setty et al.,
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2008), this model could be considered to be based on only two independent cargoes and
thus had the potential to substantially benefit from data contributed by the investigation
of the trafficking of an additional cargo. Our studies with OCA2 demonstrated its value
as an additional model cargo and surprisingly revealed a trafficking “phenotype” that
incorporates features of both Tyr and Tyrp1/ATP7A (Figure 4.1). OCA2 binds both AP1 and AP-3 but appears to depend heavily on AP-3 for steady-state melanosomal
localization like Tyr, but OCA2 is largely mislocalized in BLOC-1-deficient melanocytes
like Tyrp1/ATP7A. Thus, OCA2 is trafficked in a manner distinct from that of Tyr,
Tyrp1, and ATP7A.

4.3.2 Cargo selection and entry into endosomal tubules
As discussed in the Introduction, the molecular function of BLOC-1 is not known. What
is clear is that BLOC-1-deficiency causes a buildup of Tyrp1 in vacuolar endosomal
domains and a dramatic increase in the flux of Tyrp1 through the endocytic recycling
pathway to the cell surface (Setty et al., 2007). Transferrin-positive tubules that are
depleted of Tyrp1 are detectable emanating from endosomes in wild-type melanocytes as
well as in BLOC-1-deficient melanocytes, suggesting that BLOC-1 activity primarily
directs recruitment of cargo and/or effectors into the tubules, although since tubules also
mediate recycling to the plasma membrane and the Golgi, the destination of the tubules
observed in BLOC-1-deficient cells is not clear and thus a role for BLOC-1 in the
formation or stabilization of melanosome-bound tubules cannot be ruled out.
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Figure 4.1

Figure 4.1. New model of endosome to melanosome trafficking.
Previous research suggested a model of endosome to melanosome trafficking with two
independent pathways, one mediated by AP-3 and used by the majority of tyrosinase, and
one mediated by BLOC-1 in conjunction with AP-1 and used by Tyrp1. The research
presented here suggest that OCA2 utilizes a distinct pathway that is both BLOC-1- and
AP-3-dependent.
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The similarity of the AP-1 knockdown and BLOC-1-deficiency phenotypes on Tyrp1
trafficking suggest that BLOC-1 and AP-1 functionally cooperate in cargo recruitment to
the endosomal tubules (Setty et al., 2007; Delevoye et al., 2009). Localization of OCA2
has not been investigated in melanocytes in which AP-1 has been knocked down, but in
wild-type cells, the OCA2 proline mutants, deficient in AP-1 binding but competent to
bind AP-3, are still able to traffic to melanosomes, albeit less efficiently. This suggests
that BLOC-1 can additionally work with AP-3 to facilitate cargo entry into the
endosomal tubules (Figure 4.2). The role of the AP complex in BLOC-1 cargo selection
might be in the regulation of BLOC-1 membrane recruitment. The percentage of BLOC-1
that cofractionates with membranes relative to cytosol from mouse skin fibroblasts is
reduced when AP-3 is genetically deficient (Di Pietro et al., 2006). Furthermore, AP-3
and BLOC-1 interactions appear to be regulated by cargo. For example, AP-3 and
BLOC-1 can be co-immunoprecipitated with epitope-tagged PI4KIIalpha, an AP-3 cargo
protein, from HEK293T cells in which the cargo has been transiently expressed (Salazar
et al., 2009), but coprecipitation of both is reduced in cells that express a PI4KIIalpha
with a mutation in its dileucine motif; this suggests that BLOC-1 recruitment requires an
AP-3/PI4KIIalpha interaction. An alternative explanation for this result is that both
BLOC-1 and AP-3 interact simultaneously with cargo proteins via the dileucine motif,
but it is difficult to imagine how two complexes could simultaneously engage such a
small peptide, especially considering the tight fit of the acidic and leucine residues into
pockets within the AP complex. Moreover, BLOC-1 has never been shown to bind to the
cytoplasmic domains of any of its cargoes. Finally, the OCA2 LL1 signal, like the acidic
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Figure 4.2

Figure 4.2 Model of endosome-to-melanosome trafficking of OCA2.
Transferrin-positive tubules emanating from recycling endosomal domains making
physical connections with melanosomes have been visualized in a human melanoma cell
line. Tyrp1 has also been visualized on AP-1 coated endosomal tubules, and deficiency in
BLOC-1 or AP-1 causes mislocalization of Tyrp1 to vacuolar endosomal domains,
suggesting that BLOC-1 and AP-1 together mediate Tyrp1 entry into tubules. Our results
from studies of OCA2 trafficking in mouse melanocytes are consistent with a model in
which entry of OCA2 (blue) into tubules is also BLOC-1-dependent. Final delivery of
OCA2 to melanosomes requires interaction with AP-3, predicted to take place in AP-3coated buds analogous to the AP-1-coated buds that are proposed to traffic Tyrp1.
(Modified from (Delevoye et al., 2009))
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dileucine-based signal of tyrosinase (Theos et al., 2005), interacts with both AP-1 and
AP-3, but unlike tyrosinase, OCA2 is highly dependent on BLOC-1 for its trafficking.
This reliance on BLOC-1 is maintained even when the LL1 signal on OCA2 is replaced by
that of tyrosinase, as indicated by the lack of overlap of OCA2-AA23 hTyr with PMELcontaining melanosomes in BLOC-1-deficient cells. This indicates that the sorting signal
itself is not sufficient to determine whether or not the cargo uses a BLOC-1-dependent or
–independent pathway.

Other determinants must distinguish the choice of whether to utilize the BLOC-1
pathway (Figure 4.1). I can only speculate on the identity of such determinants, but one
possibility is suggested by the exclusion of transferrin from melanosomes during the
formation of transient, tubular connections between recycling endosomes and
melanosomes. Transferrin remains associated with transferrin receptor—a dimeric, single
transmembrane domain containing type II integral membrane protein—throughout the
endocytic system (Dautry-Varsat et al., 1983). One might speculate that a “gating”
mechanism that prevents transferrin/transferrin receptor accumulation in the melanosome
is more generally used to prevent similarly composed integral membrane proteins from
indiscriminately diffusing into the melanosome. Such a gate might function by excluding
proteins of a certain size, membrane spanning domain content, or lipid microdomain.
OCA2 is a 12-transmembrane domain protein and is therefore much larger than
tyrosinase, which is a single-pass protein like transferrin receptor. Although Tyrp1
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traverses the tubules and is approximately the same size as tyrosinase, previously
published (Setty et al., 2008) and unpublished evidence suggests that Tyrp1 traffics to
melanosomes together with ATP7A; indeed, ATP7A depletion results in the mistargeting
of Tyrp1 to lysosomes and in its degradation (unpublished results). ATP7A is a P-type
ATPase with 8 membrane-spanning domains (Lutsenko et al., 2007), and thus might have
properties more in common with OCA2. Finally, when the OCA2 N-terminal
cytoplasmic domain was fused to the transmembrane and lumenal domains of human TfR
and expressed in non-melanocytic Chinese hamster ovary cells, the chimera was able to
localize to lysosomes in a dileucine motif-dependent manner (Sitaram et al., 2009), as
expected for a melanosomal protein expressed in a non-melanocytic cell. However, in
melanocytes the chimera localized to an unidentified intracellular compartment that did
not colocalize with pigment, perhaps falling prey to the same mechanism that prevents
melanosomal accumulation of native transferrin receptor. These examples suggest the
existence of a gating mechanism through the BLOC-1-dependent pathway that might only
permit entry to proteins or protein complexes with multiple membrane spanning
domains.

The gating mechanism might not function at the level of the proteins themselves, but
rather through lipid interactions. Tyrp1 and tyrosinase both require glycosphingolipids
for proper intracellular trafficking to melanosomes (Sprong et al., 2001; Groux-Degroote
et al., 2008). Furthermore, experiments with chimeric proteins consisting of lumenal and
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cytoplasmic domain swaps between Tyrp1 and the lysosomal protein, LAMP1, or
between Tyr and LAMP1 showed that the determinants for the lipid-dependent behavior
reside in the lumenal domains of the proteins. The failure of the OCA2 cytoplasmic
domain chimera to traffic to melanosomes could thus be explained if similar interactions
between lipids and OCA2 lumenal determinants regulated trafficking and passage through
the endosome/melanosome “gate”. It will be interesting to see whether OCA2 trafficking
similarly depends on glycosphingolipids.

4.3.3 BLOC-2 and AP-3
What happens once OCA2 has entered the endosomal tubular transport intermediates?
As discussed above, this localization might be sufficient to allow for OCA2 transport
activity to rescue melanin synthesis in OCA2-deficient cells. However, BLOC-2 is likely
to facilitate the ultimate delivery of OCA2 via these tubular intermediates to
melanosomes. Although we currently do not yet understand BLOC-2 function at the
molecular level, analyses of Tyrp1 trafficking in our laboratory implicate BLOC-2 as
functioning downstream of BLOC-1 in directing Tyrp1 towards melanosomes via the
tubular intermediates (Setty et al., 2007). As in BLOC-1-deficient cells, a cohort of
Tyrp1 in BLOC-2-deficient cells is aberrantly localized to early endosomes and the
plasma membrane, but substantial cohorts are also delivered to the TGN and to
multivesicular endosomes/lysosomes. This steady state redistribution of Tyrp1, together
with live cell imaging analyses, suggests that BLOC-2 facilitates the directed fusion of
the tubular intermediates with melanosomes. Is OCA2 also dependent on BLOC-2 for
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trafficking? Preliminary results suggest that OCA2 is indeed mislocalized in BLOC-2deficient melanocytes derived from the cocoa mouse model of HPS type 3, but further
experiments are needed. A genetic interaction between OCA2 and BLOC-2 has also been
suggested by results from Hoyle et al, in which BLOC-2-deficient mice were observed to
progressively lose pigmentation with the loss of one or both alleles of OCA2 (Hoyle et
al., 2011). Because OCA2 mutations alone are typically recessive and phenotypes are not
typically observed in heterozygotes, Hoyle et al interpreted their results to suggest that
OCA2 requires BLOC-2 to traffic to melanosomes. Thus, depletion of BLOC-2
compromises the melanosomal content of OCA2 such that gene dosage effects become
apparent. In further support of a role for BLOC-2 in regulating OCA2 delivery to
melanosomes, Tyr activity in both OCA2-deficient mouse melanocytes and BLOC-2deficient melanocytes cultured from human patients is normal or increased relative to
wild-type melanocytes in vitro, but Tyr activity is diminished in vivo (Manga et al., 2001;
Chen et al., 2002; Toyofuku et al., 2002; Boissy et al., 2005; Helip-Wooley et al., 2007)
– likely a reflection of altered pH or copper content in melanosomes. Moreover, Tyr in
both models is mislocalized to cytoplasmic vesicles that are not themselves pigmented
but that stain positively in DOPA histochemical assays, suggesting that in intact cells the
lumenal environment in these vesicles does not support melanin formation (Manga et al.,
2001; Boissy et al., 2005; Helip-Wooley et al., 2007). The similarity of the phenotypes in
the two cell lines suggest that OCA2 relies in part on BLOC-2 for its trafficking. BLOC1-deficient melanocytes are more severely hypopigmented than BLOC-2-deficient
melanocytes, at least partially due to a failure in BLOC-1-deficient cells to deliver
ATP7A, the copper transporter, to melanosomes to supply Tyr with its cofactor, copper
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(Setty et al., 2008). The higher pigmentation level of BLOC-2-deficient melanocytes
suggests that like OCA2, ATP7A is also likely to be weakly dependent on BLOC-2 for its
localization to melanosomes. The partial mislocalization of Tyrp1 and reduced but not
ablated activities of OCA2, and ATP7A in BLOC-2-deficient melanocytes is consistent
with a role for BLOC-2 as a tether, such that melanosomal targeting of tubular transport
structures is impaired but not entirely eliminated in its absence.

Interestingly, the BLOC-2 and AP-3 double mutant mouse is reported to be as severely
hypopigmented as the BLOC-1-deficient mouse in both coat and eye color (Di Pietro et
al., 2006; Gautam et al., 2006). Dependence of OCA2 on both BLOC-2 and AP-3
suggests one possible contributing factor to this severe hypopigmentation. If OCA2
melanosomal localization and function is hampered but not eliminated by either BLOC-2
or AP-3 deficiency, the combined loss of the two might result in a severe loss of OCA2
localization and function, phenocopying the loss of BLOC-1, which most likely prevents
entry of OCA2 into the tubular transport intermediates. Although the hypopigmentation
phenotype of BLOC-1-deficient cells has been attributed largely to loss of copper-loading
of tyrosinase due to ATP7A mislocalization (Setty et al., 2008), OCA2 functional loss
could also contribute. The in vitro assays showing that DOPA activity is restored in
BLOC-1-deficient cells upon addition of copper do not reveal whether in vivo pH
dysregulation attributed to OCA2 deficiency was also a factor contributing to low in vivo
Tyr activity.
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Current data suggest that BLOC-1 functions upstream of BLOC-2 (Setty et al., 2007), but
where does AP-3 act? As described above, I propose that AP-3 can function together
with BLOC-1 to divert cargo into melanosome-bound endosomal tubular transport
intermediates (Figure 4.2), but whether AP-3 is additionally needed downstream for
delivery from within the tubules to melanosomes is unclear. At the light microscopy level
it may not be possible to tell whether the structures to which E96D is localized are the
tubules themselves or the vacuolar endosomes, reflecting a simple block in initial entry to
the tubules. Both AP-1 and AP-3 coated buds have been observed on the endosomal
tubules near melanosomes by immunoelectron microscopy (Theos et al., 2005; Delevoye
et al., 2009), and the AP-1 coated buds are proposed to help deliver Tyrp1 to the adjacent
melanosomes (Delevoye et al., 2009). Moreover, by electron tomography, unidentified
buds are observed to extend from the tubules that connect endosomes to melanosomes
(Delevoye et al., 2009). AP-3 has previously been localized to buds on endosomal
tubules that are decorated with BLOC-1 in spatially distinct areas (Di Pietro et al., 2006);
whether these tubules are the same as those that are continuous with melanosomes is not
clear (Di Pietro et al., 2006). We speculate that AP-3-coated buds will be found on these
tubular transport intermediates continuous with melanosomes, and that the buds function
in anterograde transport from the tubules to melanosomes (Figure 4.2). If true, this
would provide evidence that AP-3 plays a sorting role downstream of BLOC-1/AP cargo
selection. One might postulate that OCA2 is “handed off” from BLOC-1/AP-3 to BLOC2 and perhaps finally to AP-3 again for melanosomal delivery. This would be consistent
with evidence for physical interactions between BLOC-1 and BLOC-2, between BLOC-1
and AP-3 (Di Pietro et al., 2006), and more recently between BLOC-2 and AP-3 (Salazar
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et al., 2009) in skin fibroblasts. Careful examination at the light and electron microscopy
levels of OCA2 trafficking in cells deficient in BLOC-2 or AP-3 will be required to sort
out the spatiotemporal order of these complexes in melanosomal trafficking.

4.4 OCA2 function and Tyr trafficking
What do my results imply about OCA2 function? In OCA2-deficient cells, an unusually
high proportion of Tyr is sensitive to endoglycosidase H at steady state (Chen et al.,
2002; Toyofuku et al., 2002; Chen et al., 2004). This has been interpreted as a defect in
Tyr maturation and ER exit. Moreover, Tyr is abnormally cleaved and secreted from
these cells, and is also found in small vesicles distributed throughout the cytoplasm
(Manga et al., 2001; Manga and Orlow, 2001; Chen et al., 2002; Toyofuku et al., 2002;
Chen et al., 2004; Ni-Komatsu and Orlow, 2006). How does one explain these findings
in the context of our model?

4.4.1 OCA2 as a pH regulator
Sequence homology places OCA2 in the ArsB/NhaD family of transporters. The NhaD
founder is a Na+/H+ exchanger, and since OCA2 is thought to regulate pH, some
researchers have proposed that OCA2 might also be a proton transporter (Lee et al.,
1995; Ancans et al., 2001a), though this hypothesis is disputed (Brilliant and Gardner,
2001; Brilliant, 2001). The regulation of lumenal pH appears to be important for melanin
synthesis. Fluorescent assays show a higher steady-state pH in Black melanocytes than in
Caucasian melanocytes (Fuller et al., 2001). Treatment of Caucasian melanocytes with
chemicals that raise organellar pH stimulates melanin synthesis in these cells; a similar
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induction in melanin synthesis is seen in OCA2-deficient melanocytes receiving the same
treatments (Ancans et al., 2001a; Ancans et al., 2001b; Fuller et al., 2001; Manga and
Orlow, 2001; Chen et al., 2002; Chen et al., 2004; Ni-Komatsu and Orlow, 2006). NHE
activity has been demonstrated to be a determinant of the difference in melanin synthesis
activity between Caucasian and Black melanocytes (Smith et al., 2004), and population
genetics analyses consistently demonstrate strong linkage between OCA2 polymorphisms
and racial differences in skin color (Shriver et al., 2003; Lao et al., 2007; Norton et al.,
2007). However, the NHE activity that was seen to be a factor in the activity in the
different melanocytes was sensitive to derivatives of the fairly promiscuous NHE
inhibitor amiloride (Sarangarajan et al., 2001; Smith et al., 2004), and researchers noted
that the amino acid sequence that confers EIPA sensitivity on an NHE is not present
within OCA2 (Smith et al., 2004), making it unlikely to be the critical NHE. My
unpublished results also suggest that OCA2 does not directly act as an NHE.
Heterologous expression of a plasma membrane-localized mutant of OCA2 (lacking
active LL1 and LL2) in NHE-deficient fibroblasts was not sufficient to rescue these cells
from death following intracellular acid loading, while cells expressing a bona fide NHE
protein survived. pH-sensitive live-cell fluorescence assays gave similar results, showing
that the same OCA2-expressing fibroblasts could not recover their pH after short-term
acid loading in a flow chamber apparatus. These experiments do not rule out pH
regulation by OCA2 via some other mechanism within melanocytes.

The proposed role of OCA2 as a pH regulator may also explain the appearance of the
aberrant cytoplasmic Tyr vesicles seen in OCA2-deficient melanocytes. The origin of
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these vesicles is not completely clear. Tyrosinase has been visualized in AP-3 and AP-1
coated endosomal buds near melanosomes in wild-type cells (Theos et al., 2005). If
OCA2 acting within the endosomes/melanosomes is required to promote correct targeting
of endosomally-derived Tyr-containing vesicles, then OCA2 deficiency could lead to the
accumulation of vesicles that bud appropriately but are unable to fuse with their target
compartments. The fact that the vesicles detected in OCA2-deficient cells are not
pigmented but stain positively for Tyr activity by classical DOPA histochemistry (Manga
et al., 2001) indicates that the Tyr in these vesicles is inactive in vivo but likely already
loaded with copper (if it were not copper loaded, excess copper would be needed during
DOPA histochemistry; (Setty et al., 2008)). This might reflect a failure to strip copper in
endosomes (Setty et al., 2008) in OCA2-deficient cells, such that copper remains bound
in endosome-derived transport vesicles. Failure to strip copper in endosomes due to loss
of OCA2-mediated pH regulation is consistent with the appearance of some induced
melanin deposition in endosome-like structures in OCA2-deficient melanocytes that have
been treated with the vATPase inhibitor bafilomycin A1 (Chen et al., 2004), though the
majority of the induced activity was correctly localized to melanosomes.

Alternatively, the accumulated Tyr vesicles could originate from the TGN instead of
endosomes. In this case, OCA2 might be predicted to function at the endosome to
facilitate targeting and/or fusion of the incoming Tyr vesicles. In support of the idea that
OCA2-mediated pH regulation could affect TGN-derived Tyr-containing vesicle fusion
at the endosome, modulation of lumenal pH has previously been proposed to play a role
in membrane fusion at the yeast vacuole (Ungermann et al., 1999), and mutations in the
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endosomal Ca2+ transporter MCOLN3 affect endosomal acidification as well as the rate
of homotypic endosomal fusion in vitro (Lelouvier and Puertollano, 2011). Interestingly,
a gain-of-function mutation in MCOLN3 gives rise to the varitint-waddler mouse, which
exhibits hypopigmentation among other phenotypes (Di Palma et al., 2002).

4.4.2 Could OCA2 act elsewhere?
Other researchers have suggested that OCA2 might facilitate transmembrane glutathione
transport, since heterologous expression in yeast leads to localization of the transgene to
the vacuolar membrane and a correlated reduction in cellular glutathione levels due to
degradation following import into the vacuolar lumen (Staleva et al., 2002). Because the
Tyr glycosylation and cleavage/secretion defects seen in OCA2-deficient melanocytes
reflect problems at relatively early steps in Tyr biogenesis, Chen, Manga and Orlow have
proposed that OCA2 acts within the endoplasmic reticulum to promote Tyr maturation
(Chen et al., 2002). Tyr contains several disulfide bonds, and its maturation might thus be
particularly sensitive to changes in the redox state of the ER (Wang and Hebert, 2006). If
OCA2 were an ER-localized glutathione transporter for example, it could greatly affect
Tyr biosynthesis. My results from rescue assays performed with ER-localized OCA2
mutants show that OCA2 must traffic to a post-Golgi compartment for melanin synthesis
to take place. I speculate that substrate gradients generated by OCA2 in distal endosomal
compartments might be transduced back to the ER and correct the early defects in Tyr
maturation. However, another untested possibility is that OCA2 actually functions in both
the ER and the endosome/melanosome. In the ER it could act to promote Tyr folding and
glycosylation while in the endosome/melanosome it could facilitate fusion of Tyr159

containing vesicles or promote the lumenal conditions needed for melanin synthesis in
melanosomes. Our rescue assay only examined the most distal phenotype, melanin
synthesis. It would be informative to see whether ER-restricted OCA2 mutants could
correct the observed differences in Tyr glycosylation, cleavage and secretion, or
mislocalization to scattered cytoplasmic vesicles.

4.5 Concluding remarks
The completion of the work in this thesis has led to the resolution of a debate surrounding
the localization of the OCA2 protein, the confirmation that a putative sorting signal does
in fact play a critical role in OCA2 trafficking to melanosomes, and the reconciliation of
our model of melanosomal trafficking with data from studies in several cell types. But
beyond that, my initial work with this protein has also paved the way for its use in further
investigation of the determinants of AP complex interaction with dileucine motifs and
characterization of the melanosomal trafficking pathway in additional mutant cells. The
differences in structure and sorting between OCA2 and Tyr/Tyrp1 should additionally
provide new testable hypotheses regarding the mechanism for determining the BLOC-1dependence of LRO cargo proteins, perhaps ultimately leading to the elucidation of
BLOC-1 function.

The question of the function of OCA2 itself, however, also remains unanswered. Though
use of OCA2 as a trafficking model does not strictly require knowledge of the protein’s
function, we have seen for example that the localization of the protein appears to be
somewhat flexible within the endocytic system, and I believe that future elucidation of
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the putative transport function of OCA2, likely to be achieved via in vitro studies or
expression in heterologous systems, will undoubtedly contribute to the determination of
its “true” site of action. Solving the riddle of OCA2 function will also help us understand
its biological role in normal pigmentation and how this function is disrupted by the
numerous disease-causing mutations that have been cataloged.
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CHAPTER 5: MATERIALS AND METHODS
Chemicals
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise
specified.

Cell Culture and Transgene Expression
All culture reagents were purchased from Invitrogen (Carlsbad, CA) unless stated
otherwise. All cells were grown in media that included 1% penicillin/streptomycin and
incubated at 37°C and 10% CO2 unless stated otherwise. HeLa cells were grown in
DMEM supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, UT).
Immortalized mouse melanocyte cell lines melan-Ink4a and melan-pallid (Sviderskaya et
al., 2002), melan-p1 (Sviderskaya et al., 1997), and melan-pearl (Theos et al., 2005) were
grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (Atlanta
Biologicals, Lawrenceville, GA) and 200 nM phorbol 12-myristate-13-acetate. Melanpearl growth media was additionally supplemented with 200 nM cholera toxin. MNT-1
human melanoma cells (Cuomo et al., 1991) were grown in DMEM supplemented with
15% fetal bovine serum, 10% AIM-V, 1% nonessential amino acids, 1% sodium pyruvate
(Mediatech, Herndon, VA), and antibiotics. Chinese hamster ovary (CHO) cells subclone
K1 were a gift from Dr. Monty Krieger (Massachusetts Institute of Technology,
Cambridge, MA). Chinese hamster ovary (CHO) cells were grown in minimal essential
medium with 5% fetal bovine serum (HyClone Laboratories) in 5% CO2. Transfections in
HeLa, CHO, and mouse melanocytes were performed using FuGENE-6 (Roche
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Diagnostics, Indianapolis, IN) according to manufacturer’s instructions with 1–2 µg of
DNA. Transfections in MNT-1 cells were performed using Lipofectamine 2000
(Invitrogen) according to manufacturer’s instructions, with 1.6 µg of DNA and OptiMEM (Invitrogen).

Construction of OCA2 Expression Plasmids
To clone the full-length human OCA2, a human melanoma library in the Uni-Zap vector
(Stratagene, La Jolla, CA) was screened using a 953-base pair probe derived from the
central portion of OCA2 cDNA by reverse transcription-polymerase chain reaction (RTPCR) (with Pfu DNA polymerase; Promega, Madison, WI) from total melanocyte cDNA
synthesized with the SuperScript preamplification system kit (Invitrogen). Among several
independent positive clones isolated, two contained full-length OCA2 cDNA with
an internal deletion of 72 base pairs encompassing transmembrane domain 3 and
corresponding to exon 10 of the OCA2 gene; the deleted region was reinserted by
subcloning an encompassing unique AccI–HindIII fragment obtained by RT-PCR into
AccI–HindIII-digested OCA2 cDNA. The entire cDNA was subcloned into the BamHI
and XhoI sites of pCR3 (Invitrogen), and its sequence was confirmed (Bio Molecular
Research, DNA sequencing service at the University of Padua, Italy;
http://bmr.cribi.unipd.it/). Compared with the originally published sequence (Rinchik et
al., 1993), the pCR3/OCA2 contains four silent mismatches and the previously reported
nonpathologic polymorphism D257A (Oetting et al., 1998). In most experiments (except
those in Figure 1), the entire 5´-untranslated region was replaced by a synthetic Kozak
consensus sequence immediately upstream of the OCA2 translational start site. To
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generate a lumenally exposed epitope-tagged form of OCA2, three consecutive copies of
an influenza hemagglutinin epitope tag (3xHA) were introduced into the first lumenal
loop as follows. The codons for the unconserved R243P244 residues in this loop were
subjected to site-directed mutagenesis by using two-step amplification (Higuchi et al.,
1988) with AmpliTaq (Applied Biosystems, Foster City, CA) to generate a BsiWI
restriction site (converting P244 to T). The 3xHA tag with a 5´ BsiWI site and a 3´ Acc65I
site was amplified by thermal cycling with AmpliTaq from pCI-pallidin-HA
(Moriyama and Bonifacino, 2002) and subcloned into the new BsiWI site on OCA2,
creating OCA2-HA. To construct OCA2-HMGCR, we amplified a fragment beginning 5´
of the unique BstXI site, encoding the C terminus of human OCA2 fused to the last eight
amino acids of human HMG CoA reductase (GACTKKTA), and followed by an XhoI
site, and the product was subcloned in place of the BstXI–XhoI fragment of
pCR3/OCA2-HA. Mutated forms of OCA2-HMGCR were constructed in a similar
manner. To construct OCA2-ΔN91, an oligonucleotide encoding amino acids 92-102 of
OCA2 and flanked by BamHI and EcoRI sites was subcloned to replace the BamHI–
EcoRI fragment of pCR3/OCA2-HA, excising amino acids 2-91 of OCA2.
MHRRROCA2-ΔN91 and MHAAA-OCA2-ΔN91 were constructed in the same way
using oligonucleotides that encoded the sequences MHRRR (the first five amino acids of
the p35 form of human Invariant chain; (Schutze et al., 1994) or MHAAA (in which the
tribasic ER retention signal is mutated) fused to amino acid 92 of OCA2. To alter the
leucine residues within the N-terminal cytoplasmic domain of OCA2, the codons for the
indicated pairs of leucine residues were replaced with those for two alanines by sitedirected mutagenesis using two-step amplification. Expression vectors for chimeric
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OCA2-human transferrin receptor (hTfR) proteins were constructed from pCR3OCA2 and pCDM8-hTfR (Marks et al., 1996) by site-directed mutagenesis using twostep amplification with primers that bridged the junction between the OCA2 N-terminal
cytoplasmic domain and the transmembrane domain of human transferrin receptor. The
final chimera contained amino acids 1-173 of human OCA2 and amino acids 62-761 of
hTfR. To generate the GST fusion proteins, the 5´ end of the OCA2 cDNA,
corresponding to the first 162 amino acids, was amplified from pCR3-OCA2 and cloned
into the BamHI and SalI sites of the prokaryotic expression vector pGEX5X-1 (GE
Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). Constructs containing
the various combinations of mutations at the dileucine motifs were generated by
amplification from the corresponding pCR3 vectors. The construction of the yeast threehybrid pBridge plasmids containing the sigma constructs and the cytoplasmic domain of
tyrosinase (Theos et al., 2005) and the construction of the pGADT7 plasmids containing
fusions of murine gamma1, rat alphaC, and human delta to yeast Gal4-AD (Janvier et al.,
2003) have been previously described. The yeast three-hybrid OCA2-containing pBridge
constructs were made by PCR amplification of the N-terminal portion of the appropriate
pCR3/OCA2-containing plasmid with primers that added a 5' EcoRI site and 3' SalI site.
The products were subcloned into the same restriction sites downstream of yeast Gal4BD in pBridge plasmids containing human sigma1A, rat sigma2, or human sigma3A in
the second transcription unit. Unless stated otherwise, all recombinant plasmids were
verified by automated sequencing by the University of Pennsylvania Cell Center or the
Nucleic Acid/Protein Research Core Facility at the Children's Hospital of Pennsylvania.
Details of PCR primers, sequences, and conditions can be provided upon request.
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Antibodies
Antibodies used were as follows: rat anti-HA 3F10 and mouse B3/25 antitransferrin
receptor were from Roche Diagnostics, TA99 (Mel-5) anti-Tyrp1 was from American
Type Culture Collection (Manassas, VA), mouse H4A3 anti-human lysosome-associated
membrane protein (LAMP)-1 and rat GL2A7 anti-mouse LAMP-2 were from
Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA), rabbit antiLAMP-1 was from Affinity Bioreagents (Golden, CO), mouse anti-HA 16B12 was from
Covance Research Products (Princeton, NJ), mouse MAB3126 anti-calnexin was from
Millipore (Billerica, MA), HMB45 anti-PMEL was from LabVision (Fremont, CA),
mouse anti-AP-3 µ3A (anti-p47A) was from BD Biosciences Transduction Laboratories
(Lexington, KY), mouse anti-Rab5 was from Synaptic Systems (Göttingen, Germany),
and the mouse monoclonal antibodies 100/3 anti-AP-1γ, 100/2 anti-AP-2α, anti-αtubulin, and anti-β-actin were from Sigma-Aldrich. The mouse anti-pallidin monoclonal
antibody (mAb) 2G5 was described previously (Nazarian et al., 2008). Goat antiimmunoglobulin G (IgG) secondary antibodies conjugated to Alexa-488 and Alexa-594
were from Invitrogen. Donkey anti-IgG secondary antibodies conjugated to 7-amino-4methylcoumarin-3-acetic acid or conjugated to DyLight 488 and unconjugated donkey
anti-mouse IgG antibodies were from Jackson ImmunoResearch Laboratories (West
Grove, PA). Conjugation of Alexa-488 to monoclonal antibodies was performed using a
protein labeling kit from Invitrogen. The NOCA2 anti-OCA2 antibody was generated by
conjugating the first thirteen amino acids of human OCA2 (MHLEGRDGRRYPG) with a
C-terminal cysteine to keyhole limpet hemocyanin and immunizing rabbits from
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Genemed Biosynthesis (San Francisco, CA) with the conjugate. NOCA2 was further
affinity purified against the antigenic peptide conjugated to SulfoLink coupling gel
(Pierce Chemical, Rockford, IL) according to the manufacturer’s instructions.

Glutathione Transferase (GST) Pull-Down Assays
The GST-OCA2 fusion constructs were expressed in Escherichia coli and purified as
described previously (Starcevic and Dell'Angelica, 2004). Detergent extracts of MNT-1
or HeLa cells were prepared in MNT-1 buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, 1
MgCl2, 1 mM NaF, and 0.5% NP-40) or HeLa buffer (25 mM HEPES, pH 7.4, 0.15 M
NaCl, 1 mM EDTA, 1 mM NaF, 0.5 mM MgCl2, and 0.5% Triton X-100), respectively,
containing protease inhibitor mixture [1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride,
10 µg/ml leupeptin, 5 µg/ml aprotinin, and 1 µg/l pepstatin A]. The MNT-1 extract was
subsequently diluted with 1 volume of MNT-1 buffer lacking detergent and precleared by
incubation with glutathione-Sepharose 4 Fast Flow beads (GE Healthcare) and
centrifugation. Aliquots of the cleared detergent extracts were incubated for 1 h at 4°C
with GST-fusion proteins (20 µg) that had been immobilized onto 15 µl of glutathioneSepharose beads. After the incubation period, beads were collected by brief
centrifugation and washed three times with MNT-1 buffer containing 0.1% NP-40 or
HeLa buffer containing 0.1% Triton X-100, respectively, and one time with buffer
lacking detergent. Proteins bound to the beads were fractionated by SDS-polyacrylamide
gel electrophoresis (PAGE) and subjected to immunoblotting as described previously
(d'Addio et al., 2000).
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Metabolic Labeling and Endoglycosidase Assays
Metabolic labeling of MNT-1 cells or transiently transfected HeLa cells and
immunoprecipitation from Triton X-100 cell lysates were done essentially as described
previously (Berson et al., 2000) by using EXPRE35S35S 35S-cysteine/methionine mixture
(PerkinElmer Life and Analytical Sciences, Boston, MA). Cells were labeled for 30 min
at 37°C and chased for the indicated times. For endoglycosidase treatments,
immunoprecipitates were denatured, split into equal aliquots, and mock treated or
incubated with endoglycosidase H (endoH) or peptide N-glycosidase F (PNGase F) (both
from New England Biolabs, Ipswich, MA), according to manufacturer’s instructions, for
4 h with the addition of phenylmethylsulfonyl fluoride, leupeptin (Roche Diagnostics),
and 1% NP-40 (Roche Diagnostics). Samples were fractionated by SDS-PAGE using 8%
acrylamide gels, dried, and analyzed using a Storm 860 PhosphorImager and ImageQuest
software (GE Healthcare) as described.

Transfections and Immunofluorescence Microscopy
For HeLa and CHO cells, cells were seeded onto glass coverslips in six-well dishes at
1.5x105 per well. Mouse melanocytes were seeded at 1x105 per well in six-well dishes or
at 0.5-0.75x105 per well in 12-well dishes on coverslips coated with Matrigel (BD
Biosciences, San Jose, CA) according to manufacturer’s instructions. The next day, cells
were transfected with 1–2 µg of the relevant OCA2 construct by using FuGENE-6
reagent. Two days later, cells were fixed for 30 min in 2% formaldehyde (Thermo Fisher
Scientific, Waltham, MA), stained with primary and fluorochrome-conjugated secondary
antibodies, and mounted onto glass slides as described previously (Calvo et al., 1999). In
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some experiments, transfected HeLa cells were incubated in fresh medium with or
without 50 µg/ml cycloheximide for 3 h before fixation. For lysosomal inhibition,
transfected CHO cells were incubated in fresh medium with or without 50 mM NH4Cl
(Thermo Fisher Scientific) for 4 h before fixation. For surface staining, chilled cells were
labeled with 1 µg/ml anti-HA antibody for 10–30 min on ice, and then unbound antibody
was removed by rinsing in ice cold phosphate-buffered saline before fixation as
described. Slides were analyzed on a DM IRBE microscope (Leica, Wetzlar, Germany)
equipped with an Orca digital camera (Hamamatsu, Bridgewater, NJ) or a Retiga Exi Fast
1394 digital camera (Qimaging, Surrey, BC, Canada). Images were captured and
manipulated using OpenLab software (Improvision, Lexington, MA), with the volume
deconvolution package. Final images were prepared using Adobe Photoshop (Adobe
Systems, Mountain View, CA).

Yeast Culture, Transformation, and Three-hybrid Assays
The Saccharomyces cerevisiae strain HF7c (Clontech), was maintained on complete YPD
plates. Co-transformation with pBridge and pGADT7 plasmids was performed by a
modification of the lithium acetate procedure as described in the Yeast Protocols
Handbook from Clontech. HF7c transformants were selected by spreading on plates
lacking leucine, tryptophan, and methionine. For colony growth assays, HF7c
transformants were pooled and spotted once or in 5-fold serial dilutions on plates lacking
leucine, tryptophan, methionine, and histidine, and allowed to grow at 30° C for 3–5
days.
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Statistical Analysis
Quantification of melanin synthesis rescue was performed as follows. Transfected cells
were identified by positive labeling with anti-HA antibody by immunofluorescence
microscopy and then assessed for the presence of pigmented melanosomes by bright field
microscopy. Within each experiment, the percentage of transfected cells (>100
cells/experiment) that were positive for pigment rescue was calculated. Graphs represent
rescue by each construct averaged over three independent experiments. In Figures 2.3 and
2.11, an initial repeated measures analysis of variance was performed on the matched
sets, followed by Dunnett’s multiple comparison test to compare rescue by each mutant
to rescue by wild-type OCA2. In Figure 2.3, a two-tailed t test was used to compare
rescue by OCA2-HMGCR and OCA2-HMGCR-AATA. To quantify overlap of OCA2
dileucine mutants with pigment or with Tyrp1, deconvolved paired images were rendered
binary in ImageJ by density slicing and the total area of overlap between them was
calculated for objects containing more than 5 pixels, excluding the densely labeled
perinuclear area. Seven to 10 cell profiles were quantified for each pairwise comparison.
To compare colocalization with pigment, a one-way analysis of variance was performed
on the unmatched sets, followed by Bonferroni's multiple comparison test. To compare
the colocalization of OCA2-AA23 or OCA2-AA23 E96D with Tyrp1, an unpaired twotailed t test was performed. All statistical analyses were performed using GraphPad Prism
(GraphPad Software, San Diego, CA).

170

REFERENCES
Ancans, J., Hoogduijn, M.J., and Thody, A.J. (2001a). Melanosomal pH, pink locus
protein and their roles in melanogenesis. J Invest Dermatol 117, 158-159.
Ancans, J., and Thody, A.J. (2000). Activation of melanogenesis by vacuolar type H(+)ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma
cells. FEBS Lett 478, 57-60.
Ancans, J., Tobin, D.J., Hoogduijn, M.J., Smit, N.P., Wakamatsu, K., and Thody, A.J.
(2001b). Melanosomal pH controls rate of melanogenesis,
eumelanin/phaeomelanin ratio and melanosome maturation in melanocytes and
melanoma cells. Exp Cell Res 268, 26-35.
Anderson, P.D., Huizing, M., Claassen, D.A., White, J., and Gahl, W.A. (2003).
Hermansky-Pudlak syndrome type 4 (HPS-4): clinical and molecular
characteristics. Hum Genet 113, 10-17.
Aroca, P., Garcia-Borron, J.C., Solano, F., and Lozano, J.A. (1990). Regulation of
mammalian melanogenesis. I: Partial purification and characterization of a
dopachrome converting factor: dopachrome tautomerase. Biochimica et
biophysica acta 1035, 266-275.
Barber, J.I., Townsend, D., Olds, D.P., and King, R.A. (1985). Decreased dopachrome
oxidoreductase activity in yellow mice. J Hered 76, 59-60.
Basrur, V., Yang, F., Kushimoto, T., Higashimoto, Y., Yasumoto, K., Valencia, J.,
Muller, J., Vieira, W.D., Watabe, H., Shabanowitz, J., Hearing, V.J., Hunt, D.F.,
and Appella, E. (2003). Proteomic analysis of early melanosomes: identification
of novel melanosomal proteins. Journal of proteome research 2, 69-79.
Beermann, F., Orlow, S.J., Boissy, R.E., Schmidt, A., Boissy, Y.L., and Lamoreux, M.L.
(1995). Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of
the murine platinum (cp) mutation. Exp Eye Res 61, 599-607.
Berson, J.F., Frank, D.W., Calvo, P.A., Bieler, B.M., and Marks, M.S. (2000). A
common temperature-sensitive allelic form of human tyrosinase is retained in the
endoplasmic reticulum at the nonpermissive temperature. J Biol Chem 275,
12281-12289.
Berson, J.F., Harper, D.C., Tenza, D., Raposo, G., and Marks, M.S. (2001). Pmel17
initiates premelanosome morphogenesis within multivesicular bodies. Mol Biol
Cell 12, 3451-3464.
Berson, J.F., Theos, A.C., Harper, D.C., Tenza, D., Raposo, G., and Marks, M.S. (2003).
Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident
glycoprotein to initiate melanosome biogenesis. J Cell Biol 161, 521-533.
Bhatnagar, V., Anjaiah, S., Puri, N., Darshanam, B.N., and Ramaiah, A. (1993). pH of
melanosomes of B 16 murine melanoma is acidic: its physiological importance in
the regulation of melanin biosynthesis. Arch Biochem Biophys 307, 183-192.
Bhatnagar, V., and Ramalah, A. (1998). Characterization of Mg2+-ATPase activity in
isolated B16 murine melanoma melanosomes. Molecular and cellular
biochemistry 189, 99-106.
Birbeck, M.S. (1963). Electron microscopy of melanocytes: The fine structure of hairbulb premelanosomes. Ann N Y Acad Sci 100, 540-547.
171

Blagoveshchenskaya, A.D., Hewitt, E.W., and Cutler, D.F. (1999). Di-leucine signals
mediate targeting of tyrosinase and synaptotagmin to synaptic-like microvesicles
within PC12 cells. Mol Biol Cell 10, 3979-3990.
Blasius, A.L., Arnold, C.N., Georgel, P., Rutschmann, S., Xia, Y., Lin, P., Ross, C., Li,
X., Smart, N.G., and Beutler, B. (2010). Slc15a4, AP-3, and Hermansky-Pudlak
syndrome proteins are required for Toll-like receptor signaling in plasmacytoid
dendritic cells. Proc Natl Acad Sci U S A 107, 19973-19978.
Boehm, M., and Bonifacino, J.S. (2001). Adaptins: the final recount. Mol Biol Cell 12,
2907-2920.
Boissy, R.E. (1988). The melanocyte. Its structure, function, and subpopulations in skin,
eyes, and hair. Dermatologic clinics 6, 161-173.
Boissy, R.E., Richmond, B., Huizing, M., Helip-Wooley, A., Zhao, Y., Koshoffer, A.,
and Gahl, W.A. (2005). Melanocyte-specific proteins are aberrantly trafficked in
melanocytes of Hermansky-Pudlak syndrome-type 3. Am J Pathol 166, 231-240.
Boissy, R.E., Zhao, H., Oetting, W.S., Austin, L.M., Wildenberg, S.C., Boissy, Y.L.,
Zhao, Y., Sturm, R.A., Hearing, V.J., King, R.A., and Nordlund, J.J. (1996).
Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in
melanocytes from an individual with brown oculocutaneous albinism: a new
subtype of albinism classified as "OCA3". Am J Hum Genet 58, 1145-1156.
Bonifacino, J.S., and Traub, L.M. (2003). Signals for sorting of transmembrane proteins
to endosomes and lysosomes. Annu Rev Biochem 72, 395-447.
Borner, G.H., Harbour, M., Hester, S., Lilley, K.S., and Robinson, M.S. (2006).
Comparative proteomics of clathrin-coated vesicles. J Cell Biol 175, 571-578.
Bothwell, J.E. (1997). Pigmented skin lesions in tyrosinase-positive oculocutaneous
albinos: a study in black South Africans. International journal of dermatology 36,
831-836.
Bouchard, B., Fuller, B.B., Vijayasaradhi, S., and Houghton, A.N. (1989a). Induction of
pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. The
Journal of experimental medicine 169, 2029-2042.
Bouchard, B., Fuller, B.B., Vijayasaradhi, S., and Houghton, A.N. (1989b). Induction of
pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J.
Exp. Med. 169, 2029-2042.
Braasch, I., Schartl, M., and Volff, J.N. (2007). Evolution of pigment synthesis pathways
by gene and genome duplication in fish. BMC evolutionary biology 7, 74.
Branicki, W., Brudnik, U., Draus-Barini, J., Kupiec, T., and Wojas-Pelc, A. (2008).
Association of the SLC45A2 gene with physiological human hair colour
variation. Journal of human genetics 53, 966-971.
Branicki, W., Brudnik, U., and Wojas-Pelc, A. (2009). Interactions between HERC2,
OCA2 and MC1R may influence human pigmentation phenotype. Annals of
human genetics 73, 160-170.
Bresnahan, P.A., Yonemoto, W., Ferrell, S., Williams-Herman, D., Geleziunas, R., and
Greene, W.C. (1998). A dileucine motif in HIV-1 Nef acts as an internalization
signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 8,
1235-1238.
172

Brett, C.L., Plemel, R.L., Lobinger, B.T., Vignali, M., Fields, S., and Merz, A.J. (2008).
Efficient termination of vacuolar Rab GTPase signaling requires coordinated
action by a GAP and a protein kinase. J Cell Biol 182, 1141-1151.
Brilliant, M., and Gardner, J. (2001). Melanosomal pH, pink locus protein and their roles
in melanogenesis. J Invest Dermatol 117, 386-387.
Brilliant, M.H. (2001). The mouse p (pink-eyed dilution) and human P genes,
oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res
14, 86-93.
Bultman, S.J., Michaud, E.J., and Woychik, R.P. (1992). Molecular characterization of
the mouse agouti locus. Cell 71, 1195-1204.
Burkhardt, J.K., Hester, S., Lapham, C.K., and Argon, Y. (1990). The lytic granules of
natural killer cells are dual-function organelles combining secretory and prelysosomal compartments. J Cell Biol 111, 2327-2340.
Calvo, P.A., Frank, D.W., Bieler, B.M., Berson, J.F., and Marks, M.S. (1999). A
cytoplasmic sequence in human tyrosinase defines a second class of di-leucinebased sorting signals for late endosomal and lysosomal delivery. J Biol Chem
274, 12780-12789.
Caplan, S., Hartnell, L.M., Aguilar, R.C., Naslavsky, N., and Bonifacino, J.S. (2001).
Human Vam6p promotes lysosome clustering and fusion in vivo. J Cell Biol 154,
109-122.
Chapuy, B., Tikkanen, R., Muhlhausen, C., Wenzel, D., von Figura, K., and Honing, S.
(2008). AP-1 and AP-3 mediate sorting of melanosomal and lysosomal membrane
proteins into distinct post-Golgi trafficking pathways. Traffic 9, 1157-1172.
Chaudhuri, R., Lindwasser, O.W., Smith, W.J., Hurley, J.H., and Bonifacino, J.S. (2007).
Downregulation of CD4 by human immunodeficiency virus type 1 Nef is
dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin
adaptor. J Virol 81, 3877-3890.
Chaudhuri, R., Mattera, R., Lindwasser, O.W., Robinson, M.S., and Bonifacino, J.S.
(2009). A basic patch on alpha-adaptin is required for binding of human
immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2
complex. J Virol 83, 2518-2530.
Cheli, V.T., and Dell'Angelica, E.C. (2010). Early origin of genes encoding subunits of
biogenesis of lysosome-related organelles complex-1, -2 and -3. Traffic 11, 579586.
Chen, K., Manga, P., and Orlow, S.J. (2002). Pink-eyed dilution protein controls the
processing of tyrosinase. Mol Biol Cell 13, 1953-1964.
Chen, K., Minwalla, L., Ni, L., and Orlow, S.J. (2004). Correction of defective early
tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution
melanocytes. Pigment Cell Res 17, 36-42.
Chi, A., Valencia, J.C., Hu, Z.Z., Watabe, H., Yamaguchi, H., Mangini, N.J., Huang, H.,
Canfield, V.A., Cheng, K.C., Yang, F., Abe, R., Yamagishi, S., Shabanowitz, J.,
Hearing, V.J., Wu, C., Appella, E., and Hunt, D.F. (2006). Proteomic and
bioinformatic characterization of the biogenesis and function of melanosomes.
Journal of proteome research 5, 3135-3144.
173

Chintala, S., Li, W., Lamoreux, M.L., Ito, S., Wakamatsu, K., Sviderskaya, E.V.,
Bennett, D.C., Park, Y.M., Gahl, W.A., Huizing, M., Spritz, R.A., Ben, S.,
Novak, E.K., Tan, J., and Swank, R.T. (2005). Slc7a11 gene controls production
of pheomelanin pigment and proliferation of cultured cells. Proc Natl Acad Sci U
S A 102, 10964-10969.
Claas, M.J., Timmermans, A., and Bruinse, H.W. (2010). Case report: a black and white
twin. J Perinatol 30, 434-436.
Clark, R., and Griffiths, G.M. (2003). Lytic granules, secretory lysosomes and disease.
Current opinion in immunology 15, 516-521.
Cone, R.D., Lu, D., Koppula, S., Vage, D.I., Klungland, H., Boston, B., Chen, W., Orth,
D.N., Pouton, C., and Kesterson, R.A. (1996). The melanocortin receptors:
agonists, antagonists, and the hormonal control of pigmentation. Recent progress
in hormone research 51, 287-317; discussion 318.
Cortese, K., Giordano, F., Surace, E.M., Venturi, C., Ballabio, A., Tacchetti, C., and
Marigo, V. (2005). The ocular albinism type 1 (OA1) gene controls melanosome
maturation and size. Investigative ophthalmology & visual science 46, 4358-4364.
Costin, G.E., Valencia, J.C., Vieira, W.D., Lamoreux, M.L., and Hearing, V.J. (2003).
Tyrosinase processing and intracellular trafficking is disrupted in mouse primary
melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous
albinism (OCA) type 4. J Cell Sci 116, 3203-3212.
Cuomo, M., Nicotra, M.R., Apollonj, C., Fraioli, R., Giacomini, P., and Natali, P.G.
(1991). Production and characterization of the murine monoclonal antibody 2G10
to a human T4-tyrosinase epitope. J Invest Dermatol 96, 446-451.
d'Addio, M., Pizzigoni, A., Bassi, M.T., Baschirotto, C., Valetti, C., Incerti, B., Clementi,
M., De Luca, M., Ballabio, A., and Schiaffino, M.V. (2000). Defective
intracellular transport and processing of OA1 is a major cause of ocular albinism
type 1. Hum Mol Genet 9, 3011-3018.
Darnell, R.B., Furneaux, H.M., and Posner, J.B. (1991). Antiserum from a patient with
cerebellar degeneration identifies a novel protein in Purkinje cells, cortical
neurons, and neuroectodermal tumors. J Neurosci 11, 1224-1230.
Darsow, T., Burd, C.G., and Emr, S.D. (1998). Acidic di-leucine motif essential for AP3-dependent sorting and restriction of the functional specificity of the Vam3p
vacuolar t-SNARE. J Cell Biol 142, 913-922.
Dautry-Varsat, A., Ciechanover, A., and Lodish, H.F. (1983). pH and the recycling of
transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A 80,
2258-2262.
Delevoye, C., Hurbain, I., Tenza, D., Sibarita, J.B., Uzan-Gafsou, S., Ohno, H., Geerts,
W.J., Verkleij, A.J., Salamero, J., Marks, M.S., and Raposo, G. (2009). AP-1 and
KIF13A coordinate endosomal sorting and positioning during melanosome
biogenesis. J Cell Biol 187, 247-264.
Dell'Angelica, E.C. (2004). The building BLOC(k)s of lysosomes and related organelles.
Current opinion in cell biology 16, 458-464.
Dell'Angelica, E.C., Mullins, C., and Bonifacino, J.S. (1999). AP-4, a novel protein
complex related to clathrin adaptors. J Biol Chem 274, 7278-7285.
174

Dell'Angelica, E.C., Mullins, C., Caplan, S., and Bonifacino, J.S. (2000). Lysosomerelated organelles. Faseb J 14, 1265-1278.
Detter, J.C., Zhang, Q., Mules, E.H., Novak, E.K., Mishra, V.S., Li, W., McMurtrie,
E.B., Tchernev, V.T., Wallace, M.R., Seabra, M.C., Swank, R.T., and Kingsmore,
S.F. (2000). Rab geranylgeranyl transferase alpha mutation in the gunmetal
mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci U S A
97, 4144-4149.
Devi, C.C., Tripathi, R.K., and Ramaiah, A. (1987). pH-dependent interconvertible
allosteric forms of murine melanoma tyrosinase. Physiological implications. Eur J
Biochem 166, 705-711.
Di Palma, F., Belyantseva, I.A., Kim, H.J., Vogt, T.F., Kachar, B., and Noben-Trauth, K.
(2002). Mutations in Mcoln3 associated with deafness and pigmentation defects
in varitint-waddler (Va) mice. Proc Natl Acad Sci U S A 99, 14994-14999.
Di Pietro, S.M., and Dell'Angelica, E.C. (2005). The cell biology of Hermansky-Pudlak
syndrome: recent advances. Traffic 6, 525-533.
Di Pietro, S.M., Falcon-Perez, J.M., Tenza, D., Setty, S.R., Marks, M.S., Raposo, G., and
Dell'Angelica, E.C. (2006). BLOC-1 interacts with BLOC-2 and the AP-3
complex to facilitate protein trafficking on endosomes. Mol Biol Cell 17, 40274038.
Donatien, P.D., and Orlow, S.J. (1995). Interaction of melanosomal proteins with
melanin. Eur J Biochem 232, 159-164.
Doray, B., Knisely, J.M., Wartman, L., Bu, G., and Kornfeld, S. (2008). Identification of
acidic dileucine signals in LRP9 that interact with both GGAs and AP-1/AP-2.
Traffic 9, 1551-1562.
Doray, B., Lee, I., Knisely, J., Bu, G., and Kornfeld, S. (2007). The gamma/sigma1 and
alpha/sigma2 hemicomplexes of clathrin adaptors AP-1 and AP-2 harbor the
dileucine recognition site. Mol Biol Cell 18, 1887-1896.
Drake, M.T., Zhu, Y., and Kornfeld, S. (2000). The assembly of AP-3 adaptor complexcontaining clathrin-coated vesicles on synthetic liposomes. Mol Biol Cell 11,
3723-3736.
Durham-Pierre, D., Gardner, J.M., Nakatsu, Y., King, R.A., Francke, U., Ching, A.,
Aquaron, R., del Marmol, V., and Brilliant, M.H. (1994). African origin of an
intragenic deletion of the human P gene in tyrosinase positive oculocutaneous
albinism. Nat Genet 7, 176-179.
Eiberg, H., Troelsen, J., Nielsen, M., Mikkelsen, A., Mengel-From, J., Kjaer, K.W., and
Hansen, L. (2008). Blue eye color in humans may be caused by a perfectly
associated founder mutation in a regulatory element located within the HERC2
gene inhibiting OCA2 expression. Hum Genet 123, 177-187.
Falcon-Perez, J.M., Nazarian, R., Sabatti, C., and Dell'Angelica, E.C. (2005).
Distribution and dynamics of Lamp1-containing endocytic organelles in
fibroblasts deficient in BLOC-3. J Cell Sci 118, 5243-5255.
Falcon-Perez, J.M., Romero-Calderon, R., Brooks, E.S., Krantz, D.E., and Dell'Angelica,
E.C. (2007). The Drosophila pigmentation gene pink (p) encodes a homologue of
human Hermansky-Pudlak syndrome 5 (HPS5). Traffic 8, 154-168.
175

Faundez, V., Horng, J.T., and Kelly, R.B. (1998). A function for the AP3 coat complex in
synaptic vesicle formation from endosomes. Cell 93, 423-432.
Feng, L., Novak, E.K., Hartnell, L.M., Bonifacino, J.S., Collinson, L.M., and Swank,
R.T. (2002). The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes
independently contribute to the production and function of platelet dense
granules, melanosomes, and lysosomes. Blood 99, 1651-1658.
Feng, L., Seymour, A.B., Jiang, S., To, A., Peden, A.A., Novak, E.K., Zhen, L., Rusiniak,
M.E., Eicher, E.M., Robinson, M.S., Gorin, M.B., and Swank, R.T. (1999). The
beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse
hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and
night blindness. Hum Mol Genet 8, 323-330.
Fontana, S., Parolini, S., Vermi, W., Booth, S., Gallo, F., Donini, M., Benassi, M.,
Gentili, F., Ferrari, D., Notarangelo, L.D., Cavadini, P., Marcenaro, E., Dusi, S.,
Cassatella, M., Facchetti, F., Griffiths, G.M., Moretta, A., Notarangelo, L.D., and
Badolato, R. (2006). Innate immunity defects in Hermansky-Pudlak type 2
syndrome. Blood 107, 4857-4864.
Fujita, H., Sasano, E., Yasunaga, K., Furuta, K., Yokota, S., Wada, I., and Himeno, M.
(2001). Evidence for distinct membrane traffic pathways to melanosomes and
lysosomes in melanocytes. The journal of investigative dermatology. Symposium
proceedings / the Society for Investigative Dermatology, Inc 6, 19-24.
Fukamachi, S., Asakawa, S., Wakamatsu, Y., Shimizu, N., Mitani, H., and Shima, A.
(2004). Conserved function of medaka pink-eyed dilution in melanin synthesis
and its divergent transcriptional regulation in gonads among vertebrates. Genetics
168, 1519-1527.
Fukamachi, S., Shimada, A., and Shima, A. (2001). Mutations in the gene encoding B, a
novel transporter protein, reduce melanin content in medaka. Nat Genet 28, 381385.
Fuller, B.B., Spaulding, D.T., and Smith, D.R. (2001). Regulation of the catalytic activity
of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures.
Exp Cell Res 262, 197-208.
Gahl, W.A., Potterf, B., Durham-Pierre, D., Brilliant, M.H., and Hearing, V.J. (1995).
Melanosomal tyrosine transport in normal and pink-eyed dilution murine
melanocytes. Pigment Cell Res 8, 229-233.
Gaidarov, I., and Keen, J.H. (1999). Phosphoinositide-AP-2 interactions required for
targeting to plasma membrane clathrin-coated pits. J Cell Biol 146, 755-764.
Gardner, J.M., Nakatsu, Y., Gondo, Y., Lee, S., Lyon, M.F., King, R.A., and Brilliant,
M.H. (1992). The mouse pink-eyed dilution gene: association with human PraderWilli and Angelman syndromes. Science 257, 1121-1124.
Gardner, J.M., Wildenberg, S.C., Keiper, N.M., Novak, E.K., Rusiniak, M.E., Swank,
R.T., Puri, N., Finger, J.N., Hagiwara, N., Lehman, A.L., Gales, T.L., Bayer,
M.E., King, R.A., and Brilliant, M.H. (1997). The mouse pale ear (ep) mutation is
the homologue of human Hermansky-Pudlak syndrome. Proc Natl Acad Sci U S
A 94, 9238-9243.
Gautam, R., Chintala, S., Li, W., Zhang, Q., Tan, J., Novak, E.K., Di Pietro, S.M.,
Dell'Angelica, E.C., and Swank, R.T. (2004). The Hermansky-Pudlak syndrome 3
176

(cocoa) protein is a component of the biogenesis of lysosome-related organelles
complex-2 (BLOC-2). J Biol Chem 279, 12935-12942.
Gautam, R., Novak, E.K., Tan, J., Wakamatsu, K., Ito, S., and Swank, R.T. (2006).
Interaction of Hermansky-Pudlak Syndrome genes in the regulation of lysosomerelated organelles. Traffic 7, 779-792.
Geisler, C., Dietrich, J., Nielsen, B.L., Kastrup, J., Lauritsen, J.P., Odum, N., and
Christensen, M.D. (1998). Leucine-based receptor sorting motifs are dependent
on the spacing relative to the plasma membrane. J Biol Chem 273, 21316-21323.
Geschwind, II. (1966). Change in hair color in mice induced by injection of alpha-MSH.
Endocrinology 79, 1165-1167.
Ghiani, C.A., Starcevic, M., Rodriguez-Fernandez, I.A., Nazarian, R., Cheli, V.T., Chan,
L.N., Malvar, J.S., de Vellis, J., Sabatti, C., and Dell'Angelica, E.C. (2010). The
dysbindin-containing complex (BLOC-1) in brain: developmental regulation,
interaction with SNARE proteins and role in neurite outgrowth. Molecular
psychiatry 15, 115, 204-115.
Ginger, R.S., Askew, S.E., Ogborne, R.M., Wilson, S., Ferdinando, D., Dadd, T., Smith,
A.M., Kazi, S., Szerencsei, R.T., Winkfein, R.J., Schnetkamp, P.P., and Green,
M.R. (2008). SLC24A5 Encodes a trans-Golgi Network Protein with Potassiumdependent Sodium-Calcium Exchange Activity That Regulates Human Epidermal
Melanogenesis. J Biol Chem 283, 5486-5495.
Giordano, F., Bonetti, C., Surace, E.M., Marigo, V., and Raposo, G. (2009). The ocular
albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at
early stages of melanogenesis to control melanosome identity and composition.
Hum Mol Genet 18, 4530-4545.
Graf, J., Voisey, J., Hughes, I., and van Daal, A. (2007). Promoter polymorphisms in the
MATP (SLC45A2) gene are associated with normal human skin color variation.
Hum Mutat 28, 710-717.
Granger, B.L., Green, S.A., Gabel, C.A., Howe, C.L., Mellman, I., and Helenius, A.
(1990). Characterization and cloning of lgp110, a lysosomal membrane
glycoprotein from mouse and rat cells. J Biol Chem 265, 12036-12043.
Griffiths, G. (2002). What's special about secretory lysosomes? Seminars in cell &
developmental biology 13, 279-284.
Groux-Degroote, S., van Dijk, S.M., Wolthoorn, J., Neumann, S., Theos, A.C., De
Maziere, A.M., Klumperman, J., van Meer, G., and Sprong, H. (2008).
Glycolipid-dependent sorting of melanosomal from lysosomal membrane proteins
by lumenal determinants. Traffic 9, 951-963.
Gruneberg, H. (1952). The Genetics of the Mouse. Nijhoff: The Hague.
Guillery, R.W., Okoro, A.N., and Witkop, C.J., Jr. (1975). Abnormal visual pathways in
the brain of a human albino. Brain research 96, 373-377.
Gurkan, C., Lapp, H., Alory, C., Su, A.I., Hogenesch, J.B., and Balch, W.E. (2005).
Large-scale profiling of Rab GTPase trafficking networks: the membrome. Mol
Biol Cell 16, 3847-3864.
Guttentag, S.H., Akhtar, A., Tao, J.Q., Atochina, E., Rusiniak, M.E., Swank, R.T., and
Bates, S.R. (2005). Defective surfactant secretion in a mouse model of
177

Hermansky-Pudlak syndrome. American journal of respiratory cell and molecular
biology 33, 14-21.
Halaban, R., Patton, R.S., Cheng, E., Svedine, S., Trombetta, E.S., Wahl, M.L., Ariyan,
S., and Hebert, D.N. (2002). Abnormal acidification of melanoma cells induces
tyrosinase retention in the early secretory pathway. J Biol Chem 277, 1482114828.
Hayes, M.J., Bryon, K., Satkurunathan, J., and Levine, T.P. (2011). Yeast homologues of
three BLOC-1 subunits highlight KxDL proteins as conserved interactors of
BLOC-1. Traffic 12, 260-268.
Hearing, V.J. (2005). Biogenesis of pigment granules: a sensitive way to regulate
melanocyte function. Journal of dermatological science 37, 3-14.
Helip-Wooley, A., Westbroek, W., Dorward, H.M., Koshoffer, A., Huizing, M., Boissy,
R.E., and Gahl, W.A. (2007). Improper trafficking of melanocyte-specific
proteins in Hermansky-Pudlak syndrome type-5. J Invest Dermatol 127, 14711478.
Hermann, G.J., Schroeder, L.K., Hieb, C.A., Kershner, A.M., Rabbitts, B.M., Fonarev,
P., Grant, B.D., and Priess, J.R. (2005). Genetic analysis of lysosomal trafficking
in Caenorhabditis elegans. Mol Biol Cell 16, 3273-3288.
Hickey, C.M., Stroupe, C., and Wickner, W. (2009). The major role of the Rab Ypt7p in
vacuole fusion is supporting HOPS membrane association. J Biol Chem 284,
16118-16125.
Higuchi, R., Krummel, B., and Saiki, R.K. (1988). A general method of in vitro
preparation and specific mutagenesis of DNA fragments: study of protein and
DNA interactions. Nucleic Acids Res 16, 7351-7367.
Hirobe, T., Ito, S., and Wakamatsu, K. (2011). The mouse pink-eyed dilution allele of the
P-gene greatly inhibits eumelanin but not pheomelanin synthesis. Pigment cell &
melanoma research 24, 241-246.
Hoashi, T., Muller, J., Vieira, W.D., Rouzaud, F., Kikuchi, K., Tamaki, K., and Hearing,
V.J. (2006). The repeat domain of the melanosomal matrix protein
PMEL17/GP100 is required for the formation of organellar fibers. J Biol Chem
281, 21198-21208.
Hoashi, T., Watabe, H., Muller, J., Yamaguchi, Y., Vieira, W.D., and Hearing, V.J.
(2005). MART-1 is required for the function of the melanosomal matrix protein
PMEL17/GP100 and the maturation of melanosomes. J Biol Chem 280, 1400614016.
Honing, S., Sandoval, I.V., and von Figura, K. (1998). A di-leucine-based motif in the
cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3.
Embo J 17, 1304-1314.
Hopkins, C.R., and Trowbridge, I.S. (1983). Internalization and processing of transferrin
and the transferrin receptor in human carcinoma A431 cells. J Cell Biol 97, 508521.
Hoyle, D.J., Rodriguez-Fernandez, I.A., and Dell'angelica, E.C. (2011). Functional
interactions between OCA2 and the protein complexes BLOC-1, BLOC-2, and
AP-3 inferred from epistatic analyses of mouse coat pigmentation. Pigment cell &
melanoma research 24, 275-281.
178

Huang, L., Kuo, Y.M., and Gitschier, J. (1999). The pallid gene encodes a novel,
syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nat
Genet 23, 329-332.
Huizing, M., Helip-Wooley, A., Westbroek, W., Gunay-Aygun, M., and Gahl, W.A.
(2008). Disorders of lysosome-related organelle biogenesis: clinical and
molecular genetics. Annual review of genomics and human genetics 9, 359-386.
Huizing, M., Pederson, B., Hess, R.A., Griffin, A., Helip-Wooley, A., Westbroek, W.,
Dorward, H., O'Brien, K.J., Golas, G., Tsilou, E., White, J.G., and Gahl, W.A.
(2009). Clinical and cellular characterisation of Hermansky-Pudlak syndrome
type 6. Journal of medical genetics 46, 803-810.
Huizing, M., Sarangarajan, R., Strovel, E., Zhao, Y., Gahl, W.A., and Boissy, R.E.
(2001). AP-3 mediates tyrosinase but not TRP-1 trafficking in human
melanocytes. Mol Biol Cell 12, 2075-2085.
Hume, A.N., Collinson, L.M., Hopkins, C.R., Strom, M., Barral, D.C., Bossi, G.,
Griffiths, G.M., and Seabra, M.C. (2002). The leaden gene product is required
with Rab27a to recruit myosin Va to melanosomes in melanocytes. Traffic 3, 193202.
Hunt, D.M., and Johnson, D.R. (1971). Abnormal spermiogenesis in two pink-eyed
sterile mutants in the mouse. Journal of embryology and experimental
morphology 26, 111-121.
Hurbain, I., Geerts, W.J., Boudier, T., Marco, S., Verkleij, A.J., Marks, M.S., and
Raposo, G. (2008). Electron tomography of early melanosomes: implications for
melanogenesis and the generation of fibrillar amyloid sheets. Proc Natl Acad Sci
U S A 105, 19726-19731.
Hutton, S.M., and Spritz, R.A. (2008). Comprehensive analysis of oculocutaneous
albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent
OCA type. J Invest Dermatol 128, 2442-2450.
Ilardi, J.M., Mochida, S., and Sheng, Z.H. (1999). Snapin: a SNARE-associated protein
implicated in synaptic transmission. Nature neuroscience 2, 119-124.
Inagaki, K., Suzuki, T., Ito, S., Suzuki, N., Fukai, K., Horiuchi, T., Tanaka, T., Manabe,
E., and Tomita, Y. (2005). OCA4: evidence for a founder effect for the p.D157N
mutation of the MATP gene in Japanese and Korean. Pigment Cell Res 18, 385388.
Inagaki, K., Suzuki, T., Shimizu, H., Ishii, N., Umezawa, Y., Tada, J., Kikuchi, N.,
Takata, M., Takamori, K., Kishibe, M., Tanaka, M., Miyamura, Y., Ito, S., and
Tomita, Y. (2004). Oculocutaneous albinism type 4 is one of the most common
types of albinism in Japan. Am J Hum Genet 74, 466-471.
Iozumi, K., Hoganson, G.E., Pennella, R., Everett, M.A., and Fuller, B.B. (1993). Role of
tyrosinase as the determinant of pigmentation in cultured human melanocytes. J
Invest Dermatol 100, 806-811.
Jackson, I.J. (1988). A cDNA encoding tyrosinase-related protein maps to the brown
locus in mouse. Proc Natl Acad Sci U S A 85, 4392-4396.
Jackson, I.J., Chambers, D.M., Tsukamoto, K., Copeland, N.G., Gilbert, D.J., Jenkins,
N.A., and Hearing, V. (1992). A second tyrosinase-related protein, TRP-2, maps
to and is mutated at the mouse slaty locus. Embo J 11, 527-535.
179

Jackson, M.R., Nilsson, T., and Peterson, P.A. (1990). Identification of a consensus motif
for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J.
9, 3153-3162.
Janvier, K., Kato, Y., Boehm, M., Rose, J.R., Martina, J.A., Kim, B.Y., Venkatesan, S.,
and Bonifacino, J.S. (2003). Recognition of dileucine-based sorting signals from
HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3
hemicomplexes. J Cell Biol 163, 1281-1290.
Johanson, H.C., Chen, W., Wicking, C., and Sturm, R.A. (2010). Inheritance of a novel
mutated allele of the OCA2 gene associated with high incidence of
oculocutaneous albinism in a Polynesian community. Journal of human genetics
55, 103-111.
Kantheti, P., Qiao, X., Diaz, M.E., Peden, A.A., Meyer, G.E., Carskadon, S.L.,
Kapfhamer, D., Sufalko, D., Robinson, M.S., Noebels, J.L., and Burmeister, M.
(1998). Mutation in AP-3 delta in the mocha mouse links endosomal transport to
storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 21,
111-122.
Kelly, B.T., McCoy, A.J., Spate, K., Miller, S.E., Evans, P.R., Honing, S., and Owen,
D.J. (2008). A structural explanation for the binding of endocytic dileucine motifs
by the AP2 complex. Nature 456, 976-979.
Kim, B.Y., Kramer, H., Yamamoto, A., Kominami, E., Kohsaka, S., and Akazawa, C.
(2001). Molecular characterization of mammalian homologues of class C Vps
proteins that interact with syntaxin-7. J Biol Chem 276, 29393-29402.
King, R.A. (1998). Albinism. In: The Pigmentary System: Physiology and
Pathophysiology., eds. J.J. Nordlund, R.E. Boissy, V.J. Hearing, R.A. King, and
J.-P. Ortonne, New York: Oxford University Press, 553-575.
King, R.A., Willaert, R.K., Schmidt, R.M., Pietsch, J., Savage, S., Brott, M.J., Fryer, J.P.,
Summers, C.G., and Oetting, W.S. (2003). MC1R mutations modify the classic
phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet 73, 638645.
Kobayashi, T., Vieira, W.D., Potterf, B., Sakai, C., Imokawa, G., and Hearing, V.J.
(1995). Modulation of melanogenic protein expression during the switch from euto pheomelanogenesis. J Cell Sci 108 ( Pt 6), 2301-2309.
Kongsvik, T.L., Honing, S., Bakke, O., and Rodionov, D.G. (2002). Mechanism of
interaction between leucine-based sorting signals from the invariant chain and
clathrin-associated adaptor protein complexes AP1 and AP2. J Biol Chem 277,
16484-16488.
Kromberg, J.G., Castle, D.J., Zwane, E.M., Bothwell, J., Kidson, S., Bartel, P., Phillips,
J.I., and Jenkins, T. (1990). Red or rufous albinism in southern Africa.
Ophthalmic paediatrics and genetics 11, 229-235.
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., and Gruters, A. (1998).
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused
by POMC mutations in humans. Nat Genet 19, 155-157.
Kugelman, T.P., and Van Scott, E.J. (1961). Tyrosinase activity in melanocytes of human
albinos. J Invest Dermatol 37, 73-76.
180

Kwon, H.Y., Bultman, S.J., Loffler, C., Chen, W.J., Furdon, P.J., Powell, J.G., Usala,
A.L., Wilkison, W., Hansmann, I., and Woychik, R.P. (1994). Molecular structure
and chromosomal mapping of the human homolog of the agouti gene. Proc Natl
Acad Sci U S A 91, 9760-9764.
Lamason, R.L., Mohideen, M.A., Mest, J.R., Wong, A.C., Norton, H.L., Aros, M.C.,
Jurynec, M.J., Mao, X., Humphreville, V.R., Humbert, J.E., Sinha, S., Moore,
J.L., Jagadeeswaran, P., Zhao, W., Ning, G., Makalowska, I., McKeigue, P.M.,
O'Donnell, D., Kittles, R., Parra, E.J., Mangini, N.J., Grunwald, D.J., Shriver,
M.D., Canfield, V.A., and Cheng, K.C. (2005). SLC24A5, a putative cation
exchanger, affects pigmentation in zebrafish and humans. Science 310, 17821786.
Lamoreux, M.L., Woolley, C., and Pendergast, P. (1986). Genetic controls over activities
of tyrosinase and dopachrome conversion factor in murine melanocytes. Genetics
113, 967-984.
Lamoreux, M.L., Zhou, B.K., Rosemblat, S., and Orlow, S.J. (1995). The pinkeyeddilution protein and the eumelanin/pheomelanin switch: in support of a unifying
hypothesis. Pigment Cell Res 8, 263-270.
Lane, P.W., and Deol, M.S. (1974). Mocha, a new coat color and behavior mutation on
chromosome 10 of the mouse. J Hered 65, 362-364.
Lao, O., de Gruijter, J.M., van Duijn, K., Navarro, A., and Kayser, M. (2007). Signatures
of positive selection in genes associated with human skin pigmentation as
revealed from analyses of single nucleotide polymorphisms. Annals of human
genetics 71, 354-369.
Lee, S.T., Nicholls, R.D., Jong, M.T., Fukai, K., and Spritz, R.A. (1995). Organization
and sequence of the human P gene and identification of a new family of transport
proteins. Genomics 26, 354-363.
Lee, Z.H., Hou, L., Moellmann, G., Kuklinska, E., Antol, K., Fraser, M., Halaban, R.,
and Kwon, B.S. (1996). Characterization and subcellular localization of human
Pmel 17/silver, a 110-kDa (pre)melanosomal membrane protein associated with
5,6,-dihydroxyindole-2-carboxylic acid (DHICA) converting activity. J Invest
Dermatol 106, 605-610.
Lehman, A.L., Silvers, W.K., Puri, N., Wakamatsu, K., Ito, S., and Brilliant, M.H.
(2000). The underwhite (uw) locus acts autonomously and reduces the production
of melanin. J Invest Dermatol 115, 601-606.
Lelouvier, B., and Puertollano, R. (2011). Mucolipin-3 regulates luminal calcium,
acidification, and membrane fusion in the endosomal pathway. J Biol Chem 286,
9826-9832.
Lepage, S., and Lapointe, R. (2006). Melanosomal targeting sequences from gp100 are
essential for MHC class II-restricted endogenous epitope presentation and
mobilization to endosomal compartments. Cancer research 66, 2423-2432.
Letourneur, F., and Klausner, R.D. (1992). A novel di-leucine motif and a tyrosine-based
motif independently mediate lysosomal targeting and endocytosis of CD3 chains.
Cell 69, 1143-1157.

181

Levinson, B., Vulpe, C., Elder, B., Martin, C., Verley, F., Packman, S., and Gitschier, J.
(1994). The mottled gene is the mouse homologue of the Menkes disease gene.
Nat Genet 6, 369-373.
Levy, F., Muehlethaler, K., Salvi, S., Peitrequin, A.L., Lindholm, C.K., Cerottini, J.C.,
and Rimoldi, D. (2005). Ubiquitylation of a melanosomal protein by HECT-E3
ligases serves as sorting signal for lysosomal degradation. Mol Biol Cell 16,
1777-1787.
Li, W., Rusiniak, M.E., Chintala, S., Gautam, R., Novak, E.K., and Swank, R.T. (2004).
Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related
organelles. Bioessays 26, 616-628.
Lloyd, V., Ramaswami, M., and Kramer, H. (1998). Not just pretty eyes: Drosophila eyecolour mutations and lysosomal delivery. Trends in cell biology 8, 257-259.
Loftus, S.K., Larson, D.M., Baxter, L.L., Antonellis, A., Chen, Y., Wu, X., Jiang, Y.,
Bittner, M., Hammer, J.A., 3rd, and Pavan, W.J. (2002). Mutation of melanosome
protein RAB38 in chocolate mice. Proc Natl Acad Sci U S A 99, 4471-4476.
Lu, D., Willard, D., Patel, I.R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W.,
Woychik, R.P., Wilkison, W.O., and et al. (1994). Agouti protein is an antagonist
of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802.
Lutsenko, S., Barnes, N.L., Bartee, M.Y., and Dmitriev, O.Y. (2007). Function and
regulation of human copper-transporting ATPases. Physiological reviews 87,
1011-1046.
Lyon, M.F., King, T.R., Gondo, Y., Gardner, J.M., Nakatsu, Y., Eicher, E.M., and
Brilliant, M.H. (1992). Genetic and molecular analysis of recessive alleles at the
pink-eyed dilution (p) locus of the mouse. Proc Natl Acad Sci U S A 89, 69686972.
Manga, P., Boissy, R.E., Pifko-Hirst, S., Zhou, B.-K., and Orlow, S.J. (2001).
Mislocalization of Melanosomal Proteins in Melanocytes from Mice with
Oculocutaneous Albinism Type 2. Experimental Eye Research 72, 695-710.
Manga, P., Kromberg, J.G., Box, N.F., Sturm, R.A., Jenkins, T., and Ramsay, M. (1997).
Rufous oculocutaneous albinism in southern African Blacks is caused by
mutations in the TYRP1 gene. Am J Hum Genet 61, 1095-1101.
Manga, P., and Orlow, S.J. (2001). Inverse correlation between pink-eyed dilution protein
expression and induction of melanogenesis by bafilomycin A1. Pigment Cell Res
14, 362-367.
Marks, M.S., and Seabra, M.C. (2001). The melanosome: membrane dynamics in black
and white. Nat Rev Mol Cell Biol 2, 738-748.
Marks, M.S., Woodruff, L., Ohno, H., and Bonifacino, J.S. (1996). Protein targeting by
tyrosine- and di-leucine-based signals: evidence for distinct saturable
components. J Cell Biol 135, 341-354.
Menasche, G., Ho, C.H., Sanal, O., Feldmann, J., Tezcan, I., Ersoy, F., Houdusse, A.,
Fischer, A., and de Saint Basile, G. (2003). Griscelli syndrome restricted to
hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon
deletion (GS1). The Journal of clinical investigation 112, 450-456.
Menasche, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S., Wulffraat, N.,
Bianchi, D., Fischer, A., Le Deist, F., and de Saint Basile, G. (2000). Mutations in
182

RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome.
Nat Genet 25, 173-176.
Mengel-From, J., Borsting, C., Sanchez, J.J., Eiberg, H., and Morling, N. (2010). Human
eye colour and HERC2, OCA2 and MATP. Forensic science international 4, 323328.
Meyer, C., Zizioli, D., Lausmann, S., Eskelinen, E.L., Hamann, J., Saftig, P., von Figura,
K., and Schu, P. (2000). mu1A-adaptin-deficient mice: lethality, loss of AP-1
binding and rerouting of mannose 6-phosphate receptors. Embo J 19, 2193-2203.
Moriyama, K., and Bonifacino, J.S. (2002). Pallidin is a component of a multi-protein
complex involved in the biogenesis of lysosome-related organelles. Traffic 3,
666-677.
Mullins, C., Hartnell, L.M., and Bonifacino, J.S. (2000). Distinct requirements for the
AP-3 adaptor complex in pigment granule and synaptic vesicle biogenesis in
Drosophila melanogaster. Mol Gen Genet 263, 1003-1014.
Mullins, C., Hartnell, L.M., Wassarman, D.A., and Bonifacino, J.S. (1999). Defective
expression of the mu3 subunit of the AP-3 adaptor complex in the Drosophila
pigmentation mutant carmine. Mol Gen Genet 262, 401-412.
Naeyaert, J.M., Eller, M., Gordon, P.R., Park, H.Y., and Gilchrest, B.A. (1991). Pigment
content of cultured human melanocytes does not correlate with tyrosinase
message level. The British journal of dermatology 125, 297-303.
Nazarian, R., Huizing, M., Helip-Wooley, A., Starcevic, M., Gahl, W.A., and
Dell'Angelica, E.C. (2008). An immunoblotting assay to facilitate the molecular
diagnosis of Hermansky-Pudlak syndrome. Molecular genetics and metabolism
93, 134-144.
Newell-Litwa, K., Salazar, G., Smith, Y., and Faundez, V. (2009). Roles of BLOC-1 and
adaptor protein-3 complexes in cargo sorting to synaptic vesicles. Mol Biol Cell
20, 1441-1453.
Newman, L.S., McKeever, M.O., Okano, H.J., and Darnell, R.B. (1995). Beta-NAP, a
cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell 82,
773-783.
Newton, J.M., Cohen-Barak, O., Hagiwara, N., Gardner, J.M., Davisson, M.T., King,
R.A., and Brilliant, M.H. (2001). Mutations in the human orthologue of the mouse
underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.
Am J Hum Genet 69, 981-988.
Nguyen, T., Novak, E.K., Kermani, M., Fluhr, J., Peters, L.L., Swank, R.T., and Wei,
M.L. (2002). Melanosome morphologies in murine models of hermansky-pudlak
syndrome reflect blocks in organelle development. J Invest Dermatol 119, 11561164.
Nguyen, T., and Wei, M.L. (2004). Characterization of melanosomes in murine
Hermansky-Pudlak syndrome: mechanisms of hypopigmentation. J Invest
Dermatol 122, 452-460.
Nguyen, T., and Wei, M.L. (2007). Hermansky-Pudlak HPS1/pale ear gene regulates
epidermal and dermal melanocyte development. J Invest Dermatol 127, 421-428.
Ni-Komatsu, L., and Orlow, S.J. (2006). Heterologous expression of tyrosinase
recapitulates the misprocessing and mistrafficking in oculocutaneous albinism
183

type 2: effects of altering intracellular pH and pink-eyed dilution gene expression.
Exp Eye Res 82, 519-528.
Noebels, J.L., and Sidman, R.L. (1989). Persistent hypersynchronization of neocortical
neurons in the mocha mutant of mouse. Journal of neurogenetics 6, 53-56.
Norton, H.L., Kittles, R.A., Parra, E., McKeigue, P., Mao, X., Cheng, K., Canfield, V.A.,
Bradley, D.G., McEvoy, B., and Shriver, M.D. (2007). Genetic evidence for the
convergent evolution of light skin in Europeans and East Asians. Molecular
biology and evolution 24, 710-722.
O'Donnell, F.E., Jr., Hambrick, G.W., Jr., Green, W.R., Iliff, W.J., and Stone, D.L.
(1976). X-linked ocular albinism. An oculocutaneous macromelanosomal
disorder. Archives of ophthalmology 94, 1883-1892.
Oetting, W.S., Fryer, J.P., Shriram, S., and King, R.A. (2003). Oculocutaneous albinism
type 1: the last 100 years. Pigment Cell Res 16, 307-311.
Oetting, W.S., Gardner, J.M., Fryer, J.P., Ching, A., Durham-Pierre, D., King, R.A., and
Brilliant, M.H. (1998). Mutations of the human P gene associated with Type II
oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online. Hum Mutat
12, 434.
Oikawa, A., Saeki, H., Akiyama, T., and Matsumoto, J. (1987). Electron microscopic
evidence for stimulation of melanosomal maturation by lysosomotropic agents
and monensin in cultured B16 mouse melanoma cells. Pigment Cell Res 1, 44-50.
Ooi, C.E., Moreira, J.E., Dell'Angelica, E.C., Poy, G., Wassarman, D.A., and Bonifacino,
J.S. (1997). Altered expression of a novel adaptin leads to defective pigment
granule biogenesis in the Drosophila eye color mutant garnet. Embo J 16, 45084518.
Orlow, S.J., Osber, M.P., and Pawelek, J.M. (1992). Synthesis and characterization of
melanins from dihydroxyindole-2-carboxylic acid and dihydroxyindole. Pigment
Cell Res 5, 113-121.
Orlowski, J., and Grinstein, S. (1997). Na+/H+ exchangers of mammalian cells. J Biol
Chem 272, 22373-22376.
Panessa, B.J., and Zadunaisky, J.A. (1981). Pigment granules: a calcium reservoir in the
vertebrate eye. Exp Eye Res 32, 593-604.
Pastural, E., Barrat, F.J., Dufourcq-Lagelouse, R., Certain, S., Sanal, O., Jabado, N.,
Seger, R., Griscelli, C., Fischer, A., and de Saint Basile, G. (1997). Griscelli
disease maps to chromosome 15q21 and is associated with mutations in the
myosin-Va gene. Nat Genet 16, 289-292.
Pawelek, J.M. (1991). After dopachrome? Pigment Cell Res 4, 53-62.
Peden, A.A., Oorschot, V., Hesser, B.A., Austin, C.D., Scheller, R.H., and Klumperman,
J. (2004). Localization of the AP-3 adaptor complex defines a novel endosomal
exit site for lysosomal membrane proteins. J Cell Biol 164, 1065-1076.
Peden, A.A., Rudge, R.E., Lui, W.W., and Robinson, M.S. (2002). Assembly and
function of AP-3 complexes in cells expressing mutant subunits. J Cell Biol 156,
327-336.
Peng, G., Taylor, J.D., and Tchen, T.T. (1994). Goldfish tyrosinase related protein I
(TRP-1): deduced amino acid sequence from cDNA and comments on structural
features. Pigment Cell Res 7, 9-16.
184

Peters, C., and Mayer, A. (1998). Ca2+/calmodulin signals the completion of docking
and triggers a late step of vacuole fusion. Nature 396, 575-580.
Peters, P.J., Borst, J., Oorschot, V., Fukuda, M., Krahenbuhl, O., Tschopp, J., Slot, J.W.,
and Geuze, H.J. (1991). Cytotoxic T lymphocyte granules are secretory
lysosomes, containing both perforin and granzymes. The Journal of experimental
medicine 173, 1099-1109.
Pevsner, J., Volknandt, W., Wong, B.R., and Scheller, R.H. (1994). Two rat homologs of
clathrin-associated adaptor proteins. Gene 146, 279-283.
Piccirillo, R., Palmisano, I., Innamorati, G., Bagnato, P., Altimare, D., and Schiaffino,
M.V. (2006). An unconventional dileucine-based motif and a novel cytosolic
motif are required for the lysosomal and melanosomal targeting of OA1. J Cell
Sci.
Pond, L., Kuhn, L.A., Teyton, L., Schutze, M.P., Tainer, J.A., Jackson, M.R., and
Peterson, P.A. (1995). A role for acidic residues in di-leucine motif-based
targeting to the endocytic pathway. J Biol Chem 270, 19989-19997.
Potterf, S.B., Furumura, M., Sviderskaya, E.V., Santis, C., Bennett, D.C., and Hearing,
V.J. (1998). Normal tyrosine transport and abnormal tyrosinase routing in pinkeyed dilution melanocytes. Exp Cell Res 244, 319-326.
Poupon, V., Stewart, A., Gray, S.R., Piper, R.C., and Luzio, J.P. (2003). The role of
mVps18p in clustering, fusion, and intracellular localization of late endocytic
organelles. Mol Biol Cell 14, 4015-4027.
Protas, M.E., Hersey, C., Kochanek, D., Zhou, Y., Wilkens, H., Jeffery, W.R., Zon, L.I.,
Borowsky, R., and Tabin, C.J. (2006). Genetic analysis of cavefish reveals
molecular convergence in the evolution of albinism. Nat Genet 38, 107-111.
Pryor, P.R., Mullock, B.M., Bright, N.A., Gray, S.R., and Luzio, J.P. (2000). The role of
intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the
reformation of lysosomes from hybrid organelles. J Cell Biol 149, 1053-1062.
Pulipparacharuvil, S., Akbar, M.A., Ray, S., Sevrioukov, E.A., Haberman, A.S., Rohrer,
J., and Kramer, H. (2005). Drosophila Vps16A is required for trafficking to
lysosomes and biogenesis of pigment granules. J Cell Sci 118, 3663-3673.
Puri, N., Gardner, J.M., and Brilliant, M.H. (2000). Aberrant pH of melanosomes in pinkeyed dilution (p) mutant melanocytes. J Invest Dermatol 115, 607-613.
Raposo, G., and Marks, M.S. (2002). The dark side of lysosome-related organelles:
specialization of the endocytic pathway for melanosome biogenesis. Traffic 3,
237-248.
Raposo, G., and Marks, M.S. (2007). Melanosomes--dark organelles enlighten endosomal
membrane transport. Nat Rev Mol Cell Biol 8, 786-797.
Raposo, G., Marks, M.S., and Cutler, D.F. (2007). Lysosome-related organelles: driving
post-Golgi compartments into specialisation. Current opinion in cell biology 19,
394-401.
Raposo, G., Tenza, D., Murphy, D.M., Berson, J.F., and Marks, M.S. (2001). Distinct
protein sorting and localization to premelanosomes, melanosomes, and lysosomes
in pigmented melanocytic cells. J Cell Biol 152, 809-824.
Raymond, C.K., Howald-Stevenson, I., Vater, C.A., and Stevens, T.H. (1992).
Morphological classification of the yeast vacuolar protein sorting mutants:
185

evidence for a prevacuolar compartment in class E vps mutants. Mol Biol Cell 3,
1389-1402.
Richardson, S.C., Winistorfer, S.C., Poupon, V., Luzio, J.P., and Piper, R.C. (2004).
Mammalian late vacuole protein sorting orthologues participate in early
endosomal fusion and interact with the cytoskeleton. Mol Biol Cell 15, 11971210.
Richmond, B., Huizing, M., Knapp, J., Koshoffer, A., Zhao, Y., Gahl, W.A., and Boissy,
R.E. (2005). Melanocytes derived from patients with Hermansky-Pudlak
Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking. J Invest
Dermatol 124, 420-427.
Rinchik, E.M., Bultman, S.J., Horsthemke, B., Lee, S.T., Strunk, K.M., Spritz, R.A.,
Avidano, K.M., Jong, M.T., and Nicholls, R.D. (1993). A gene for the mouse
pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature
361, 72-76.
Robbins, L.S., Nadeau, J.H., Johnson, K.R., Kelly, M.A., Roselli-Rehfuss, L., Baack, E.,
Mountjoy, K.G., and Cone, R.D. (1993). Pigmentation phenotypes of variant
extension locus alleles result from point mutations that alter MSH receptor
function. Cell 72, 827-834.
Robila, V., Ostankovitch, M., Altrich-Vanlith, M.L., Theos, A.C., Drover, S., Marks,
M.S., Restifo, N., and Engelhard, V.H. (2008). MHC class II presentation of
gp100 epitopes in melanoma cells requires the function of conventional
endosomes and is influenced by melanosomes. J Immunol 181, 7843-7852.
Robinson, M.S. (2004). Adaptable adaptors for coated vesicles. Trends in cell biology 14,
167-174.
Rohrer, J., Schweizer, A., Russell, D., and Kornfeld, S. (1996). The targeting of Lamp1
to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting
motif relative to the membrane. J Cell Biol 132, 565-576.
Rosemblat, S., Durham-Pierre, D., Gardner, J.M., Nakatsu, Y., Brilliant, M.H., and
Orlow, S.J. (1994). Identification of a melanosomal membrane protein encoded
by the pink-eyed dilution (type II oculocutaneous albinism) gene. Proc Natl Acad
Sci U S A 91, 12071-12075.
Rosemblat, S., Sviderskaya, E.V., Easty, D.J., Wilson, A., Kwon, B.S., Bennett, D.C.,
and Orlow, S.J. (1998). Melanosomal defects in melanocytes from mice lacking
expression of the pink-eyed dilution gene: correction by culture in the presence of
excess tyrosine. Exp Cell Res 239, 344-352.
Saeki, H., and Oikawa, A. (1983). Stimulation of tyrosinase activity of cultured
melanoma cells by lysosomotropic agents. J Cell Physiol 116, 93-97.
Salazar, G., Craige, B., Styers, M.L., Newell-Litwa, K.A., Doucette, M.M., Wainer, B.H.,
Falcon-Perez, J.M., Dell'Angelica, E.C., Peden, A.A., Werner, E., and Faundez,
V. (2006). BLOC-1 complex deficiency alters the targeting of adaptor protein
complex-3 cargoes. Mol Biol Cell 17, 4014-4026.
Salazar, G., Zlatic, S., Craige, B., Peden, A.A., Pohl, J., and Faundez, V. (2009).
Hermansky-Pudlak syndrome protein complexes associate with
phosphatidylinositol 4-kinase type II alpha in neuronal and non-neuronal cells. J
Biol Chem 284, 1790-1802.
186

Salceda, R., and Sanchez-Chavez, G. (2000). Calcium uptake, release and ryanodine
binding in melanosomes from retinal pigment epithelium. Cell Calcium 27, 223229.
Sandoval, I.V., Martinez-Arca, S., Valdueza, J., Palacios, S., and Holman, G.D. (2000).
Distinct reading of different structural determinants modulates the dileucinemediated transport steps of the lysosomal membrane protein LIMPII and the
insulin-sensitive glucose transporter GLUT4. J Biol Chem 275, 39874-39885.
Sarangarajan, R., and Boissy, R.E. (2001). Tyrp1 and oculocutaneous albinism type 3.
Pigment Cell Res 14, 437-444.
Sarangarajan, R., Shumaker, H., Soleimani, M., Le Poole, C., and Boissy, R.E. (2001).
Molecular and functional characterization of sodium--hydrogen exchanger in skin
as well as cultured keratinocytes and melanocytes. Biochimica et biophysica acta
1511, 181-192.
Sasai, M., Linehan, M.M., and Iwasaki, A. (2010). Bifurcation of Toll-like receptor 9
signaling by adaptor protein 3. Science 329, 1530-1534.
Schiaffino, M.V., d'Addio, M., Alloni, A., Baschirotto, C., Valetti, C., Cortese, K., Puri,
C., Bassi, M.T., Colla, C., De Luca, M., Tacchetti, C., and Ballabio, A. (1999).
Ocular albinism: evidence for a defect in an intracellular signal transduction
system. Nat Genet 23, 108-112.
Schutze, M.P., Peterson, P.A., and Jackson, M.R. (1994). An N-terminal double-arginine
motif maintains type II membrane proteins in the endoplasmic reticulum. Embo J
13, 1696-1705.
Seabra, M.C., Mules, E.H., and Hume, A.N. (2002). Rab GTPases, intracellular traffic
and disease. Trends in molecular medicine 8, 23-30.
Seiji, M., Fitzpatrick, T.B., Simpson, R.T., and Birbeck, M.S. (1963). Chemical
composition and terminology of specialized organelles (melanosomes and
melanin granules) in mammalian melanocytes. Nature 197, 1082-1084.
Setty, S.R., Tenza, D., Sviderskaya, E.V., Bennett, D.C., Raposo, G., and Marks, M.S.
(2008). Cell-specific ATP7A transport sustains copper-dependent tyrosinase
activity in melanosomes. Nature 454, 1142-1146.
Setty, S.R., Tenza, D., Truschel, S.T., Chou, E., Sviderskaya, E.V., Theos, A.C.,
Lamoreux, M.L., Di Pietro, S.M., Starcevic, M., Bennett, D.C., Dell'Angelica,
E.C., Raposo, G., and Marks, M.S. (2007). BLOC-1 is required for cargo-specific
sorting from vacuolar early endosomes toward lysosome-related organelles. Mol
Biol Cell 18, 768-780.
Sevrioukov, E.A., He, J.P., Moghrabi, N., Sunio, A., and Kramer, H. (1999). A role for
the deep orange and carnation eye color genes in lysosomal delivery in
Drosophila. Mol Cell 4, 479-486.
Shriver, M.D., Parra, E.J., Dios, S., Bonilla, C., Norton, H., Jovel, C., Pfaff, C., Jones, C.,
Massac, A., Cameron, N., Baron, A., Jackson, T., Argyropoulos, G., Jin, L.,
Hoggart, C.J., McKeigue, P.M., and Kittles, R.A. (2003). Skin pigmentation,
biogeographical ancestry and admixture mapping. Hum Genet 112, 387-399.
Sidman, R.L., Pearlstein, R., and Waymouth, C. (1965). Pink-eyed dilution (p) gene in
rodents: increased pigmentation in tissue culture. Dev Biol 12, 93-116.
187

Silvers, W.K. (1979). The Coat Colors of Mice: A Model for Mammalian Gene Action
and Interaction. Springer.
Simmen, T., Schmidt, A., Hunziker, W., and Beermann, F. (1999). The tyrosinase tail
mediates sorting to the lysosomal compartment in MDCK cells via a di-leucine
and a tyrosine-based signal. J Cell Sci 112 ( Pt 1), 45-53.
Simpson, F., Peden, A.A., Christopoulou, L., and Robinson, M.S. (1997).
Characterization of the adaptor-related protein complex, AP-3. J Cell Biol 137,
835-845.
Sitaram, A., Piccirillo, R., Palmisano, I., Harper, D.C., Dell'Angelica, E.C., Schiaffino,
M.V., and Marks, M.S. (2009). Localization to mature melanosomes by virtue of
cytoplasmic dileucine motifs is required for human OCA2 function. Mol Biol Cell
20, 1464-1477.
Smith, D.R., Spaulding, D.T., Glenn, H.M., and Fuller, B.B. (2004). The relationship
between Na(+)/H(+) exchanger expression and tyrosinase activity in human
melanocytes. Exp Cell Res 298, 521-534.
Sprong, H., Degroote, S., Claessens, T., van Drunen, J., Oorschot, V., Westerink, B.H.,
Hirabayashi, Y., Klumperman, J., van der Sluijs, P., and van Meer, G. (2001).
Glycosphingolipids are required for sorting melanosomal proteins in the Golgi
complex. J Cell Biol 155, 369-380.
Sriram, V., Krishnan, K.S., and Mayor, S. (2003). deep-orange and carnation define
distinct stages in late endosomal biogenesis in Drosophila melanogaster. J Cell
Biol 161, 593-607.
Staleva, L., Manga, P., and Orlow, S.J. (2002). Pink-eyed dilution protein modulates
arsenic sensitivity and intracellular glutathione metabolism. Mol Biol Cell 13,
4206-4220.
Starcevic, M., and Dell'Angelica, E.C. (2004). Identification of snapin and three novel
proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of
biogenesis of lysosome-related organelles complex-1 (BLOC-1). J Biol Chem
279, 28393-28401.
Staricco, R.J., and Pinkus, H. (1957). Quantitative and qualitative data on the pigment
cells of adult human epidermis. J Invest Dermatol 28, 33-45.
Stroupe, C., Collins, K.M., Fratti, R.A., and Wickner, W. (2006). Purification of active
HOPS complex reveals its affinities for phosphoinositides and the SNARE
Vam7p. Embo J 25, 1579-1589.
Sturm, R.A. (2006). A golden age of human pigmentation genetics. Trends Genet 22,
464-468.
Sturm, R.A., Duffy, D.L., Zhao, Z.Z., Leite, F.P., Stark, M.S., Hayward, N.K., Martin,
N.G., and Montgomery, G.W. (2008). A single SNP in an evolutionary conserved
region within intron 86 of the HERC2 gene determines human blue-brown eye
color. Am J Hum Genet 82, 424-431.
Sulem, P., Gudbjartsson, D.F., Stacey, S.N., Helgason, A., Rafnar, T., Magnusson, K.P.,
Manolescu, A., Karason, A., Palsson, A., Thorleifsson, G., Jakobsdottir, M.,
Steinberg, S., Palsson, S., Jonasson, F., Sigurgeirsson, B., Thorisdottir, K.,
Ragnarsson, R., Benediktsdottir, K.R., Aben, K.K., Kiemeney, L.A., Olafsson,
J.H., Gulcher, J., Kong, A., Thorsteinsdottir, U., and Stefansson, K. (2007).
188

Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet
39, 1443-1452.
Summers, C.G. (2009). Albinism: classification, clinical characteristics, and recent
findings. Optom Vis Sci 86, 659-662.
Suzuki, T., Li, W., Zhang, Q., Karim, A., Novak, E.K., Sviderskaya, E.V., Hill, S.P.,
Bennett, D.C., Levin, A.V., Nieuwenhuis, H.K., Fong, C.T., Castellan, C.,
Miterski, B., Swank, R.T., and Spritz, R.A. (2002). Hermansky-Pudlak syndrome
is caused by mutations in HPS4, the human homolog of the mouse light-ear gene.
Nat Genet 30, 321-324.
Sviderskaya, E.V., Bennett, D.C., Ho, L., Bailin, T., Lee, S.T., and Spritz, R.A. (1997).
Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse
melanocytes by normal human P cDNA, and defective complementation by
OCA2 mutant sequences. J Invest Dermatol 108, 30-34.
Sviderskaya, E.V., Hill, S.P., Evans-Whipp, T.J., Chin, L., Orlow, S.J., Easty, D.J.,
Cheong, S.C., Beach, D., DePinho, R.A., and Bennett, D.C. (2002). p16(Ink4a) in
melanocyte senescence and differentiation. J Natl Cancer Inst 94, 446-454.
Swank, R.T., Reddington, M., Howlett, O., and Novak, E.K. (1991). Platelet storage pool
deficiency associated with inherited abnormalities of the inner ear in the mouse
pigment mutants muted and mocha. Blood 78, 2036-2044.
Swank, R.T., Reddington, M., and Novak, E.K. (1996). Inherited prolonged bleeding
time and platelet storage pool deficiency in the subtle gray (sut) mouse.
Laboratory animal science 46, 56-60.
Szabo, G., Gerald, A.B., Pathak, M.A., and Fitzpatrick, T.B. (1969). Racial differences in
the fate of melanosomes in human epidermis. Nature 222, 1081-1082.
Tabata, H., Kawamura, N., Sun-Wada, G.H., and Wada, Y. (2008). Vacuolar-type H(+)ATPase with the a3 isoform is the proton pump on premature melanosomes. Cell
and tissue research 332, 447-460.
Tamate, H.B., and Takeuchi, T. (1984). Action of the e locus of mice in the response of
phaeomelanic hair follicles to alpha-melanocyte-stimulating hormone in vitro.
Science 224, 1241-1242.
Theos, A.C., Berson, J.F., Theos, S.C., Herman, K.E., Harper, D.C., Tenza, D.,
Sviderskaya, E.V., Lamoreux, M.L., Bennett, D.C., Raposo, G., and Marks, M.S.
(2006a). Dual loss of ER export and endocytic signals with altered melanosome
morphology in the silver mutation of Pmel17. Mol Biol Cell 17, 3598-3612.
Theos, A.C., Tenza, D., Martina, J.A., Hurbain, I., Peden, A.A., Sviderskaya, E.V.,
Stewart, A., Robinson, M.S., Bennett, D.C., Cutler, D.F., Bonifacino, J.S., Marks,
M.S., and Raposo, G. (2005). Functions of adaptor protein (AP)-3 and AP-1 in
tyrosinase sorting from endosomes to melanosomes. Mol Biol Cell 16, 53565372.
Theos, A.C., Truschel, S.T., Tenza, D., Hurbain, I., Harper, D.C., Berson, J.F., Thomas,
P.C., Raposo, G., and Marks, M.S. (2006b). A lumenal domain-dependent
pathway for sorting to intralumenal vesicles of multivesicular endosomes
involved in organelle morphogenesis. Dev Cell 10, 343-354.
Thody, A.J., and Burchill, S.A. (1992). Tyrosinase and the regulation of coat color
changes in C3H-HeAvy mice. Pigment Cell Res 5, 335-339.
189

Toda, K., Pathak, M.A., Parrish, J.A., Fitzpatrick, T.B., and Quevedo, W.C., Jr. (1972).
Alteration of racial differences in melanosome distribution in human epidermis
after exposure to ultraviolet light. Nature: New biology 236, 143-145.
Townsend, D., Guillery, P., and King, R.A. (1984). Optimized assay for mammalian
tyrosinase (polyhydroxyl phenyloxidase). Analytical Biochemistry 139, 345-352.
Toyofuku, K., Valencia, J.C., Kushimoto, T., Costin, G.E., Virador, V.M., Vieira, W.D.,
Ferrans, V.J., and Hearing, V.J. (2002). The etiology of oculocutaneous albinism
(OCA) type II: the pink protein modulates the processing and transport of
tyrosinase. Pigment Cell Res 15, 217-224.
Tripathi, R.K., Chaya Devi, C., and Ramaiah, A. (1988). pH-dependent interconversion
of two forms of tyrosinase in human skin. Biochem J 252, 481-487.
Truschel, S.T., Simoes, S., Setty, S.R., Harper, D.C., Tenza, D., Thomas, P.C., Herman,
K.E., Sackett, S.D., Cowan, D.C., Theos, A.C., Raposo, G., and Marks, M.S.
(2009). ESCRT-I function is required for Tyrp1 transport from early endosomes
to the melanosome limiting membrane. Traffic 10, 1318-1336.
Tsukamoto, K., Jackson, I.J., Urabe, K., Montague, P.M., and Hearing, V.J. (1992). A
second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed
DOPAchrome tautomerase. Embo J 11, 519-526.
Tumer, Z., and Moller, L.B. (2010). Menkes disease. Eur J Hum Genet 18, 511-518.
Ungermann, C., Wickner, W., and Xu, Z. (1999). Vacuole acidification is required for
trans-SNARE pairing, LMA1 release, and homotypic fusion. Proc Natl Acad Sci
U S A 96, 11194-11199.
Valverde, P., Healy, E., Jackson, I., Rees, J.L., and Thody, A.J. (1995). Variants of the
melanocyte-stimulating hormone receptor gene are associated with red hair and
fair skin in humans. Nat Genet 11, 328-330.
Van Den Bossche, K., Naeyaert, J.M., and Lambert, J. (2006). The quest for the
mechanism of melanin transfer. Traffic 7, 769-778.
Vijayasaradhi, S., Xu, Y., Bouchard, B., and Houghton, A.N. (1995). Intracellular sorting
and targeting of melanosomal membrane proteins: identification of signals for
sorting of the human brown locus protein, gp75. J Cell Biol 130, 807-820.
Vites, O., Rhee, J.S., Schwarz, M., Rosenmund, C., and Jahn, R. (2004). Reinvestigation
of the role of snapin in neurotransmitter release. J Biol Chem 279, 26251-26256.
Vogel, P., Read, R.W., Vance, R.B., Platt, K.A., Troughton, K., and Rice, D.S. (2008).
Ocular albinism and hypopigmentation defects in Slc24a5-/- mice. Veterinary
pathology 45, 264-279.
Wang, N., and Hebert, D.N. (2006). Tyrosinase maturation through the mammalian
secretory pathway: bringing color to life. Pigment Cell Res 19, 3-18.
Wasmeier, C., Romao, M., Plowright, L., Bennett, D.C., Raposo, G., and Seabra, M.C.
(2006). Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes.
J Cell Biol 175, 271-281.
Watt, B., van Niel, G., Fowler, D.M., Hurbain, I., Luk, K.C., Stayrook, S.E., Lemmon,
M.A., Raposo, G., Shorter, J., Kelly, J.W., and Marks, M.S. (2009). N-terminal
domains elicit formation of functional Pmel17 amyloid fibrils. J Biol Chem 284,
35543-35555.
190

Wei, M.L. (2006). Hermansky-Pudlak syndrome: a disease of protein trafficking and
organelle function. Pigment Cell Res 19, 19-42.
White, S., Hatton, S.R., Siddiqui, M.A., Parker, C.D., Trowbridge, I.S., and Collawn, J.F.
(1998). Analysis of the structural requirements for lysosomal membrane targeting
using transferrin receptor chimeras. J Biol Chem 273, 14355-14362.
Wilson, B.D., Ollmann, M.M., Kang, L., Stoffel, M., Bell, G.I., and Barsh, G.S. (1995).
Structure and function of ASP, the human homolog of the mouse agouti gene.
Hum Mol Genet 4, 223-230.
Winder, A.J., Wittbjer, A., Rosengren, E., and Rorsman, H. (1993). The mouse brown (b)
locus protein has dopachrome tautomerase activity and is located in lysosomes in
transfected fibroblasts. J Cell Sci 106 ( Pt 1), 153-166.
Witkop, C.J., Jr., Hill, C.W., Desnick, S., Thies, J.K., Thorn, H.L., Jenkins, M., and
White, J.G. (1973). Ophthalmologic, biochemical, platelet, and ultrastructural
defects in the various types of oculocutaneous albinism. J Invest Dermatol 60,
443-456.
Witkop, J., Carl J. (1985). Inherited disorders of pigmentation. Clinics in Dermatology 3,
70-134.
Wu, X., Rao, K., Bowers, M.B., Copeland, N.G., Jenkins, N.A., and Hammer, J.A., 3rd.
(2001). Rab27a enables myosin Va-dependent melanosome capture by recruiting
the myosin to the organelle. J Cell Sci 114, 1091-1100.
Wurmser, A.E., Sato, T.K., and Emr, S.D. (2000). New component of the vacuolar class
C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNAREdependent docking and fusion. J Cell Biol 151, 551-562.
Yang, W., Li, C., Ward, D.M., Kaplan, J., and Mansour, S.L. (2000). Defective
organellar membrane protein trafficking in Ap3b1-deficient cells. J Cell Sci 113 (
Pt 22), 4077-4086.
Yi, Z., Garrison, N., Cohen-Barak, O., Karafet, T.M., King, R.A., Erickson, R.P.,
Hammer, M.F., and Brilliant, M.H. (2003). A 122.5-kilobase deletion of the P
gene underlies the high prevalence of oculocutaneous albinism type 2 in the
Navajo population. Am J Hum Genet 72, 62-72.
Zhang, Q., Zhao, B., Li, W., Oiso, N., Novak, E.K., Rusiniak, M.E., Gautam, R.,
Chintala, S., O'Brien, E.P., Zhang, Y., Roe, B.A., Elliott, R.W., Eicher, E.M.,
Liang, P., Kratz, C., Legius, E., Spritz, R.A., O'Sullivan, T.N., Copeland, N.G.,
Jenkins, N.A., and Swank, R.T. (2003). Ru2 and Ru encode mouse orthologs of
the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6. Nat
Genet 33, 145-153.
Zhen, L., Jiang, S., Feng, L., Bright, N.A., Peden, A.A., Seymour, A.B., Novak, E.K.,
Elliott, R., Gorin, M.B., Robinson, M.S., and Swank, R.T. (1999). Abnormal
expression and subcellular distribution of subunit proteins of the AP-3 adaptor
complex lead to platelet storage pool deficiency in the pearl mouse. Blood 94,
146-155.
Zhu, Y., Drake, M.T., and Kornfeld, S. (1999). ADP-ribosylation factor 1 dependent
clathrin-coat assembly on synthetic liposomes. Proc Natl Acad Sci U S A 96,
5013-5018.
191

Zizioli, D., Meyer, C., Guhde, G., Saftig, P., von Figura, K., and Schu, P. (1999). Early
embryonic death of mice deficient in gamma-adaptin. J Biol Chem 274, 53855390.

192

